EP歐洲藥典標(biāo)準(zhǔn)品

簡要描述：EP歐洲藥典標(biāo)準(zhǔn)品

產(chǎn)品型號：
廠商性質(zhì)：生產(chǎn)廠家
更新時間：2024-08-07
訪問量：16419

產(chǎn)品分類

試劑/標(biāo)準(zhǔn)品/對照品

重金屬標(biāo)準(zhǔn)品/有色金屬 EP標(biāo)準(zhǔn)品 USP標(biāo)準(zhǔn)品 Lumiprobe活性染料和化和物多糖/單糖類化合物標(biāo)準(zhǔn)品查看全部產(chǎn)品

相關(guān)文章

詳細(xì)介紹

	Order Code	Reference Standard	Batch n°	Quantity per vial	Sale Unit	Information	Monograph	Leaflet	Storage
	Y0001561	Abacavir sulfate	1	20 mg	1		2589	Yes	+5°C ± 3°C
	Y0001552	Abacavir for peak identification	1	10 mg	1		2589	Yes	+5°C ± 3°C
	Y0001551	Abacavir for system suitability	1	10 mg	1		2589	Yes	+5°C ± 3°C
	Y0000055	Acamprosate calcium - reference spectrum	1	n/a	1		1585
	Y0000116	Acamprosate impurity A	2	110 mg	1	3-aminopropane-1-sulfonic acid (homotaurine) ; Batch 1 is valid until 31 January 2017	1585	Yes	+5°C ± 3°C
	Y0000500	Acarbose	3	100 mg	1	See leaflet	2089	Yes	+5°C ± 3°C
	Y0000354	Acarbose for identification	1	10 mg	1		2089	Yes	+5°C ± 3°C
	Y0000427	Acarbose for peak identification	4	20 mg	1	Batch 3 is valid until 31 May 2017	2089	Yes	+5°C ± 3°C
	A0040000	Acebutolol hydrochloride	1	50 mg	1		0871	Yes	+5°C ± 3°C
	Y0000359	Acebutolol impurity B	2	10 mg	1	N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy] phenyl]acetamide (diacetolol)	0871	Yes	+5°C ± 3°C
	Y0000127	Acebutolol impurity C	1	20 mg	1	N-(3-acetyl-4-hydroxyphenyl)but*	0871	Yes	+5°C ± 3°C
	Y0000128	Acebutolol impurity I	2	0.004 mg	1	N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]but*	0871	Yes	+5°C ± 3°C
	Y0000056	Aceclofenac - reference spectrum	1	n/a	1		1281
	Y0000085	Aceclofenac impurity F	2	15 mg	1	benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (benzyl ester of aceclofenac)	1281	Yes	+5°C ± 3°C
	Y0000086	Aceclofenac impurity H	1	10 mg	1	[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy] acetic acid (diacetic aceclofenac)	1281	Yes	+5°C ± 3°C
	Y0001094	Aceclofenac for peak identification	1	10 mg	1		1281	Yes	+5°C ± 3°C
New	Y0001915	Aceclofenac impurity I	1	15 mg	1		1281	Yes	+5°C ± 3°C
	Y0000810	Acemetacin	1	100 mg	1		1686	Yes	+5°C ± 3°C
	Y0000811	Acemetacin impurity A	1	10 mg	1	4-chlorobenzoic acid	1686	Yes	+5°C ± 3°C
	Y0000842	Acemetacin impurity mixture	1	0.06 mg	1		1686	Yes	+5°C ± 3°C
	A0070000	Acesulfame potassium	2	50 mg	1		1282	Yes	+5°C ± 3°C
	A0070020	Acesulfame potassium impurity B	4	15 mg	1	see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3§)-one 2,2-dioxide	1282	Yes	+5°C ± 3°C
	A0100000	Acetazolamide	1	100 mg	1		0454	Yes	+5°C ± 3°C
	Y0001084	Acetazolamide for system suitability	2	0.0068 mg	1		0454	Yes	+5°C ± 3°C
	Y0000002	Acetylcholine chloride	1	50 mg	1		1485.1971	Yes	-20°C ± 5°C
	A0150000	Acetylcysteine	3	50 mg	1		0967	Yes	+5°C ± 3°C
	A0152000	Acetylcysteine impurity C	11	10 mg	1	(2R,2'R)-3,3'-disulfanediylbis[2-(acetylamino)propanoic acid] (N,N'-diacetyl- L-cystine) ; Batch 9 is valid until 31 July 2016	0967	Yes	+5°C ± 3°C
	A0153000	Acetylcysteine impurity D	7	10 mg	1	(2R)-2-(acetylamino)-3-(acetylsulfanyl)propanoic acid (N,S-diacetyl-L- cysteine) ; Batch 6 is valid until 31 May 2017	0967	Yes	+5°C ± 3°C
	Y0000565	ß-Acetyldigoxin	2	50 mg	1	See leaflet C÷–HÿÿOŒ—	2168	Yes	+5°C ± 3°C
	Y0000642	ß-Acetyldigoxin for peak identification	1	10 mg	1		2168	Yes	+5°C ± 3°C
	A0200000	Acetylsalicylic acid	5	10 mg	1	Batch 4 is valid until 31 December 2016	0309	Yes	+5°C ± 3°C
	Y0001460	Acetylsalicylic acid for peak identification	3	10.3 mg	1	Batch 2 is valid until 31 December 2016	0309	Yes	+5°C ± 3°C
	Y0001462	Acetylsulfadiazine	1	0.002 mg	1		0294	Yes	+5°C ± 3°C
	A0208000	N-Acetyltryptophan	2	125 mg	1		1383	Yes	+5°C ± 3°C
	A0202000	N-Acetyltyrosine	1	200 mg	1		1384	Yes	+5°C ± 3°C
	Y0000693	Acholeplasma laidlawii BRP	1	1 ml	1		20607	Yes	-80°C ± 10°C
	A0220000	Aciclovir	3	75 mg	1		0968	Yes	+5°C ± 3°C
	Y0001271	Aciclovir for peak identification 1	4	0.3 mg	1	Batch 3 is valid until 31 July 2016	0968	Yes	+5°C ± 3°C
	Y0001269	Aciclovir for peak identification 2	4	0.004 mg	1	Batch 3 is valid until 31 August 2016	0968	Yes	+5°C ± 3°C
	Y0001264	Aciclovir for system suitability	1	10 mg	1		0968	Yes	+5°C ± 3°C
	A0225000	Acitretin	2	100 mg	1	See leaflet CœŒHœÿO–	1385	Yes	+5°C ± 3°C
	Y0001463	Actaea racemosa HRS	1	1200 mg	1		2069	Yes	+5°C ± 3°C
	Y0001543	Actaea racemosa for assay CRS	1	300 mg	1	See leaflet C÷œHÿ—NOŒÿ; Monoammonium glycyrrhizate	2069	Yes	+5°C ± 3°C
	Y0001464	Actaea racemosa dry extract for system suitability HRS	1	1200 mg	1		2069	Yes	-20°C ± 5°C
	Y0001121	Adapalene	1	100 mg	1	See leaflet Cœ‡Hœ‡O–	2445	Yes	+5°C ± 3°C
	Y0001120	Adapalene impurity C	3	6 mg	1	1-(2-methoxyphenyl)tricyclo[3.3.1.1]decane	2445	Yes	+5°C ± 3°C
	Y0001119	Adapalene for peak identification	2	2.02 mg	1		2445	Yes	+5°C ± 3°C
	A0230000	Adenine	2	50 mg	1		0800	Yes	+5°C ± 3°C
	A0230200	Adenosine	1	50 mg	1		1486	Yes	+5°C ± 3°C
	Y0000110	Adipic acid	1	50 mg	1		1586	Yes	+5°C ± 3°C
	Y0000882	Adrenaline	1	5 mg	1		2303	Yes	+5°C ± 3°C
	Y0000740	Adrenaline impurity mixture	3	0.005 mg	1		0254.2303	Yes	+5°C ± 3°C
	Y0000883	Adrenaline with impurity F	1	10 mg	1		2303	Yes	+5°C ± 3°C
	A0300000	Adrenaline tartrate	6	100 mg	1	Batch 5 is valid until 31 October 2016	0254	Yes	+5°C ± 3°C
	Y0000707	Adrenaline tartrate with impurity A	1	15 mg	1		0254	Yes	+5°C ± 3°C
	Y0001527	Aescin for LC assay HRS	1	150 mg	1	see leaflet C—÷H‡÷Oœ–	1830.1829	Yes	+5°C ± 3°C
	Y0001724	Agnus castus fruit dry extract	1	350 mg	1	see leaflet	2309, 2147	Yes	-20°C ± 5°C
	A0325000	Alanine	3	60 mg	1		0752	Yes	+5°C ± 3°C
	A0325100	Albendazole	2	50 mg	1		1386	Yes	+5°C ± 3°C
	A0325200	Alcuronium chloride	2	50 mg	1		1285	Yes	-20°C ± 5°C
	A0325450	Alfacalcidol	9	5 mg	1	See leaflet	1286	Yes	-20°C ± 5°C
	Y0001601	Alfacalcidol for system suitability	1	2.5 mg	1		1286	Yes	-20°C ± 5°C
	A0325451	Alfacalcidol - reference spectrum	1	n/a	1		1286
	A1225000	Alfadex	3	150 mg	1	See leaflet [CÿHŒÐ0—]ÿ	1070.1487	Yes	+5°C ± 3°C
	A0325500	* hydrochloride - reference spectrum	1	n/a	1		1062
	Y0001883	Alfuzosin for peak identification	1	10 mg	1		1287	Yes	+5°C ± 3°C
	Y0001906	Alfuzosin for system suitability A	1	10 mg	1		1287	Yes	+5°C ± 3°C
	A0325800	Alfuzosin hydrochloride	2	10 mg	1		1287	Yes	+5°C ± 3°C
	Y0001583	Alimemazine hemitartrate	1	15 mg	1		2650	Yes	+5°C ± 3°C
	Y0001581	Alimemazine for system suitability	1	5 mg	1		2650	Yes	+5°C ± 3°C
	A0349000	Allantoin	1	60 mg	1		1288	Yes	+5°C ± 3°C
	A0350000	Allopurinol	3	100 mg	1	See leaflet	0576	Yes	+5°C ± 3°C
	A0350010	Allopurinol impurity A	2	10 mg	1	5-amiH-pyrazole-4-carboxamide	0576	Yes	+5°C ± 3°C
	A0350020	Allopurinol impurity B	3	10 mg	1	5-formylamiH-pyrazole-4-carboxamide	0576	Yes	+5°C ± 3°C
	A0350030	Allopurinol impurity C	3	10 mg	1	5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide	0576	Yes	+5°C ± 3°C
	A0350040	Allopurinol impurity D	4	15 mg	1	ethyl 5-amiH-pyrazole-4-carboxylate	0576	Yes	+5°C ± 3°C
	A0350050	Allopurinol impurity E	1	20 mg	1	ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate	0576	Yes	+5°C ± 3°C
	A0351000	Allylstrychnine bromide	1	10 mg	1		1285	Yes	-20°C ± 5°C
	Y0000235	Almagate	2	50 mg	1	See leaflet	2010	Yes	+5°C ± 3°C
	Y0000255	Almagate - reference spectrum	1	n/a	1		2010
	A0357000	Alprazolam - * psy	2	100 mg	1		1065	Yes	+5°C ± 3°C
	A0360000	Alprenolol hydrochloride	1	100 mg	1		0628.0876	Yes	+5°C ± 3°C
	Y0000054	Alprostadil	3	25 mg	1	See leaflet ; Batch 2 is valid until 31 July 2016	1488	Yes	-20°C ± 5°C
	Y0000606	Altizide	2	150 mg	1	See leaflet CŒŒHŒ÷ClN–O÷S–	0370.2185	Yes	+5°C ± 3°C
	Y0000843	Altizide impurity B	1	15 mg	1	3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene	2185	Yes	+5°C ± 3°C
	Y0000687	Alverine citrate	1	5 mg	1		2156	Yes	+5°C ± 3°C
	Y0001819	Alverine impurity C	2	40 mg	1	N-ethyl-3-phenylpropan-1-amine ; Batch 1 is valid until 4 February 2017	2156	Yes	-20°C ± 5°C
	Y0000607	Alverine impurity D	1	10 mg	1	N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine	2156	Yes	+5°C ± 3°C
	A0363000	Amantadine hydrochloride	1	100 mg	1		0463	Yes	+5°C ± 3°C
	A0363700	Ambroxol hydrochloride	3	125 mg	1		1489	Yes	+5°C ± 3°C
	A0900000	Amfetamine sulfate - reference spectrum	1	n/a	1		0368
	A0365000	Amidotrizoic acid dihydrate	1	100 mg	1		0873	Yes	+5°C ± 3°C
	Y0001461	Amidotrizoic acid for system suitability	1	0.08 mg	1		0873	Yes	+5°C ± 3°C
	A0368000	Amikacin	3	200 mg	1	See leaflet	1289.1290	Yes	+5°C ± 3°C
	Y0001467	Amikacin impurity I	1	20 mg	1	(2S)-4-amino-2-hydroxybutanoic acid	1289, 1290	Yes	+5°C ± 3°C
	Y0001117	Amikacin for system suitability	3	10 mg	1	Batch 2 is valid until 30 June 2016	1289.1290	Yes	+5°C ± 3°C
	A0365900	Amikacin sulfate	3	200 mg	1	The batch 3 is not suitable for use in the assay in monograph 1290:07/2014. Amikacin CRS A0368000 is also needed. See leaflet.	1290	Yes	+5°C ± 3°C
	Y0001902	Amiloride for peak identification	1	10 mg	1		0651	Yes	+5°C ± 3°C
	A0370000	Amiloride hydrochloride	2	100 mg	1		0651	Yes	+5°C ± 3°C
	Y0000020	Amiloride impurity A	3	20 mg	1	methyl-3,5-diamino-6-chloropyrazine-2-carboxylate	0651	Yes	+5°C ± 3°C
	Y0000173	4-Aminobenzoic acid	2	60 mg	1		1687	Yes	+5°C ± 3°C
	A0420000	Aminocaproic acid	1	50 mg	1		0874	Yes	+5°C ± 3°C
	A0460000	7-Aminodesacetoxycephalosporanic acid	2	20 mg	1	Cefadroxyl impurity B	0708.0813	Yes	+5°C ± 3°C
	A0496000	Aminoglutethimide	1	125 mg	1		1291	Yes	+5°C ± 3°C
	A0496005	Aminoglutethimide impurity A	1	20 mg	1	(3¢£)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione (3-aminoglutethimide)	1291	Yes	+5°C ± 3°C
	A0496020	Aminoglutethimide impurity D	1	10 mg	1	3,3'-[diazenediylbis(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide)	1291	Yes	+5°C ± 3°C
	A0575000	Amiodarone hydrochloride	3	100 mg	1		0803	Yes	+5°C ± 3°C
	Y0000129	Amiodarone impurity D	3	20 mg	1	(2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone	0803	Yes	+5°C ± 3°C
	Y0000130	Amiodarone impurity E	3	20 mg	1	(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone	0803	Yes	+5°C ± 3°C
	A0590000	Amisulpride	2	10 mg	1		1490	Yes	+5°C ± 3°C
	Y0001534	Amisulpride for system suitability	1	1.0015 mg	1		1490	Yes	+5°C ± 3°C
	Y0000563	Amitriptyline hydrochloride	1	10 mg	1		0464	Yes	+5°C ± 3°C
	Y0000049	Amlodipine besilate	4	150 mg	1	See leaflet	1491	Yes	+5°C ± 3°C
	Y0001068	Amlodipine impurity A	3	15 mg	1	3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	1491	Yes	+5°C ± 3°C
	Y0001069	Amlodipine impurity B	3	15 mg	1	3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2- (methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5- dicarboxylate ; Batch 2 is valid until 31 December 2016	1491	Yes	+5°C ± 3°C
	Y0001070	Amlodipine impurity G	3	10 mg	1	dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5- dicarboxylate	1491	Yes	+5°C ± 3°C
	Y0001067	Amlodipine for peak identification	3	15 mg	1	Batch 2 is valid until 30 November 2016	1491	Yes	+5°C ± 3°C
	Y0000302	Ammonio methacrylate copolymer(type A) - reference spectrum	1	n/a	1		2081
	Y0000303	Ammonio methacrylate copolymer(type B) - reference spectrum	1	n/a	1		2082
	A0650000	Amobarbital - * psy	1	500 mg	1		0594	Yes	+5°C ± 3°C
	A0700000	Amobarbital sodium - * psy	1	500 mg	1		0166	Yes	+5°C ± 3°C
	Y0001794	Amorolfine Hydrochloride	1	10 mg	1		2756	Yes	+5°C ± 3°C
	Y0001795	Amorolfine for system suitability	1	10 mg	1		2756	Yes	+5°C ± 3°C
	A0800000	Amoxicillin trihydrate	5	200 mg	1	See leaflet CŒÿHŒ„N–O—S	0167,0168,0 260, 0577,0578,0 813, 1140,1653	Yes	+5°C ± 3°C
	Y0001521	Amoxicillin trihydrate for performance verification	2	5000 mg	1	See leaflet ; Batch 1 is valid until 30 April 2017	20232, 20512,	Yes	+5°C ± 3°C
	Y0000005	Amphotericin B	5	100 mg	1	See leaflet	1292	Yes	-20°C ± 5°C
New	Y0001361	Amphotericin B for microbiological assay	2	100 mg	1	See leaflet ; Batch 1 is valid until 30 November 2017	20702	Yes	-20°C ± 5°C
	Y0001014	Amphotericin B for peak identification	2	10 mg	1		1292	Yes	-20°C ± 5°C
	A1000000	Ampicillin (anhydrous)	5	220 mg	1	See leaflet CŒÿHŒ„N–O÷S	0167,0168,0 578, 1168,1169	Yes	+5°C ± 3°C
	A1100000	Ampicillin trihydrate	2	150 mg	1		0168,0260,0 577, 0578,0808,2 211, 2212	Yes	+5°C ± 3°C
	Y0001244	Amylmetacresol	1	285 mg	1	See leaflet CŒœHŒ‡O	2405	Yes	+5°C ± 3°C
	Y0001245	Amylmetacresol for peak identification	1	10 mg	1		2405	Yes	+5°C ± 3°C
	Y0001522	Anastrozole	1	100 mg	1	See leaflet CŒŸHŒ„N—	2406	Yes	+5°C ± 3°C
	Y0001531	Anastrozole impurity E	1	10 mg	1	2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)	2406	Yes	+5°C ± 3°C
	Y0001870	Andrographis herb HRS	1	2050 mg	1		2712	Yes	+5°C ± 3°C
	Y0001866	Andrographolide	1	15 mg	1	see leaflet CœÐH–ÐO—	2712	Yes	+5°C ± 3°C
	Y0001753	Anemarrhena rhizome for system suitability HRS	1	150 mg	1		2661	Yes	+5°C ± 3°C
	Y0001386	Angelica dahurica root HRS	1	160 mg	1		2556	Yes	+5°C ± 3°C
	Y0001385	Angelica pubescens root	1	500 mg	1		2557	Yes	+5°C ± 3°C
	A1200000	Anhydrotetracycline hydrochloride	5	25 mg	1	See leaflet ; Batch 4 is valid until 28 February 2017	0210,0211,1 654	Yes	+5°C ± 3°C
	Y0001466	Anhydrous Docetaxel	1	15 mg	1		2593	Yes	+5°C ± 3°C
	A1210000	Antazoline hydrochloride	1	50 mg	1		0972	Yes	+5°C ± 3°C
	Y0001777	Apigenin 7-glucoside	1	25 mg	1	see leaflet CœŒHœÐOŒÐ	0404	Yes	+5°C ± 3°C
	Y0001465	Apomorphine hydrochloride hemihydrate	1	15 mg	1		0136	Yes	+5°C ± 3°C
	Y0001471	Apomorphine impurity B (morphine sulfate) -* narc	1	40 mg	1	See leaflet; 7,8-didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol (morphine)	0136	Yes	+5°C ± 3°C
	Y0001825	Aprepitant	1	150 mg	1	see leaflet Cœ–HœŒFŸN÷O–	2757	Yes	+5°C ± 3°C
	Y0001826	Aprepitant for system suitability	1	15 mg	1		2757	Yes	+5°C ± 3°C
	Y0001154	Aprotinin for system suitability	1	2.7 mg	1		0580, 0579	Yes	+5°C ± 3°C
	A1250000	Aprotinin solution BRP	4	0.5 mL	1	See leaflet	0579.0580	Yes	+5°C ± 3°C
	A1269000	L-Arabinitol	2	10 mg	1		1381	Yes	+5°C ± 3°C
	Y0000806	Arbutin	2	110 mg	1	See leaflet CŒœHŒÿOŸ ; Batch 1 is valid until 30 September 2016	1054	Yes	+5°C ± 3°C
	A1270000	Arginine	4	60 mg	1	See leaflet	0806, 1654, 2114, 2566	Yes	+5°C ± 3°C
	Y0000304	Arginine aspartate	1	20 mg	1		2096	Yes	+5°C ± 3°C
	A1271000	Arginine hydrochloride	3	60 mg	1		0805.0885	Yes	+5°C ± 3°C
	Y0001649	Aripiprazole	2	170 mg	1	See leaflet ; Batch 1 is valid until 31 March 2017	2617	Yes	+5°C ± 3°C
	Y0001650	Aripiprazole impurity F	2	15 mg	1	7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]butoxy]-3,4- dihydroquinolin-2(1H)-one	2617	Yes	+5°C ± 3°C
	Y0001323	Aristolochia	1	140 mg	1	See leaflet	20821	Yes	+5°C ± 3°C
	Y0001185	Aristolochic acid I	1	11 mg	1	See leaflet	20821	Yes	+5°C ± 3°C
	Y0001175	Aristolochic acid for system suitability	1	1 mg	1		20821	Yes	+5°C ± 3°C
	Y0000079	Articaine hydrochloride	3	200 mg	1		1688	Yes	+5°C ± 3°C
	Y0000080	Articaine impurity A	3	25 mg	1	methyl 4-methyl-3-[[2-(propylamino)acetyl]amino]thiophene-2-carboxylate (acetamidoarticaine)	1688	Yes	+5°C ± 3°C
	Y0000081	Articaine impurity E	2	10 mg	1	methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino] thiophene-2-carboxylate (isopropylarticaine)	1688	Yes	+5°C ± 3°C
	Y0001091	Artichoke leaf dry extract HRS	1	60 mg	1		2389	Yes	-20°C ± 5°C
	A1300000	Ascorbic acid	4	100 mg	1	Vitamin C	0253,0958,1 791	Yes	+5°C ± 3°C
	Y0001024	Ascorbic acid impurity C	3	20 mg	1	see leaflet CÿHŒÐOŸ; L-xylo-hex-2-ulosonic acid (L-sorbosonic acid)	0253.1791	Yes	+5°C ± 3°C
	Y0001170	Ascorbic acid impurity D	2	10 mg	1	methyl L-xylo-hex-2-ulosonate (methyl L-sorbosonate)	0253.1791	Yes	+5°C ± 3°C
	Y0000800	Ascorbyl palmitate	1	10 mg	1		0807	Yes	+5°C ± 3°C
	Y0001206	Asiaticoside	1	40 mg	1	see leaflet C÷‡HŸ‡OŒ„	1498	Yes	+5°C ± 3°C
	Y0000305	Asparagine monohydrate	2	60 mg	1	Batch 1 is valid until 31 January 2017	2086	Yes	+5°C ± 3°C
	A1320000	Aspartame	2	40 mg	1		0973	Yes	+5°C ± 3°C
	A1321000	Aspartame impurity A	5	10 mg	1	2-[(2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl]acetic acid ; Batch 4 is valid until 30 June 2017	0973	Yes	+5°C ± 3°C
	A1330000	Aspartic acid	2	50 mg	1		0750.0797	Yes	+5°C ± 3°C
New	Y0001171	Astragaloside IV	2	40 mg	1	See leaflet C÷ŒHÿ‡OŒ÷ ; Batch 1 is valid until 19 July 2017	2435	Yes	-20°C ± 5°C
	A1340000	Atenolol	3	100 mg	1		0703	Yes	+5°C ± 3°C
	Y0001089	Atenolol for system suitability	2	5 mg	1	Batch 1 is valid until 31 October 2016	0703	Yes	+5°C ± 3°C
	Y0001586	Atomoxetine hydrochloride	1	110 mg	1	See leaflet CŒŸHœœClNO	2640	Yes	+5°C ± 3°C
	Y0001588	Atomoxetine impurity B	1	10 mg	1	(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1- amine	2640	Yes	+5°C ± 3°C
	Y0001589	Atomoxetine impurity D	1	5 mg	1	(3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1- amine	2640	Yes	+5°C ± 3°C
	Y0001587	Atomoxetine for impurity A identification	1	10 mg	1	N-methyl-3-phenoxy-3-phenylpropan-1-amine	2640	Yes	+5°C ± 3°C
	Y0001327	Atorvastatin calcium trihydrate	3	150 mg	1	See leaflet CÿÿHÿ‡CaFœN÷OŒÐ ; Batch 2 is valid until 31 August 2016	2191	Yes	+5°C ± 3°C
	Y0001328	Atorvastatin impurity A	3	5 mg	1	(3R,5R)-3,5-dihydroxy-7-[5-(1-methylethyl)-2,3-diphenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]heptanoic acid (desfluoroatorvastatin) ; Batch 2 is valid until 31 July 2017	2191	Yes	+5°C ± 3°C
	Y0001329	Atorvastatin impurity B	4	10 mg	1	(3RS,5SR)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid ; Batch 2 is valid until 31 October 2016 Batch 3 is valid until 30 June 2017	2191	Yes	+5°C ± 3°C
	Y0001330	Atorvastatin impurity C	2	10 mg	1	(3R,5R)-7-[2,3-bis(4-fluorophenyl)-5-(1-methylethyl)-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (fluoroatorvastatin)	2191	Yes	+5°C ± 3°C
	Y0001331	Atorvastatin impurity D	4	5 mg	1	3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2- carboxamide ; Batch 2 is valid until 31 October 2016 Batch 3 is valid until 30 April 2017	2191	Yes	+5°C ± 3°C
	Y0001332	Atorvastatin impurity E	4	5 mg	1	(3S,5S)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (ent- atorvastatin) ; Batch 2 is valid until 31 August 2016 Batch 3 is valid until 4 May 2017	2191	Yes	+5°C ± 3°C
	Y0001572	Atovaquone	1	270 mg	1	See leaflet CœœHŒ„ClO–	2192	Yes	+5°C ± 3°C
	Y0001573	Atovaquone for system suitability	1	10 mg	1		2192	Yes	+5°C ± 3°C
	Y0000424	Atracurium besilate	3	120 mg	1	see leaflet Cÿ—H‡œNœOŒ‡Sœ ; Batch 2 is valid until 30 September 2017	1970	Yes	+5°C ± 3°C
	Y0000503	Atracurium for impurity F identification	1	5 mg	1		1970	Yes	+5°C ± 3°C
	Y0000504	Atracurium for peak identification	1	5 mg	1		1970	Yes	+5°C ± 3°C
	Y0000878	Atropine	1	30 mg	1		2056	Yes	+5°C ± 3°C
	Y0000816	Atropine impurity B	2	10 mg	1	(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine) ; Batch 1 is valid until 31 December 2016	0068.2056	Yes	+5°C ± 3°C
	Y0000845	Atropine for peak identification	2	0.25 mg	1		0068.2056	Yes	+5°C ± 3°C
	A1400000	Atropine sulfate	4	20 mg	1		0068	Yes	+5°C ± 3°C
	Y0000029	Azaperone	1	50 mg	1		1708	Yes	+5°C ± 3°C
	A1500000	Azathioprine	1	100 mg	1		0369	Yes	+5°C ± 3°C
	Y0001240	Azathioprine impurity A	1	10 mg	1	1-methyl-4-nitro-1H-imidazol-5-amine	0369	Yes	+5°C ± 3°C
	Y0001246	Azathioprine impurity G	2	5 mg	1	6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine)	0369	Yes	+5°C ± 3°C
	Y0000326	Azelastine hydrochloride	1	25 mg	1		1633	Yes	+5°C ± 3°C
	Y0000327	Azelastine impurity B	1	5 mg	1	N'-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]benzohydrazide	1633	Yes	+5°C ± 3°C
	Y0000328	Azelastine impurity D	1	5 mg	1	4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one	1633	Yes	+5°C ± 3°C
	Y0000329	Azelastine impurity E	1	5 mg	1	(3E)-3-[(4-chlorophenyl)methylidene]-2-benzofuran-1(3H)-one	1633	Yes	+5°C ± 3°C
	Y0000306	Azithromycin	4	200 mg	1	See leaflet C–‡HŸœNœOŒœ	1649	Yes	+5°C ± 3°C
New	Y0000307	Azithromycin impurity A	3	10 mg	1	6-demethylazithromycin ; Batch 2 is valid until 30 November 2017	1649	Yes	+5°C ± 3°C
	Y0000637	Azithromycin for peak identification	3	15 mg	1		1649	Yes	+5°C ± 3°C
	Y0000641	Azithromycin for system suitability	9	0.05 mg	1	Batch 8 is valid until 30 June 2017	1649	Yes	+5°C ± 3°C
	Y0000285	B19 virus DNA for NAT testing BRP	1	150 mg	5	See leaflet	0557, 1527,1646	Yes	-20°C ± 5°C
	B0070000	Bacampicillin hydrochloride	3	120 mg	1	See leaflet CœŒHœ‡ClN–OŸS	0808.0852	Yes	+5°C ± 3°C
	Y0001867	Bacitracin for system suitability	1	40 mg	1		0465.0466	Yes	-20°C ± 5°C
	B0100000	Bacitracin zinc	3	150 mg	1	See leaflet	20702	Yes	-20°C ± 5°C
	B0200000	Baclofen	2	130 mg	1	Batch 1 is valid until 30 September 2016	0653	Yes	+5°C ± 3°C
	B0200050	Baclofen impurity A	4	60 mg	1	(4RS)-4-(4-chlorophenyl)pyrrolidin-2-one	0653	Yes	+5°C ± 3°C
	Y0001273	Baicalin	1	10 mg	1	See leaflet CœŒHŒ‡OŒŒ	2438	Yes	+5°C ± 3°C
	B0250000	Bambuterol hydrochloride	1	100 mg	1		1293	Yes	+5°C ± 3°C
	B0300000	Barbital - * psy	1	500 mg	1		0170	Yes	+5°C ± 3°C
	Y0001525	Basic butylated methacrylate copolymer	1	20 mg	1		1975	Yes	+5°C ± 3°C
	B0305000	Beclometasone dipropionate anhydrous	4	150 mg	1	See leaflet Cœ‡H–ŸClOŸ	0654,1449, 1709	Yes	+5°C ± 3°C
	Y0000469	Beclometasone dipropionate for peak identification	2	10 mg	1	Batch 1 is valid until 30 November 2016	0654.1709	Yes	+5°C ± 3°C
	Y0001916	Teriparatide	1	1 mg	1	see leaflet	2829	Yes	-20°C ± 5°C
	Y0000352	Beclometasone dipropionate for system suitability	3	15 mg	1		0654.1709	Yes	+5°C ± 3°C
	Y0001073	Beclometasone dipropionate impurities F and N	2	0.052 mg	1		0654.1709	Yes	+5°C ± 3°C
	Y0000351	Beclometasone dipropionate monohydrate	1	10 mg	1		1709	Yes	+5°C ± 3°C
	Y0001607	Belamcanda chinensis rhizome HRS	1	110 mg	1		2561	Yes	+5°C ± 3°C
	Y0001025	Benazepril hydrochloride	1	160 mg	1	See leaflet Cœ÷Hœ„ClNœO—	2388	Yes	+5°C ± 3°C
	Y0001026	Benazepril impurity A	2	10 mg	1	[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5- tetrahydro-1H-1-benzazepin-1-yl]acetic acid	2388	Yes	+5°C ± 3°C
	Y0001038	Benazepril for system suitability	2	0.016 mg	1	Batch 1 is valid until 30 April 2017	2388	Yes	+5°C ± 3°C
	B0400000	Bendroflumethiazide	1	100 mg	1		0370	Yes	+5°C ± 3°C
	Y0000564	Bendroflumethiazide impurity A	1	5 mg	1	4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide	0370	Yes	+5°C ± 3°C
	B0470000	Benperidol	1	100 mg	1		1010,1172,1 254, 1708	Yes	+5°C ± 3°C
	B0477000	Benserazide hydrochloride	1	50 mg	1		1173	Yes	+5°C ± 3°C
	B0477010	Benserazide impurity A	2	15 mg	1	(2RS)-2-amino-3-hydroxypropanohydrazide	1173	Yes	+5°C ± 3°C
	Y0001071	Benserazide impurity C	1	10 mg	1	(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)] propanohydrazide	1173	Yes	+5°C ± 3°C
	Y0001079	Benserazide for peak identification	1	10 mg	1		1173	Yes	+5°C ± 3°C
	Y0001064	Benzaldehyde	2	150 mg	1		0372,0371,1 740	Yes	+5°C ± 3°C
	Y0001060	Benzalkonium chloride for system suitability	4	20 mg	1		0371.0372	Yes	+5°C ± 3°C
	B0490000	Benzarone	1	10 mg	1	(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone	1393	Yes	+5°C ± 3°C
	B0500000	Benzathine benzylpenicillin	2	200 mg	1	See leaflet	0373	Yes	+5°C ± 3°C
	Y0000775	Benzbromarone	1	10 mg	1		1393	Yes	+5°C ± 3°C
	B0550000	Benzethonium chloride	1	100 mg	1		0974	Yes	+5°C ± 3°C
	B0600000	Benzocaine	1	50 mg	1		0011.1088	Yes	+5°C ± 3°C
	Y0001470	Benzoic acid	1	30 mg	1		0934	Yes	+5°C ± 3°C
	Y0000647	Benzophenone	2	40 mg	1		1784	Yes	+5°C ± 3°C
New	Y0000167	Benzyl alcohol	3	70 mg	1	See leaflet ; Batch 2 is valid until 31 October 2017	0256,0371,0 372,1827	Yes	+5°C ± 3°C
	B0670000	Benzyl benzoate - reference spectrum	1	n/a	1		0705
	B0680000	S-Benzylmercaptoacetyltriglycine	1	10 mg	1		1372	Yes	+5°C ± 3°C
	Y0001889	Benzylpenicillin for system suitability	1	10 mg	1		0113.0114	Yes	+5°C ± 3°C
	B0700000	Benzylpenicillin potassium	2	100 mg	1		0113,0148,0 149	Yes	+5°C ± 3°C
	B0900000	Benzylpenicillin sodium	7	200 mg	1	See leaflet CŒÿHŒŸNœNaO÷S	0113.0114	Yes	+5°C ± 3°C
	Y0001149	Berberine chloride	1	20 mg	1	See leaflet CœÐHŒ‡ClNO÷	1831,2500, 2715	Yes	+5°C ± 3°C
	B0950000	Betadex	4	200 mg	1	See leaflet [CÿHŒÐO—]Ÿ	1070,1487,1 804	Yes	+5°C ± 3°C
	Y0000391	Betahistine dihydrochloride	2	50 mg	1		1665	Yes	+5°C ± 3°C
	B0990000	Betahistine mesilate	2	50 mg	1		1071	Yes	+5°C ± 3°C
	B1000000	Betamethasone	5	60 mg	1		0312,0354,0 388, 0811	Yes	+5°C ± 3°C
	B1030000	Betamethasone acetate	2	100 mg	1		0548.0975	Yes	+5°C ± 3°C
	B1040000	Betamethasone dipropionate	4	200 mg	1	See leaflet Cœ‡H–ŸFOŸ ; Batch 3 is valid until 31 August 2016	0809	Yes	+5°C ± 3°C
	Y0001416	Betamethasone dipropionate for peak identification	1	10 mg	1		0809	Yes	+5°C ± 3°C
	Y0001418	Betamethasone dipropionate for system suitability	2	10 mg	1	Batch 1 is valid until 30 November 2016	0809	Yes	+5°C ± 3°C
	B1045000	Betamethasone sodium phosphate	4	100 mg	1		0549.0810	Yes	+5°C ± 3°C
	B1054000	Betamethasone 17-valerate	3	100 mg	1		0322.0811	Yes	+5°C ± 3°C
	B1055000	Betamethasone 21-valerate	3	15 mg	1		0811	Yes	+5°C ± 3°C
	Y0001027	Betamethasone valerate for system suitability	1	25 mg	1		0811	Yes	+5°C ± 3°C
	Y0001065	Betamethasone valerate impurity mixture	2	0.018 mg	1		0811	Yes	+5°C ± 3°C
	B1103000	Betaxolol hydrochloride	2	60 mg	1		1072	Yes	+5°C ± 3°C
	B1103100	Betaxolol impurity A	3	10 mg	1	(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol ; Batch 2 is valid until 28 February 2017	1072	Yes	+5°C ± 3°C
	Y0001354	Betaxolol impurity C	1	5 mg	1	(2RS)-2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane	1072	Yes	-20°C ± 5°C
	Y0001360	Betaxolol for peak identification	1	15 mg	1		1072	Yes	+5°C ± 3°C
	B1115000	Bezafibrate	2	100 mg	1	Batch 1 is valid until 31 August 2017	1394	Yes	+5°C ± 3°C
	Y0001444	Bicalutamide	1	100 mg	1	See leaflet CŒ‡HŒ÷F÷NœO÷S	2196	Yes	+5°C ± 3°C
	Y0001448	Bicalutamide for system suitability	1	15 mg	1		2196	Yes	+5°C ± 3°C
	Y0001078	Bicisate labelling kit	1	24 mg	1		2123	Yes	+5°C ± 3°C
	B1110000	Bifonazole	2	50 mg	1		1395	Yes	+5°C ± 3°C
	Y0001421	Bifonazole for system suitability	1	10 mg	1		1395	Yes	+5°C ± 3°C
	Y0001788	Bilberry dry extract HRS	1	250 mg	1	see leaflet	2394,1588,1 602	Yes	-20°C ± 5°C
	B1116000	Biotin	2	20 mg	1	Vitamin H	1073	Yes	+5°C ± 3°C
	B1120000	Biperiden hydrochloride	1	60 mg	1		1074	Yes	+5°C ± 3°C
	B1121000	Biperiden impurity A	2	20 mg	1	(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3- (piperidin-1-yl)propan-1-ol (endo form)	1074	Yes	+5°C ± 3°C
	B1140000	Bisacodyl	3	50 mg	1		0595	Yes	+5°C ± 3°C
	Y0000608	Bisacodyl for peak identification	1	10 mg	1		0595	Yes	+5°C ± 3°C
	Y0000694	Bisacodyl for system suitability	2	5 mg	1		0595	Yes	+5°C ± 3°C
	Y0000812	Bisoprolol fumarate	1	50 mg	1		1710	Yes	+5°C ± 3°C
	Y0000877	Bisoprolol for peak identification	3	1.007 mg	1	Bisoprolol for system suitability method A CRS has been renamed as Bisoprolol for peak identification CRS.	1710	Yes	+5°C ± 3°C
New	Y0000813	Bisoprolol for system suitability	4	1.003 mg	1	Bisoprolol for system suitability method B CRS has been renamed as Bisoprolol for system suitability CRS ; Batch 3 is valid until 31 October 2017	1710	Yes	+5°C ± 3°C
	B1141000	Bleomycin sulfate	2	7 mg	1	See leaflet	0976.20702	Yes	-20°C ± 5°C
	Y0000434	Boldine	3	30 mg	1	See leaflet	1396, 1816	Yes	+5°C ± 3°C
	Y0001780	Boldo leaf dry extract HRS	1	550 mg	1		1816.1396	Yes	-20°C ± 5°C
	B1142000	Bordela pertussis mouse antiserum BRP	1	0.5 mg	1	See leaflet	See leaflet, 20716	Yes	-20°C ± 5°C
	Y0001634	Brimonidine for system suitability	1	1.3 mg	1		2760	Yes	+5°C ± 3°C
	Y0001658	Brimonidine tartrate	1	5 mg	1		2760	Yes	+5°C ± 3°C
	B1143000	Bromazepam - * psy	4	60 mg	1		0778.0879	Yes	+5°C ± 3°C
	Y0000645	Bromazepam for system suitability - * psy	2	10 mg	1		0879	Yes	+5°C ± 3°C
	B1145000	Bromhexine hydrochloride	4	200 mg	1	Batch 3 is valid until 31 March 2017	0706	Yes	+5°C ± 3°C
	Y0001757	Bromhexine for system suitability	2	15 mg	1	Batch 1 is valid until 30 September 2017	0706	Yes	+5°C ± 3°C
	B1150000	Bromocriptine mesilate	2	30 mg	1		0596	Yes	-20°C ± 5°C
	Y0000677	Bromocriptine mesilate for system suitability	1	5 mg	1		0596	Yes	-20°C ± 5°C
	B1152000	Bromperidol	1	100 mg	1		0616.1178	Yes	+5°C ± 3°C
	B1152050	Bromperidol decanoate	1	60 mg	1		1397.1431	Yes	+5°C ± 3°C
	B1153000	Brompheniramine maleate	1	100 mg	1		0977.1196	Yes	+5°C ± 3°C
	Y0000468	Brotizolam - * psy	1	10 mg	1		2197	Yes	+5°C ± 3°C
	Y0000470	Brotizolam impurity B	1	10 mg	1	2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine (desmethylbrotizolam)	2197	Yes	+5°C ± 3°C
	Y0001196	Brucine	1	40 mg	1	see leaflet	2513.2514	Yes	+5°C ± 3°C
	B1157300	Budesonide	5	110 mg	1	See leaflet Cœ—H–÷Oÿ ; Batch 4 is valid until 31 January 2017	1075	Yes	+5°C ± 3°C
	Y0001148	Budesonide for system suitability	1	10 mg	1		1075	Yes	+5°C ± 3°C
	B1156000	Bufexamac	1	100 mg	1		1179	Yes	+5°C ± 3°C
	Y0001729	Bufexamac impurity A	1	10 mg	1	2-(4-butoxyphenyl)acetic acid	1179	Yes	+5°C ± 3°C
	Y0001730	Bufexamac impurity B	1	15 mg	1	methyl 2-(4-butoxyphenyl)acetate	1179	Yes	+5°C ± 3°C
	B1157400	Buflomedil hydrochloride	2	100 mg	1		1398	Yes	+5°C ± 3°C
	Y0001731	Bufexamac impurity C	1	15 mg	1	butyl 2-(4-butoxyphenyl)acetate	1179	Yes	+5°C ± 3°C
	Y0001732	Bufexamac impurity D	1	10 mg	1	2-(4-butoxyphenyl)acetamide	1179	Yes	+5°C ± 3°C
	B1157410	Buflomedil impurity B	3	20 mg	1	1-(4-hydroxy-2,6-dimethoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one	1398	Yes	+5°C ± 3°C
	Y0001529	Buflomedil for peak identification	1	0.45 mg	1		1398	Yes	+5°C ± 3°C
	B1158000	Bumetanide	1	150 mg	1		1076	Yes	+5°C ± 3°C
	Y0000309	Bumetanide impurity A	1	5 mg	1	3-nitro-4-phenoxy-5-sulphamoylbenzoic acid	1076	Yes	+5°C ± 3°C
	Y0000310	Bumetanide impurity B	1	5 mg	1	3-amino-4-phenoxy-5-sulphamoylbenzoic acid	1076	Yes	+5°C ± 3°C
	B1160000	Bupivacaine hydrochloride	2	100 mg	1		0541, 2335	Yes	+5°C ± 3°C
	Y0000088	Bupivacaine impurity B	3	20 mg	1	(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide	0541	Yes	+5°C ± 3°C
	Y0000089	Bupivacaine impurity E	3	20 mg	1	6-(butylamino)-N-(2,6-dimethylphenyl)hex*	0541	Yes	+5°C ± 3°C
	Y0001575	Bupivacaine impurity F	1	70 mg	1	2,6-dimethylaniline	0541	Yes	+5°C ± 3°C
	Y0001108	Buprenorphine - * psy	1	10 mg	1		1180	Yes	+5°C ± 3°C
	Y0001122	Buprenorphine for system suitability - * psy	2	10 mg	1	Batch 1 is valid until 31 October 2016	1180.1181	Yes	+5°C ± 3°C
	Y0001109	Buprenorphine hydrochloride - * psy	1	10 mg	1		1181	Yes	+5°C ± 3°C
	B1168000	Buserelin	2	2 mg	1	See leaflet CÿÐH‡ÿNŒÿOŒ–	1077	Yes	-20°C ± 5°C
	Y0001814	Buserelin for NMR identification	1	2 mg	1		1077	Yes	-20°C ± 5°C
	Y0001740	Buserelin for peak identification	1	1 mg	1		1077	Yes	-20°C ± 5°C
	B1168020	D-His-Buserelin	2	0.5 mg	1		1077	Yes	-20°C ± 5°C
	Y0000131	Buspirone hydrochloride	1	5 mg	1		1711	Yes	+5°C ± 3°C
	Y0000471	Buspirone for system suitability	2	2.018 mg	1		1711	Yes	+5°C ± 3°C
	B1170000	Busulfan	3	50 mg	1	Batch 1 is valid until 30 September 2016 Batch 2 is valid until 31 March 2017	0542	Yes	+5°C ± 3°C
	Y0001487	Butyl methacrylate	1	100 mg	1		1975	Yes	+5°C ± 3°C
	Y0001304	Butyl methanesulfonate	1	30 µL	1		20537,2053 8, 20539, 20540,2054	Yes	+5°C ± 3°C
	B1217000	Butyl parahydroxybenzoate	3	150 mg	1	See leaflet ; Batch 2 is valid until 31 December 2016	0881.1216	Yes	+5°C ± 3°C
	Y0001357	Butyl parahydroxybenzoate impurity E	1	15 mg	1	2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)	0881	Yes	+5°C ± 3°C
	B1212000	Butylhydroxyanisole	4	60 mg	1		0880	Yes	+5°C ± 3°C
	B1215000	Butylhydroxytoluene	1	50 mg	1	Plastic additive 07	0581,30103, 30105,3010 6, 30107	Yes	+5°C ± 3°C
	Y0000472	Cabergoline	2	160 mg	1	See leaflet	1773	Yes	-20°C ± 5°C
	C0100000	Caffeine	4	70 mg	1	See leaflet	0267,0268,1 504,2412	Yes	+5°C ± 3°C
	Y0000787	Caffeine for system suitability	4	10 mg	1	Batch 3 is valid until 31 August 2016	0267, 0268	Yes	+5°C ± 3°C
	C0166000	Calcifediol	6	5 mg	1	See leaflet ; Batch 5 is valid until 30 June 2017	1295	Yes	-20°C ± 5°C
	C0166001	Calcifediol - reference spectrum	1	n/a	1		1295
	Y0000499	Calcipotriol (anhydrous) - reference spectrum	1	n/a	1		2011
	Y0000473	Calcipotriol monohydrate	2	10 mg	1	See leaflet CœŸH÷ÐO–	2011.2284	Yes	-20°C ± 5°C
	Y0000474	Calcipotriol monohydrate - reference spectrum	1	n/a	1		2284
	C0200000	Calcitonin (salmon)	11	1 mg	2	See leaflet	0471	Yes	-20°C ± 5°C
	Y0000632	Calcitonin-Gly	2	1 ml	1	About 0.9 mg per ml	0471	Yes	-20°C ± 5°C
	C0200010	N-acetyl-cys1-calcitonin	5	0.1 mg	1	See leaflet	0471	Yes	-20°C ± 5°C
	C0225000	Calcitriol	9	10 mg	1	See leaflet	0883	Yes	-20°C ± 5°C
	C0226000	Calcitriol - reference spectrum	1	n/a	1		0883
	C0249000	Calcium ascorbate - reference spectrum	1	n/a	1		1182
New	C0250000	Calcium folinate	7	130 mg	1	See leaflet ; Batch 6 is valid until 31 October 2017	0978.1606	Yes	+5°C ± 3°C
	C0299000	Calcium glucoheptonate	2	60 mg	1	Batch 1 is valid until 7 February 2017	1399	Yes	+5°C ± 3°C
	C0300000	Calcium gluconate	3	50 mg	1	Calcium digluconate ; Batch 2 is valid until 30 April 2017	0172,0658,0 979,1399,21 61,2162,216 4,2364	Yes	+5°C ± 3°C
	C0340000	Calcium levulinate dihydrate	1	250 mg	1		1296	Yes	+5°C ± 3°C
	C0350000	Calcium oxalate monohydrate	1	500 mg	1	See leaflet	20234	Yes	+5°C ± 3°C
	C0400000	Calcium pantothenate	4	50 mg	1		0470	Yes	+5°C ± 3°C
	C0405000	Camphor (racemic)	2	50 mg	1		0655.1400	Yes	+5°C ± 3°C
	Y0001388	Candesartan cilexetil	1	60 mg	1		2573	Yes	+5°C ± 3°C
	Y0001387	Candesartan cilexetil for peak identification	2	10 mg	1	Batch 1 is valid until 31 August 2016	2573	Yes	+5°C ± 3°C
	Y0001389	Candesartan cilexetil for system suitability	1	10 mg	1		2573	Yes	+5°C ± 3°C
	C0410000	Canrenone	4	15 mg	1		0688	Yes	+5°C ± 3°C
	Y0001858	Cape jasmine fruit for system suitability	1	260 mg	1		2565	Yes	+5°C ± 3°C
	Y0001642	Capecitabine	1	150 mg	1	See leaflet CŒÐHœœFN–Oÿ	2762	Yes	+5°C ± 3°C
	Y0001643	Capecitabine impurity A	1	5 mg	1	4-ami-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-one (5?- deoxy-5-fluorocytidine)	2762	Yes	+5°C ± 3°C
	Y0001644	Capecitabine impurity B	1	5 mg	1	1-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5?- deoxy-5-fluorouridine)	2762	Yes	+5°C ± 3°C
	Y0001645	Capecitabine impurity D	1	10 mg	1	(2RS)-2-methylbutyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2- dihydropyrimidin-4-yl]carbamate	2762	Yes	+5°C ± 3°C
	C0426000	Caprylic acid	2	100 mg	1		1401.1471	Yes	+5°C ± 3°C
	Y0000671	Capsaicin	2	50 mg	1	See leaflet CŒ‡HœŸNO– ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8- methylnon-6-enamide	1859,2336,2 337, 2529	Yes	+5°C ± 3°C
	C0430000	Captopril	2	10 mg	1		1079	Yes	+5°C ± 3°C
	Y0001219	Captopril impurity B	1	10 mg	1	See leaflet C„HŒ÷BrNO–; (2S)1-[(2S)-3-bromo-2-methylpropanoyl] pyrrolidine-2-carboxylic acid	1079	Yes	+5°C ± 3°C
New	Y0001220	Captopril impurity C	2	15 mg	1	See leaflet C÷H‡OœS; (2RS)-2-methyl-3-sulfanylpropanoic acid ; Batch 1 is valid until 21 January 2017	1079	Yes	-20°C ± 5°C
	Y0001221	Captopril impurity D	2	15 mg	1	See leaflet C÷HŸBrOœ; (2RS)-3-bromo-2-methylpropanoic acid ; Batch 1 is valid until 30 September 2017	1079	Yes	+5°C ± 3°C
	Y0000435	Captopril impurity E	1	10 mg	1	(2S)-1-(2-methylpropanoyl)pyrrolidine-2-carboxylic acid	1079	Yes	+5°C ± 3°C
	Y0001450	Captopril impurity J	2	10 mg	1	See leaflet CŒŒHŒŸNO÷S; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl] pyrrolidine-2-carboxylic acid (acetylcaptopril) ; Batch 1 is valid until 31 May 2017	1079	Yes	+5°C ± 3°C
	Y0001182	Captopril for system suitability	2	20 mg	1		1079	Yes	+5°C ± 3°C
	Y0000113	Carbachol	1	50 mg	1		1971	Yes	+5°C ± 3°C
	C0450000	Carbamazepine	5	200 mg	1	See leaflet CŒ—HŒœNœO	0543	Yes	+5°C ± 3°C
	Y0000033	Carbamazepine impurity A	6	20 mg	1	10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide (10,11- dihydrocarbamazepine) ; Batch 5 is valid until 30 November 2016	0543	Yes	+5°C ± 3°C
	C0451000	Carbasalate calcium - reference spectrum	1	n/a	1		1185
	Y0001161	Carbasalate impurity B	1	5 mg	1	2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid)	1185	Yes	+5°C ± 3°C
	C0455000	Carbenicillin sodium	2	50 mg	1		0956	Yes	-20°C ± 5°C
	C0460000	Carbidopa	2	50 mg	1		0755	Yes	+5°C ± 3°C
	Y0001713	Carbidopa for system suitability	1	10 mg	1		0755	Yes	+5°C ± 3°C
New	Y0001716	Carbidopa impurity mixture	2	0.008 mg	1	Batch 1 is valid until 30 November 2017	0755	Yes	+5°C ± 3°C
	C0465000	Carbimazole	2	120 mg	1	See leaflet CŸHŒÐNœOœS	0884	Yes	+5°C ± 3°C
	C0470000	Carbocisteine	2	60 mg	1		0885	Yes	+5°C ± 3°C
	C0499900	Carbon dioxide - reference spectrum	1	n/a	1		0375
	C0550000	Carboplatin - reference spectrum	1	n/a	1		1081
	Y0000475	Carboprost trometamol	1	40 mg	1	See leaflet Cœ—H÷ŸNO‡	1712	Yes	-20°C ± 5°C
	Y0000536	Carboprost trometamol - reference spectrum	1	n/a	1		1712
	Y0000035	Carisoprodol	1	50 mg	1		1689	Yes	+5°C ± 3°C
	Y0000036	Carisoprodol impurity A	2	10 mg	1	(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)- carbamate	1689	Yes	+5°C ± 3°C
	Y0001214	Carmellose	1	10 mg	1		2360	Yes	+5°C ± 3°C
	C0580004	Carmustine - reference spectrum	1	n/a	1		1187
	C0580010	Carmustine impurity A	1	20 mg	1	1,3-bis(2-chloroethyl)urea	1187	Yes	-20°C ± 5°C
	Y0000846	Carprofen	1	30 mg	1		2201	Yes	+5°C ± 3°C
	Y0000884	Carprofen for system suitability	1	5 mg	1		2201	Yes	+5°C ± 3°C
	Y0000192	Carteolol hydrochloride - reference spectrum	1	n/a	1		1972
	Y0000193	Carteolol for system suitability	1	30 mg	1		1972	Yes	+5°C ± 3°C
	Y0001427	Carvedilol	1	50 mg	1		1745	Yes	+5°C ± 3°C
	Y0000103	Carvedilol impurity C	2	15 mg	1	(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy) propan-2-ol	1745	Yes	+5°C ± 3°C
	Y0001426	Carvedilol for system suitability	2	10 mg	1		1745	Yes	+5°C ± 3°C
	C0600000	Casein BRP	3	100000 mg	1		0350	Yes	+5°C ± 3°C
	C0630000	Cefaclor	3	450 mg	1	See leaflet CŒ—HŒ÷ClN–O÷S	0986	Yes	+5°C ± 3°C
	C0640000	Delta-3-Cefaclor	4	20 mg	1		0986	Yes	-20°C ± 5°C
	C0650000	Cefadroxil	3	250 mg	1	see leaflet	0260,0577,0 813,2342	Yes	+5°C ± 3°C
	C0675000	Cefalexin monohydrate	4	150 mg	1	See leaflet	0708.0814	Yes	+5°C ± 3°C
	C0682000	Cefalotin sodium	3	170 mg	1	See leaflet	0987	Yes	+5°C ± 3°C
	Y0000505	Cefalotin for impurity B identification	1	10 mg	1		0987	Yes	+5°C ± 3°C
	C0682300	Cefamandole nafate	3	125 mg	1	See leaflet CŒ„HŒŸNÿNaOÿSœ	1402	Yes	+5°C ± 3°C
	Y0000240	Cefapirin sodium	2	100 mg	1	See leaflet CŒŸHŒÿN–NaOÿSœ ; Batch 1 is valid until 31 October 2016	1650	Yes	+5°C ± 3°C
	C0682400	Cefatrizine propylene glycol	2	150 mg	1	see leaflet CŒ‡HŒ‡NÿO—Sœ	1403	Yes	+5°C ± 3°C
	C0682410	Cefatrizine impurity A	1	60 mg	1	acide (6R,7R)-7-amino-8-oxo-3-[[(1H-1,2,3-triazol-4-yl)sulfanyl]méthyl]-5- thia-1-azabicyclo[4.2.0]oct-2-ène-2-carboxylique (7-ACA triazole)	1403	Yes	+5°C ± 3°C
	C0682800	Cefazolin	3	150 mg	1	See leaflet CŒ÷HŒ÷N‡O÷S–	0988	Yes	+5°C ± 3°C
	Y0000633	Cefepime dihydrochloride monohydrate	3	150 mg	1	See leaflet ; Batch 2 is valid until 31 January 2017	2126	Yes	+5°C ± 3°C
	Y0001336	Cefepime impurity E	1	10 mg	1	(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5- thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	2126	Yes	-20°C ± 5°C
	Y0000634	Cefepime dihydrochloride monohydrate for system suitability	2	15 mg	1		2126	Yes	+5°C ± 3°C
	C0684000	Cefixime	4	200 mg	1	See leaflet CŒÿHŒ—N—OŸSœ ; Batch 3 is valid until 30 June 2017	1188	Yes	-20°C ± 5°C
	C0684750	Cefoperazone dihydrate	2	100 mg	1	See leaflet Cœ—HœŸN„O‡Sœ	1404	Yes	+5°C ± 3°C
	C0684800	Cefoperazone sodium - reference spectrum	1	n/a	1		1404
	C0685000	Cefotaxime sodium	5	20 mg	1		0708.0989	Yes	+5°C ± 3°C
	Y0000420	Cefotaxime acid	2	20 mg	1	See leaflet CŒÿHŒŸN—OŸSœ	0989	Yes	+5°C ± 3°C
	Y0000506	Cefotaxime for peak identification	1	10 mg	1		0989	Yes	+5°C ± 3°C
	C0688000	Cefoxitin sodium	3	100 mg	1	See leaflet CŒÿHŒÿN–NaOŸSœ	0990	Yes	+5°C ± 3°C
	Y0001496	Cefoxitin for peak identification	1	15 mg	1		0990	Yes	+5°C ± 3°C
	Y0001305	Cefpodoxime proxetil	1	70 mg	1	See leaflet CœŒHœŸN—O„Sœ	2341	Yes	-20°C ± 5°C
	Y0001318	Cefpodoxime proxetil for impurity H identification	1	10 mg	1		2341	Yes	-20°C ± 5°C
	Y0001306	Cefpodoxime proxetil for peak identification	1	10 mg	1		2341	Yes	-20°C ± 5°C
	Y0001371	Cefprozil	1	120 mg	1	See leaflet	2342	Yes	+5°C ± 3°C
	Y0001372	Cefprozil impurity A	1	20 mg	1	(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid (p-hydroxyphenylglycine)	2342	Yes	+5°C ± 3°C
	Y0001367	Cefprozil for peak identification	2	10 mg	1	Batch 1 is valid until 31 January 2017	2342	Yes	+5°C ± 3°C
	Y0001368	Cefprozil impurity mixture	2	10 mg	1	Batch 1 is valid until 30 April 2017	2342	Yes	+5°C ± 3°C
	C0690000	Cefradine	5	300 mg	1	See leaflet ; Batch 4 is valid until 31 August 2017	0167,0168,0 578, 0708,0814	Yes	+5°C ± 3°C
	Y0000568	Cefradine for peak identification	2	15 mg	1		0814	Yes	+5°C ± 3°C
	Y0001174	Cefradine impurity mixture	1	0.04 mg	1		0814	Yes	+5°C ± 3°C
	C0690500	Ceftazidime	3	200 mg	1	See leaflet CœœHœœNÿOŸSœ ; Batch 2 is valid until 31 July 2017	1405, 2344	Yes	+5°C ± 3°C
	Y0001111	Ceftazidime for peak identification	2	13 mg	1	Batch 1 is valid until 30 November 2016	1405, 2344	Yes	+5°C ± 3°C
	C0691000	Ceftriaxone sodium	3	100 mg	1	See leaflet CŒ‡HŒÿN‡NaœOŸS–	0991	Yes	+5°C ± 3°C
	C0692000	Ceftriaxone impurity A	5	10 mg	1	(6R,7R)-7-[[(2E)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2- methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ((E)-isomer) ; Batch 4 is valid until 30 September 2017	0991	Yes	+5°C ± 3°C
	C0694990	Cefuroxime axetil	4	60 mg	1	See leaflet CœÐHœœN÷OŒÐS	1300	Yes	+5°C ± 3°C
	C0695000	Cefuroxime sodium	4	70 mg	1	See leaflet CŒÿHŒ—N÷NaO‡S	0988.0992	Yes	+5°C ± 3°C
	Y0001445	Celecoxib	2	200 mg	1	See leaflet	2591	Yes	+5°C ± 3°C
	Y0001446	Celecoxib impurity A	2	10 mg	1	4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide	2591	Yes	+5°C ± 3°C
	Y0001447	Celecoxib impurity B	2	10 mg	1	4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide	2591	Yes	+5°C ± 3°C
	Y0000311	Celiprolol hydrochloride	1	10 mg	1		1632	Yes	+5°C ± 3°C
	Y0000312	Celiprolol impurity I	1	0.02 mg	1	1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea	1632	Yes	+5°C ± 3°C
	Y0000239	Celiprolol for peak identification	2	20 mg	1		1632	Yes	+5°C ± 3°C
	Y0000784	Cellulose acetate	1	40 mg	1		0887	Yes	+5°C ± 3°C
	Y0001585	Cellulose acetate butyrate	1	60 mg	1		1406	Yes	+5°C ± 3°C
	Y0001054	Cellulose acetate phthalate	1	10 mg	1		0314	Yes	+5°C ± 3°C
	Y0001764	Cenla dry extract	1	150 mg	1		1498	Yes	-20°C ± 5°C
	C0700000	Cephaeline hydrochloride	4	15 mg	1		0081,0093, 0094,1530,1 875	Yes	+5°C ± 3°C
	C0980650	Cetirizine dihydrochloride	4	100 mg	1		1084	Yes	+5°C ± 3°C
	C0980651	Cetirizine impurity A	5	10 mg	1	(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine	1084	Yes	+5°C ± 3°C
	Y0001197	Cetirizine for peak identification	2	1.01 mg	1		1084	Yes	+5°C ± 3°C
	C0984100	Cetostearyl isononanoate - reference spectrum	1	n/a	1		1085
	C0990000	Cetyl alcohol	2	300 mg	1	See leaflet CŒÿH–÷O	0540,0702,0 801, 0802,0847,0 969, 1411	Yes	+5°C ± 3°C
	Y0000073	Cetyl palmitate 15	1	60 mg	1		1906	Yes	+5°C ± 3°C
	Y0000074	Cetyl palmitate 95	2	50 mg	1	Batch 1 is valid until 31 July 2017	1906	Yes	+5°C ± 3°C
	C1000000	Cetylpyridinium chloride	2	20 mg	1		0379	Yes	+5°C ± 3°C
New	C1050000	Chenodeoxycholic acid	4	125 mg	1	Batch 3 is valid until 31 October 2017	1189.1275	Yes	+5°C ± 3°C
	Y0000104	Chitosan hydrochloride	1	30 mg	1		1774	Yes	+5°C ± 3°C
	C1100000	Chlorambucil	1	100 mg	1		0137	Yes	+5°C ± 3°C
	Y0001298	Chlorambucil for system suitability	1	10 mg	1		0137	Yes	+5°C ± 3°C
	Y0001299	Chlorambucil with impurity G	1	10 mg	1		0137	Yes	+5°C ± 3°C
	C1200000	Chloramphenicol	4	100 mg	1	Batch 3 is valid until 31 March 2017	0071,0473,0 709	Yes	+5°C ± 3°C
	C1300000	Chloramphenicol dipalmitate	1	100 mg	1		0473	Yes	+5°C ± 3°C
	C1350000	Chloramphenicol disodium disuccinate	3	25 mg	1	See leaflet CŒ„HŒ‡ClœNœNaœOŒŒ	0709	Yes	+5°C ± 3°C
	Y0001869	Chloramphenicol for peak identification	1	15 mg	1		0071	Yes	+5°C ± 3°C
	C1400000	Chloramphenicol palmitate isomer	1	100 mg	1		0473	Yes	+5°C ± 3°C
	C1425000	Chloramphenicol sodium succinate	2	30 mg	1		0709	Yes	+5°C ± 3°C
	C1435000	Chlorcyclizine hydrochloride	1	100 mg	1		1086	Yes	+5°C ± 3°C
	C1450000	Chlordiazepoxide - * psy	1	50 mg	2		0656.1974	Yes	+5°C ± 3°C
	C1500000	Chlordiazepoxide hydrochloride - * psy	1	100 mg	1		0474	Yes	+5°C ± 3°C
	Y0000476	Chlordiazepoxide impurity A	2	10 mg	1	7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide	0474.0656	Yes	+5°C ± 3°C
	C1510000	Chlorhexidine	5	50 mg	1	Batch 4 is valid until 30 September 2017	0658	Yes	+5°C ± 3°C
	C1520000	Chlorhexidine diacetate	2	10 mg	1		01/2015:0657	Yes	+5°C ± 3°C
	C1540000	Chlorhexidine dihydrochloride	2	50 mg	1		0659	Yes	+5°C ± 3°C
New	Y0001545	Chlorhexidine for system suitability	2	10 mg	1	Batch 1 is valid until 31 December 2017	0658, 0657, 0659	Yes	+5°C ± 3°C
	Y0001653	Chlormadinone acetate	1	120 mg	1	See leaflet	2702	Yes	+5°C ± 3°C
	Y0001656	Chlormadinone acetate impurity G	2	10 mg	1	3,20-dioxopregn-4-en-17-yl acetate ; Batch 1 is valid until 31 July 2017	2702	Yes	+5°C ± 3°C
	Y0001638	Chlormadinone acetate for system suitability	1	10 mg	1		2702	Yes	+5°C ± 3°C
	Y0000569	Chlorogenic acid	2	25 mg	1	See leaflet CŒÿHŒ‡O„ ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5- trihydroxycyclohexanecarboxylic acid	1821,1822,1 823, 1824,1866,1 897, 2389	Yes	+5°C ± 3°C
	C1650000	Chloroquine sulfate	3	200 mg	1		0544.0545	Yes	+5°C ± 3°C
	C1700000	Chlorothiazide	3	10 mg	1		0394	Yes	+5°C ± 3°C
	C1800000	Chlorphenamine maleate	2	20 mg	1		0386,0977,1 084, 1196	Yes	+5°C ± 3°C
	Y0000436	Chlorphenamine impurity A	4	0.01 mg	1	2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino) ethyl]butanenitrile	0386	Yes	+5°C ± 3°C
	Y0000437	Chlorphenamine impurity C	2	10 mg	1	(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine	0386	Yes	+5°C ± 3°C
	C1900000	Chlorpromazine hydrochloride	1	200 mg	1		0475	Yes	+5°C ± 3°C
	Y0000507	Chlorpromazine impurity A	1	15 mg	1	3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine sulphoxide)	0475	Yes	+5°C ± 3°C
	Y0000479	Chlorpromazine impurity D	1	10 mg	1	3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (desmethylchlorpromazine)	0475	Yes	+5°C ± 3°C
	Y0000508	Chlorpromazine impurity E	1	10 mg	1	2-chloro-10H-phenothiazine	0475	Yes	+5°C ± 3°C
	Y0001449	Chlorpromazine impurity F	1	2 mg	1	3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine	0475	Yes	+5°C ± 3°C
	C1905000	Chlorpropamide	1	100 mg	1		1087	Yes	+5°C ± 3°C
New	C1905020	Chlorpropamide impurity B	2	30 mg	1	1,3-Dipropylurea ; Batch 1 is valid until 31 December 2017	1087	Yes	+5°C ± 3°C
	C1915000	Chlorprothixene hydrochloride	5	50 mg	1	See leaflet	0815.1365	Yes	+5°C ± 3°C
	C1950000	Chlortalidone	3	150 mg	1	See leaflet CŒ÷HŒŒClNœO÷S	0546	Yes	+5°C ± 3°C
	Y0000779	Chlortalidone for peak identification	3	1.017 mg	1		0546	Yes	+5°C ± 3°C
	C2000000	Chlortetracycline hydrochloride	5	100 mg	1	See leaflet	0173	Yes	+5°C ± 3°C
	Y0001451	Chlortetracycline for system suitability	2	10 mg	1		0173	Yes	+5°C ± 3°C
	C2100000	Cholecalciferol	9	500 mg	1	See leaflet; Vitamin D3	0072, 0574, 0575, 0598, 1192, 1193, 2398	Yes	-20°C ± 5°C
	C2150000	Cholecalciferol for system suitability	7	1 mL	1		0072, 0574, 0575,0598	Yes	-20°C ± 5°C
	C2155000	Cholesterol	4	100 mg	1	See leaflet	0593, 0993, 2397	Yes	+5°C ± 3°C
	C2158000	Cholic acid	2	60 mg	1		1189	Yes	+5°C ± 3°C
	Y0000280	Chondroitin sulfate sodium	2	250 mg	1	See leaflet HœO(CŒ÷HŒ„NNaœOŒ÷S)¨	2064.2090	Yes	+5°C ± 3°C
	Y0000593	Chondroitin sulfate sodium (marine)	1	100 mg	1		2064	Yes	+5°C ± 3°C
New	C2160000	Chymotrypsin BRP	3	100 mg	1	See leaflet ; Batch 2 is valid until 30 November 2017	0476.0694	Yes	+5°C ± 3°C
	Y0001553	Ciclesonide	1	150 mg	1	See leaflet C–œH÷÷OŸ	2703	Yes	+5°C ± 3°C
	Y0001554	Ciclesonide containing impurity A	1	15 mg	1	(2′S)-2′-cyclohexyl-11β-hydroxy-3,20-dioxo-16βH-[1,3]dioxolo[4′,5′:16,17] pregna-1,4-dien-21-yl 2-methylpropanoate (S-epimer of ciclesonide)	2703	Yes	+5°C ± 3°C
	Y0001555	Ciclesonide impurity B	1	10 mg	1	(2'R)-2'-cyclohexyl-11β,21-dihydroxy-16βH-[1,3]dioxolo[4',5':16,17] pregna-1,4-diene-3,20-dione	2703	Yes	+5°C ± 3°C
	Y0001556	Ciclesonide impurity C	1	10 mg	1	(2′R)-2′-[(1RS)-cyclohex-3-enyl]-11β-hydroxy-3,20-dioxo-16βH-[1,3] dioxolo[4′,5′:16,17]pregna-1,4-dien-21-yl 2-methylpropanoate	2703	Yes	+5°C ± 3°C
New	Y0000040	Ciclopirox	2	75 mg	1	Batch 1 is valid until 30 November 2017	1407	Yes	+5°C ± 3°C
	C2162701	Ciclopirox impurity A	4	40 mg	1	[(5RS)-3-cyclohexyl-5-methyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid ; Batch 3 is valid until 31 July 2017	1302.1407	Yes	+5°C ± 3°C
	C2162702	Ciclopirox impurity B	3	20 mg	1	6-cyclohexyl-4-methyl-2H-pyran-2-one	1302.1407	Yes	-20°C ± 5°C
	C2162700	Ciclopirox olamine	2	150 mg	1		1302	Yes	+5°C ± 3°C
	C2163000	Ciclosporin	3	120 mg	1	See leaflet	0994	Yes	+5°C ± 3°C
	Y0000361	Ciclosporin for system suitability	1	5 mg	1		0994	Yes	+5°C ± 3°C
	C2170000	Cilastatin sodium	2	10 mg	1		1408	Yes	+5°C ± 3°C
	Y0001651	Cilastatin for system suitability 1	1	5 mg	1		1408	Yes	+5°C ± 3°C
	Y0001652	Cilastatin for system suitability 2	1	5 mg	1		1408	Yes	+5°C ± 3°C
	C2174000	Cilazapril	1	50 mg	1		1499	Yes	+5°C ± 3°C
	C2174002	Cilazapril impurity A	1	25 mg	1	1,1-dimethylethyl (1S,9S)-9-[[(S)-1-(ethoxycarbonyl)-3-phenylpropyl] amino]-10-oxooctahydro-6H-pyridazi,2-a][1,2]diazepine-1-carboxylate	1499	Yes	+5°C ± 3°C
	C2174005	Cilazapril impurity D	1	10 mg	1	(1S,9S)-9-[[(R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazi,2-a][1,2]diazepine-1-carboxylic acid	1499	Yes	+5°C ± 3°C
	C2175000	Cimetidine	1	50 mg	1		0756	Yes	+5°C ± 3°C
	C2175500	Cimetidine hydrochloride	1	100 mg	1		1500	Yes	+5°C ± 3°C
	Y0001130	Cimetidine for peak identification	1	10 mg	1		0756, 1500	Yes	+5°C ± 3°C
	Y0001146	Cimetidine for system suitability	1	0.5085 mg	1		0756, 1500	Yes	+5°C ± 3°C
	C2177000	Cinchocaine hydrochloride	2	60 mg	1		1088	Yes	+5°C ± 3°C
	Y0000176	Cineole	2	180 mg	1		1973	Yes	+5°C ± 3°C
	C2180000	Cinnarizine	2	100 mg	1		0816	Yes	+5°C ± 3°C
	Y0000362	Ciprofibrate	1	5 mg	1		2013	Yes	+5°C ± 3°C
	Y0000363	Ciprofibrate for system suitability	1	5 mg	1		2013	Yes	+5°C ± 3°C
	Y0000198	Ciprofloxacin	1	20 mg	1		1089	Yes	+5°C ± 3°C
New	C2190000	Ciprofloxacin hydrochloride	6	100 mg	1	See leaflet ; Batch 5 is valid until 30 November 2017	0888.1353	Yes	+5°C ± 3°C
	Y0000199	Ciprofloxacin hydrochloride for peak identification	2	15 mg	1		0888.1089	Yes	+5°C ± 3°C
	C2190050	Ciprofloxacin impurity A	5	25 mg	1	7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (fluoroquinolonic acid) ; Batch 4 is valid until 31 December 2016	0888,1089,2 229	Yes	+5°C ± 3°C
	Y0001766	Cisatracurium besilate	1	170 mg	1	See leaflet	2763	Yes	-20°C ± 5°C
	Y0001768	Cisatracurium for peak identification	1	5 mg	1		2763	Yes	-20°C ± 5°C
	Y0001767	cisatracurium for system suitability	1	5 mg	1		2763	Yes	-20°C ± 5°C
	C2210000	Cisplatin	6	100 mg	1	See leaflet [PtClœ(NH–)œ]	0599	Yes	+5°C ± 3°C
	Y0001018	Cisplatin impurity A	2	15 mg	1	trans-diamminedichloroplatinum(II) (transplatin), ; Batch 1 is valid until 31 May 2017	0599	Yes	+5°C ± 3°C
	Y0001019	Cisplatin impurity B	2	15 mg	1	See leaflet [PtCl–(NH–)]-; amminetrichloroplatinate(-)	0599	Yes	+5°C ± 3°C
	Y0001008	Citalopram hydrobromide	1	5 mg	1		2288,2758,2 733	Yes	+5°C ± 3°C
	Y0001007	Citalopram hydrochloride	1	5 mg	1		2203	Yes	+5°C ± 3°C
	Y0000855	Citalopram for system suitability	3	0.065 mg	1		2203.2288	Yes	+5°C ± 3°C
	A1202000	Citric acid (anhydrous)	2	50 mg	1		0455	Yes	+5°C ± 3°C
	C2219000	Citric acid monohydrate	1	50 mg	1		0456	Yes	+5°C ± 3°C
	Y0000639	Cladribine	2	50 mg	1	See leaflet CŒÐHŒœClN—O–	2174	Yes	-20°C ± 5°C
	Y0000610	Cladribine impurity C	1	5 mg	1	2-chloro-7H-purin-6-amine (2-chloroadenine)	2174	Yes	-20°C ± 5°C
	Y0000609	Cladribine for peak identification	1	10 mg	1		2174	Yes	-20°C ± 5°C
	Y0000320	Clarithromycin	3	160 mg	1	See leaflet C–‡Hÿ„NOŒ–	1651	Yes	+5°C ± 3°C
New	Y0000321	Clarithromycin for peak identification	3	10 mg	1	Batch 2 is valid until 31 December 2017	1651	Yes	+5°C ± 3°C
	Y0001193	Clazuril	1	10 mg	1		1714	Yes	+5°C ± 3°C
	Y0000269	Clazuril for system suitability	1	10 mg	1		1714	Yes	+5°C ± 3°C
	C2221000	Clebopride malate	1	100 mg	1		1303	Yes	+5°C ± 3°C
	C2223000	Clemastine fumarate	1	100 mg	1		1190	Yes	+5°C ± 3°C
	Y0001613	Clemastine for system suitability	1	0.165 mg	1		1190	Yes	+5°C ± 3°C
	C2248000	Clenbuterol hydrochloride	2	30 mg	1		1409	Yes	+5°C ± 3°C
	C2248010	Clenbuterol impurity B	2	10 mg	1	1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone	1409	Yes	+5°C ± 3°C
	C2250000	Clindamycin hydrochloride	5	200 mg	1	See leaflet ; Batch 4 is valid until 31 January 2017	0582	Yes	+5°C ± 3°C
	C2269000	Clindamycin phosphate	2	250 mg	1	see leaflet	0996	Yes	+5°C ± 3°C
	Y0001680	Clindamycin phosphate for system suitability	1	10 mg	1		0996	Yes	+5°C ± 3°C
	Y0000364	Clioquinol	1	5 mg	1		2111	Yes	+5°C ± 3°C
	Y0000205	Clobazam - reference spectrum	1	n/a	1		1974
	Y0000241	Clobazam impurity A	1	10 mg	1	7-chloro-5-phenyl-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione	1974	Yes	+5°C ± 3°C
	Y0000559	Clobetasol propionate	2	50 mg	1	See leaflet Cœ—H–œClFO— ; Batch 1 is valid until 31 December 2016	2127	Yes	+5°C ± 3°C
New	Y0000571	Clobetasol impurity J	3	0.4 mg	1	(17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro [androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound) ; Batch 2 is valid until 30 September 2017	2127	Yes	+5°C ± 3°C
New	Y0000570	Clobetasol for peak identification	3	2 mg	1	Batch 2 is valid until 30 September 2017	2127	Yes	+5°C ± 3°C
	C2285000	Clobetasone butyrate	1	50 mg	1		1090	Yes	+5°C ± 3°C
	Y0001137	Clobetasone butyrate for system suitability	1	30 mg	1		1090	Yes	+5°C ± 3°C
	Y0000888	Clodronate disodium tetrahydrate	1	5 mg	1		1777	Yes	+5°C ± 3°C
	Y0000885	Clodronate impurity D	1	5 mg	1	(chloromethylene)bis(phosphonic acid)	1777	Yes	+5°C ± 3°C
	Y0000313	Clofazimine	1	150 mg	1		2054	Yes	+5°C ± 3°C
	Y0000358	Clofazimine for system suitability	1	10 mg	1		2054	Yes	+5°C ± 3°C
	C2300000	Clofibrate	1	0.5 ml	1		0318	Yes	+5°C ± 3°C
	C2320000	Clomifene citrate	2	50 mg	1	See leaflet C–œH–ÿClNO‡	0997.1046	Yes	+5°C ± 3°C
	C2332000	Clomifene citrate for performance test	1	50 mg	1		0997	Yes	+5°C ± 3°C
	C2360000	Clomipramine hydrochloride	1	100 mg	1		0889	Yes	+5°C ± 3°C
	Y0000132	Clomipramine impurity C	2	20 mg	1	3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine	0889	Yes	+5°C ± 3°C
	Y0000133	Clomipramine impurity D	2	10 mg	1	See leaflet CŒ„HœœClœNœ; 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f] azepin-5-yl)-N,N-dimethylpropan-1-amine	0889	Yes	+5°C ± 3°C
	Y0000134	Clomipramine impurity F	1	5 mg	1	3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine	0889	Yes	+5°C ± 3°C
	C2385000	Clonazepam - * psy	1	50 mg	1		1974.0415	Yes	+5°C ± 3°C
	Y0000286	Clonazepam - reference spectrum	1	n/a	1		0890
	C2385015	Clonazepam impurity B	2	5 mg	1	3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one	0890	Yes	+5°C ± 3°C
	C2400000	Clonidine hydrochloride	1	100 mg	1		0477	Yes	+5°C ± 3°C
	Y0000801	Clonidine impurity B	1	20 mg	1	1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole	0477	Yes	+5°C ± 3°C
	Y0000833	Clopamide	1	40 mg	1		1747	Yes	+5°C ± 3°C
	Y0000848	Clopamide for system suitability	1	10 mg	1		1747	Yes	+5°C ± 3°C
	Y0001852	Clopidogrel besilate	1	10 mg	1		2790	Yes	+5°C ± 3°C
	Y0001334	Clopidogrel for system suitability	2	100 mg	1		2531,2790,2 791	Yes	+5°C ± 3°C
	Y0001857	Clopidogrel hydrochloride	1	100 mg	1	see leaflet	2790.2791	Yes	+5°C ± 3°C
	Y0001333	Clopidogrel hydrogen sulfate	1	60 mg	1		2531	Yes	+5°C ± 3°C
	Y0001335	Clopidogrel impurity A	2	10 mg	1	(2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic ac	2531,2790,2 791	Yes	+5°C ± 3°C
	Y0000392	Closan sodium dihydrate	1	20 mg	1		1716	Yes	+5°C ± 3°C
	Y0000393	Closan for system suitability	1	20 mg	1		1716	Yes	+5°C ± 3°C
	C2424400	Clostridia (multi-component) rabbit antiserum(for vaccines-vet.use)BRP	1	1 mg	1	See leaflet	0362,0363,0 364, 0697	Yes	-20°C ± 5°C
	C2424550	Clostridium tetani guinea pig antiserum (for vaccines - human use) BRP	1	1 mg	3	See leaflet	20708	Yes	-20°C ± 5°C
	C2424500	Clostridium tetani guinea pig antiserum (for vaccines - vet. use) BRP	1	1 mg	1	See leaflet	See leaflet, 0697	Yes	-20°C ± 5°C
	C2425600	Clostridium tetani rabbit antiserum (for vaccines - vet. use) BRP	1	1 mg	1	See leaflet	See leaflet, 0697	Yes	-20°C ± 5°C
	C2430000	Clotrimazole	4	100 mg	1	Batch 3 is valid until 28 February 2017	0757	Yes	+5°C ± 3°C
New	Y0000818	Clotrimazole impurity E	3	15 mg	1	(2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) ; Batch 2 is valid until 30 September 2017	0757	Yes	+5°C ± 3°C
	Y0000849	Clotrimazole for peak identification	2	1.005 mg	1		0757	Yes	+5°C ± 3°C
	C2450000	Cloxacillin sodium	4	200 mg	1	see leaflet	0661, 0663, 0668, 2260, 2346	Yes	+5°C ± 3°C
	C2460000	Clozapine	2	60 mg	1		1191	Yes	+5°C ± 3°C
	Y0000758	Clozapine for peak identification	2	0.41 mg	1		1191	Yes	+5°C ± 3°C
	Y0001472	Coagulation Factors V, VIII, XI and XIII plasma	1	1 mg	2	See leaflet	0903,1646,2 0740,20722	Yes	-20°C ± 5°C
	Y0000162	Cocaine hydrochloride - reference spectrum	1	n/a	1		0073
	C2480000	Cocoyl caprylocaprate	1	40 mg	1		1411	Yes	+5°C ± 3°C
	Y0000722	Codeine - * narc	1	20 mg	1	See leaflet	0076,0777,1 839,1840,18	Yes	+5°C ± 3°C
	C2500000	Codeine - reference spectrum	1	n/a	1		0074.0075
	Y0000334	Codeine impurity A	4	15 mg	1	7,8-didehydro-4,5α-epoxy-3,6α-dimethoxy-17-methylmorphinan (methylcodeine)	0074,0075,0 076, 1412	Yes	+5°C ± 3°C
	C2500100	Codeine hydrochloride dihydrate - reference spectrum	1	n/a	1		1412
	C2510000	Codergocrine mesilate	2	60 mg	1		1416.2060	Yes	+5°C ± 3°C
	Y0001500	Coix seed HRS	1	1300 mg	1		2454	Yes	+5°C ± 3°C
	C2580000	Colchicine	2	15 mg	1		0758	Yes	+5°C ± 3°C
	Y0000209	Colchicine for system suitability	2	10 mg	1		0758	Yes	+5°C ± 3°C
	Y0000374	Colestyramine	1	10 mg	1		1775	Yes	+5°C ± 3°C
	C2600000	Colistimethate sodium	2	20 mg	1	See leaflet	0319.20702	Yes	+5°C ± 3°C
New	Y0001888	Colistimethate sodium for peak identification	1	20 mg	1		0319, 20702	Yes	+5°C ± 3°C
	Y0000277	Colistin sulfate	4	25 mg	1	See leaflet	0320	Yes	-20°C ± 5°C
	C2700000	Colistin sulfate for microbiological assay	2	25 mg	1	See leaflet; For microbiological assay only	0320	Yes	-20°C ± 5°C
	C2725000	Copovidone - reference spectrum	1	n/a	1		0891
	Y0001748	Copper tetramibi tetrafluoroborate	1	15 mg	1		2547	Yes	-20°C ± 5°C
	C2800000	Cortisone acetate	6	250 mg	1		0321,0736,0 767	Yes	+5°C ± 3°C
	Y0001307	Costunolide	1	10 mg	1	See leaflet CŒ—HœÐOœ	1797	Yes	-20°C ± 5°C
	C2900000	Cotton wool standard for neps	1	1000 mg	1		0036	Yes	+5°C ± 3°C
	Y0000438	Coumarin	1	110 mg	1	See leaflet C„HÿOœ	2120	Yes	+5°C ± 3°C
	Y0001053	Crospovidone	4	25 mg	1	see leaflet ; Batch 1 is valid until 30 September 2017	0892	Yes	+5°C ± 3°C
	C2970000	Crotamiton	3	100 mg	1	see leaflet CŒ–HŒŸNO	1194	Yes	-20°C ± 5°C
	C2970005	Crotamiton impurity A	5	35 mg	1	See leaflet; N-ethyl-N-(2-methylphenyl)but-3-enamide	1194	Yes	-20°C ± 5°C
	Y0001061	Cyanidin chloride	3	25 mg	1	See leaflet CŒ—HŒŒClOÿ ; Batch 2 is valid until 31 July 2016	2394	Yes	+5°C ± 3°C
	C3000000	Cyanocobalamin	5	20 mg	1	Vitamin B12	0269,0270,0 547, 0710,1505	Yes	+5°C ± 3°C
	C3090000	Cyclizine hydrochloride	1	50 mg	1		1092	Yes	+5°C ± 3°C
	Y0000886	Cyclizine impurity A	1	15 mg	1	1-methylpiperazine	1092	Yes	+5°C ± 3°C
	Y0000887	Cyclizine impurity B	1	15 mg	1	diphenylmethanol (benzhydrol)	1092	Yes	+5°C ± 3°C
	C3200000	Cyclobenzaprine hydrochloride	1	100 mg	1		0408.0464	Yes	+5°C ± 3°C
	C3230000	Cyclohexa-1,4-dienylglycine	3	15 mg	1	(2R)-amino(cyclohexa-1,4-dienyl)acetic acid (d-dihydrophenylglycine)	0814	Yes	-20°C ± 5°C
	C3245000	Cyclopentolate hydrochloride	2	50 mg	2		1093	Yes	+5°C ± 3°C
	Y0001088	Cyclopentolate for system suitability	2	20 mg	1		1093	Yes	+5°C ± 3°C
	C3250000	Cyclophosphamide	3	50 mg	1		0711	Yes	+5°C ± 3°C
	C3280000	Cyproheptadine hydrochloride	2	15 mg	1		0817.0846	Yes	+5°C ± 3°C
	Y0001095	Cyproheptadine impurity C	1	5 mg	1	5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol	0817	Yes	+5°C ± 3°C
	C3283000	Cyproterone acetate	2	30 mg	1		1094	Yes	+5°C ± 3°C
	Y0001390	Cyproterone acetate for peak identification	1	5 mg	1		1094	Yes	+5°C ± 3°C
	Y0001223	Cyproterone impurity mixture	2	0.01 mg	1	Batch 1 is valid until 30 November 2016	1094	Yes	+5°C ± 3°C
	C3290000	Cysteine hydrochloride monohydrate	2	100 mg	1		0895	Yes	+5°C ± 3°C
	C3300000	Cystine	2	100 mg	1		0998	Yes	+5°C ± 3°C
	C3350000	Cytarabine	2	150 mg	1	Batch 1 is valid until 31 July 2016	0760	Yes	+5°C ± 3°C
	Y0000733	Dacarbazine	1	20 mg	1		1691	Yes	+5°C ± 3°C
	Y0000734	Dacarbazine impurity A	2	20 mg	1	See leaflet C÷H–N—O; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2- azahypoxanthine)	1691	Yes	+5°C ± 3°C
	Y0000735	Dacarbazine impurity B	1	10 mg	1	See leaflet; 5-amiH-imidazole-4-carboxamide	1691	Yes	+5°C ± 3°C
	D0070000	Dalteparin sodium	3	250 mg	1		1195	Yes	+5°C ± 3°C
	Y0000600	Danaparoid sodium	2	10.5 mg	1	See leaflet	2090	Yes	+5°C ± 3°C
	D0100000	Dapsone	2	100 mg	1		0077	Yes	+5°C ± 3°C
	D0125000	Daunorubicin hydrochloride	4	120 mg	1	See leaflet CœŸH–ÐClNOŒÐ	0662	Yes	+5°C ± 3°C
	D0120000	Daunorubicinone	3	10 mg	1	Daunorubicin aglycone	0662	Yes	+5°C ± 3°C
	D0160000	Deferoxamine mesilate	2	30 mg	1		0896	Yes	+5°C ± 3°C
	Y0001934	Deferoxamine for system suitability	n/a	n/a	1		0896	Yes	-20°C ± 5°C
	D0201000	Dehydrohexetidine	2	50 mg	1	2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl] hexan-1-amine	1221	Yes	+5°C ± 3°C
	Y0000611	Dembrexine hydrochloride monohydrate	1	10 mg	1		2169	Yes	+5°C ± 3°C
	Y0001707	Demeclocycline for system suitability	1	10 mg	1		0176	Yes	+5°C ± 3°C
	D0300000	Demeclocycline hydrochloride	4	100 mg	1	see leaflet	0211,0210,0 176, 0173,1654	Yes	+5°C ± 3°C
	D0350000	N-Demethylerythromycin A	3	15 mg	1		0274	Yes	+5°C ± 3°C
	Y0000228	Demethylflumazenil - reference spectrum	1	n/a	1		1917
	D0406200	Deptropine citrate	1	60 mg	1		1308	Yes	+5°C ± 3°C
	D0430000	Dequalinium chloride	1	50 mg	1		1413	Yes	+5°C ± 3°C
	D0431000	Dequalinium chloride for performance test	1	50 mg	1		1413	Yes	+5°C ± 3°C
	Y0001321	Dermatan sulfate and over-sulfated chondroitin sulfate	2	1 mL	1	See leaflet	0332.0333	Yes	-20°C ± 5°C
	D0480000	Desacetylvinblastine	1	1 mg	2		1276	Yes	-80°C ± 10°C
	Y0000879	Desflurane - reference spectrum	1	n/a	1		1666
	Y0000807	Desflurane impurity A	2	1 mL	1	1,1'-oxybis(1,2,2,2-tetrafluoroethane)	1666	Yes	+5°C ± 3°C
	D0500000	Desipramine hydrochloride	1	100 mg	1		0481	Yes	+5°C ± 3°C
	D0600000	Deslanoside	2	150 mg	1	See leaflet C÷ŸHŸ÷OŒ„	0482	Yes	+5°C ± 3°C
	Y0001584	Desloratadine	2	100 mg	1	See leaflet	2570	Yes	+5°C ± 3°C
	D0630000	Desmethylmetrifonate	2	25 mg	1		1133	Yes	+5°C ± 3°C
	Y0001582	Desloratadine for system suitability	1	5 mg	1		2570	Yes	+5°C ± 3°C
	D0650000	Desmopressin	9	1 mg	1	See leaflet C÷ÿHÿ÷NŒ÷OŒœSœ ; Batch 8 is valid until 30 June 2017	0712	Yes	-20°C ± 5°C
	Y0000509	Desogestrel	1	50 mg	1	See leaflet CœœH–ÐO	1717	Yes	+5°C ± 3°C
	Y0000510	Desogestrel for system suitability	2	10 mg	1		1717	Yes	+5°C ± 3°C
New	D0400000	Desoxycortone acetate	4	100 mg	1	Batch 2 is valid until 31 December 2017	0322, 1327	Yes	+5°C ± 3°C
	Y0000001	Detomidine hydrochloride	2	100 mg	1		1414	Yes	+5°C ± 3°C
	D0660020	Detomidine impurity B	1	20 mg	1	(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol	1414	Yes	+5°C ± 3°C
	D0700000	Dexamethasone	5	50 mg	1		0312,0388,0 548, 0768,1376,2 237,0549	Yes	+5°C ± 3°C
	Y0001593	Dexamethasone for peak identification	1	10 mg	1		0388	Yes	+5°C ± 3°C
	Y0001177	Dexamethasone for system suitability	2	10 mg	1		0388	Yes	+5°C ± 3°C
	D0710000	Dexamethasone acetate	4	100 mg	2	Batch 3 is valid until 31 May 2017	0548,0933,0 975, 2237	Yes	+5°C ± 3°C
	Y0001842	Dexamethasone acetate for peak identification	1	10 mg	1		0548		+5°C ± 3°C
	Y0001169	Dexamethasone acetate impurity E	1	0.013 mg	1	9-fluoro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregn-4-en-21-yl acetate	0548	Yes	+5°C ± 3°C
	Y0000538	Dexamethasone isonicotinate	1	10 mg	1		2237	Yes	+5°C ± 3°C
	Y0000511	Dexamethasone isonicotinate for impurity C identificatio	1	10 mg	1		2237	Yes	+5°C ± 3°C
	D0718000	Dexamethasone pivalate	1	50 mg	1		1327	Yes	+5°C ± 3°C
	D0720000	Dexamethasone sodium phosphate	6	130 mg	1	See leaflet	0549,0735,0 810	Yes	+5°C ± 3°C
	Y0001477	Dexamethasone sodium phosphate for peak identification	1	10 mg	1		0549	Yes	+5°C ± 3°C
	D0720800	Dexchlorpheniramine maleate	1	60 mg	1		1196	Yes	+5°C ± 3°C
	D0730000	Dexpanthenol	5	5 mg	1		0761	Yes	+5°C ± 3°C
	D0731000	Dextran	1	25 mg	1		0999,1000,1 001	Yes	+5°C ± 3°C
	D0731005	Dextran 1	1	50 mg	1	See leaflet; Average molecule mass : 930-1000 Fraction with less than 3 glucose units : 8.0 to 10.5% Fraction with more than 9 glucose units : 10.0 to 12.5%	1506	Yes	+5°C ± 3°C
	D0733000	Dextran 4 for calibration	1	50 mg	1	See leaflet	20239	Yes	+5°C ± 3°C
	D0734000	Dextran 10 for calibration	1	50 mg	1	See leaflet	20239	Yes	+5°C ± 3°C
	D0735000	Dextran 40 for calibration	1	50 mg	1	See leaflet	20239	Yes	+5°C ± 3°C
	D0738000	Dextran 40 for performance test	1	50 mg	1		20239	Yes	+5°C ± 3°C
	D0739000	Dextran 60/70 for performance test	1	50 mg	1		20239	Yes	+5°C ± 3°C
	D0736000	Dextran 70 for calibration	1	50 mg	1	See leaflet	20239	Yes	+5°C ± 3°C
	D0737000	Dextran 250 for calibration	1	50 mg	1	See leaflet	20239	Yes	+5°C ± 3°C
	D0732000	Dextran Vo	1	10 mg	1		20239	Yes	+5°C ± 3°C
	Y0000744	Dextranomer	1	50 mg	1		2238	Yes	+5°C ± 3°C
	D0740000	Dextromethorphan hydrobromide	4	100 mg	1		0020	Yes	+5°C ± 3°C
	Y0000261	Dextromethorphan impurity A	2	5 mg	1	ent-3-methoxymorphinan	0020	Yes	+5°C ± 3°C
	Y0001058	Dextropropoxyphene hydrochloride - * narc	1	10 mg	1		0713	Yes	+5°C ± 3°C
	Y0001150	Dextropropoxyphene for system suitability - * narc	1	5 mg	1		0713	Yes	+5°C ± 3°C
	Y0001595	Diacerein	1	150 mg	1	See leaflet CŒ„HŒœO‡	2409	Yes	+5°C ± 3°C
	Y0001596	Diacerein impurity B	1	20 mg	1	see leaflet; 1,8-dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (aloe- emodin)	2409	Yes	+5°C ± 3°C
	Y0001597	Diacerein impurity mixture	1	0.014 mg	1		2409	Yes	-20°C ± 5°C
	Y0000454	Diacetylfluorescein	1	100 mg	1	See leaflet	1213	Yes	+5°C ± 3°C
	D0940000	Diazepam - * psy	1	30 mg	1		0022	Yes	+5°C ± 3°C
	Y0000596	Diazepam for system suitability - * psy	2	0.5 mg	1		0022	Yes	+5°C ± 3°C
	D0950000	Diazoxide	1	50 mg	1		0550	Yes	+5°C ± 3°C
	D0970000	Dibenzocycloheptene	3	20 mg	1	Batch 2 is valid until 31 August 2016	0817	Yes	+5°C ± 3°C
New	D1000000	Dibenzosuberone	3	30 mg	1	Batch 2 is valid until 31 October 2017	0464,0817,0 941	Yes	+5°C ± 3°C
	Y0000480	Dibrompropamidine diisetionate	1	10 mg	1		2300	Yes	+5°C ± 3°C
	Y0000481	Dibrompropamidine for system suitability	1	20 mg	1		2300	Yes	+5°C ± 3°C
	D1010000	Dibutyl phthalate	1	1 ml	1		0762	Yes	+5°C ± 3°C
	Y0001620	2,4-dichlorobenzyl alcohol	1	250 mg	1	See leaflet CŸHÿClœO	2410	Yes	+5°C ± 3°C
	Y0001621	2,4-Dichlorobenzyl alcohol impurity A	1	25 mg	1	(2,5-dichlorophenyl)methanol	2410	Yes	+5°C ± 3°C
	Y0001622	2,4-Dichlorobenzyl alcohol impurity C	1	25 mg	1	(3,4-dichlorophenyl)methanol	2410	Yes	+5°C ± 3°C
	Y0000275	Dichlorodiaminocyclohexaneplatinum	5	15 mg	1	Batch 4 is valid until 31 October 2016	2017	Yes	+5°C ± 3°C
	Y0000264	Diclazuril for veterinary use - reference spectrum	1	n/a	1		1718
	Y0000259	Diclazuril for system suitability	1	20 mg	1		1718	Yes	+5°C ± 3°C
	D1039990	Diclofenac potassium	3	70 mg	1		1508	Yes	+5°C ± 3°C
	S0765000	Diclofenac sodium	4	100 mg	1		1002.1281	Yes	+5°C ± 3°C
	D1040000	Diclofenac impurity A	9	0.005 mg	1	1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 8 is valid until 30 June 2017	1281	Yes	+5°C ± 3°C
	Y0001635	Diclofenac for system suitability	2	1 mg	1	Batch 1 is valid until 31 August 2016	1002.1508	Yes	+5°C ± 3°C
	D1050000	Dicloxacillin sodium	5	250 mg	1	See leaflet CŒ„HŒÿClœN–NaO—S	0661, 0663, 0668, 2346	Yes	-20°C ± 5°C
	D1060000	Dicycloverine hydrochloride	2	100 mg	1		1197	Yes	+5°C ± 3°C
	Y0001864	Dicycloverine for system suitability	1	15 mg	1		1197	Yes	+5°C ± 3°C
	Y0001900	Dicycloverine impurity A	1	20 mg	1		1197	Yes	+5°C ± 3°C
	Y0000439	Didanosine	1	10 mg	1		2200	Yes	+5°C ± 3°C
	Y0000441	Didanosine impurity A	1	10 mg	1	1,7-dihydro-6H-purin-6-one (hypoxanthine)	2200	Yes	+5°C ± 3°C
	Y0000442	Didanosine impurity G	1	10 mg	1	9-(2,3-dideoxy-ß-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'- dideoxyadenosine)	2200	Yes	+5°C ± 3°C
	Y0000440	Didanosine for system suitability	1	10 mg	1		2200	Yes	+5°C ± 3°C
	D1200000	Dienestrol	3	150 mg	1	See leaflet CŒ‡HŒ‡Oœ	0484	Yes	+5°C ± 3°C
	Y0001785	Dienogest	1	80 mg	1	See leaflet CœÐHœ—NOœ	2732	Yes	+5°C ± 3°C
	Y0001782	Dienogest for system suitability	1	10 mg	1		2732	Yes	+5°C ± 3°C
	D1410000	Diethyl phthalate	2	1 mL	1	Batch 1 is valid until 31 July 2017	0897	Yes	+5°C ± 3°C
	D1300000	Diethylcarbamazine citrate	2	250 mg	1	See leaflet CŒÿHœ„N–O‡	0271	Yes	+5°C ± 3°C
	Y0000217	Diethylene glycol (monoethyl ether) - reference spectru	1	n/a	1		1198
	D1500000	Diethylstilbestrol	1	100 mg	1	See leaflet CŒ‡HœÐOœ	0484	Yes	+5°C ± 3°C
	D1600000	Diethylstilbestrol dimethyl ether	1	10 mg	1		0484	Yes	+5°C ± 3°C
	D1700000	Diethylstilbestrol monomethyl ether	1	10 mg	1		0484	Yes	+5°C ± 3°C
	Y0001423	Difloxacin hydrochloride	1	60 mg	1		2239	Yes	+5°C ± 3°C
	Y0001429	Difloxacin impurity G	1	15 mg	1	7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid	2239	Yes	+5°C ± 3°C
	D1750000	Diflunisal	1	30 mg	1		0864	Yes	+5°C ± 3°C
	D1800000	Digitoxin	4	200 mg	1	See leaflet C÷ŒHÿ÷OŒ–	0078.0117	Yes	+5°C ± 3°C
	Y0000640	Digoxigenin	3	10 mg	1	See leaflet	0079	Yes	+5°C ± 3°C
	D1900000	Digoxin	7	30 mg	1	See leaflet C÷ŒHÿ÷OŒ÷	0079	Yes	+5°C ± 3°C
	Y0000554	Digoxin for peak identification	1	10 mg	1		0079	Yes	+5°C ± 3°C
	D1940001	Dihydralazine sulfate (hydrated) - reference spectrum	1	n/a	1		1310
	Y0000232	Dihydralazine for system suitability	1	10 mg	1		1310	Yes	+5°C ± 3°C
	Y0000216	Dihydrocodeine hydrogen tartrate - reference spectrum	1	n/a	1		1776
	Y0000053	17 alpha-dihydroequilin	1	10 mg	1	See leaflet	1512	Yes	-20°C ± 5°C
	D1945000	Dihydroergocristine mesilate	3	250 mg	1		1416.2060	Yes	+5°C ± 3°C
	D1950000	Dihydroergotamine mesilate	4	50 mg	1		0551	Yes	+5°C ± 3°C
	Y0000831	Dihydroergotamine for peak identification	1	10 mg	1		0551	Yes	+5°C ± 3°C
	D1952000	Dihydroergotamine tartrate	2	150 mg	1		0600	Yes	+5°C ± 3°C
	D1954000	Dihydrostreptomycin sulfate	5	25 mg	1	See leaflet C÷œH‡‡NŒ÷O–ÿS–	0485	Yes	-20°C ± 5°C
	Y0000544	Dihydrotachysterol	2	30 mg	1	See leaflet Cœ‡H÷ÿO	2014	Yes	-20°C ± 5°C
	Y0000482	Dihydrotachysterol for system suitability	1	5 mg	1		2014	Yes	-20°C ± 5°C
	D1980000	Diltiazem hydrochloride	5	300 mg	1		1004	Yes	+5°C ± 3°C
	Y0001439	Diltiazem impurity F	2	15 mg	1	(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3- dihydro-1,5-benzothiazepin-4(5H)-one ; Batch 1 is valid until 31 March 2017	1004	Yes	+5°C ± 3°C
	Y0001141	Diltiazem for system suitability	2	10 mg	1	Replaces Diltiazem impurity A CRS	1004	Yes	+5°C ± 3°C
	D2000000	Dimenhydrinate	1	100 mg	1		0601	Yes	+5°C ± 3°C
	Y0001103	Dimenhydrinate for peak identification	2	1 mg	1	Batch 1 is valid until 30 April 2017	0601	Yes	+5°C ± 3°C
	Y0000234	N,N-Dimethylacetamide - reference spectrum	1	n/a	1		1667
	D2050000	Dimethyl sulfoxide	3	1 mL	1		0763	Yes	+5°C ± 3°C
	Y0001489	2-(Dimethylamino)ethyl methacrylate	1	50 mg	1		1975	Yes	+5°C ± 3°C
	Y0001879	(25R)-spirost-5-en-3-one	1	10 mg	1		2890	Yes	+5°C ± 3°C
	D2200000	Dimeticone	4	200 mg	1	See leaflet	0138.1470	Yes	+5°C ± 3°C
	D2205000	Dimetindene maleate	1	50 mg	1		1417	Yes	+5°C ± 3°C
	D2255000	Dinoprost trometamol	1	60 mg	1	See leaflet Cœ÷H÷—NO‡	1312	Yes	-20°C ± 5°C
New	D2250000	Dinoprostone	3	60 mg	1	See leaflet CœÐH–œO ; Batch 2 is valid until 30 November 2017	1311	Yes	-20°C ± 5°C
	D2250015	Dinoprostone impurity C	2	10 mg	1	(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5- oxocyclopentyl]hept-5-enoic acid (5-trans-PGE2; (5E)-PGE2)	1311.1488	Yes	-20°C ± 5°C
	Y0001871	Diosgenin	1	15 mg	1	see leaflet CœŸH÷œO–	2890	Yes	+5°C ± 3°C
	Y0000094	Diosmin	5	70 mg	1	See leaflet ; Batch 4 is valid until 17 June 2017	1611	Yes	+5°C ± 3°C
	Y0000095	Diosmin for system suitability	2	5 mg	1		1611	Yes	+5°C ± 3°C
	D2600000	Diphenhydramine hydrochloride	1	100 mg	1		0023.0601	Yes	+5°C ± 3°C
	Y0000135	Diphenhydramine impurity A	4	10 mg	1	2-(diphenylmethoxy)-N-methylethanamine	0023.0601	Yes	+5°C ± 3°C
	Y0001415	Diphenoxylate hydrochloride - * narc	1	15 mg	1		0819	Yes	+5°C ± 3°C
	D2630000	Diphenoxylate hydrochloride - reference spectrum	1	n/a	1		0819
	Y0001430	Diphenoxylate for system suitability - * narc	1	10 mg	1		0819	Yes	+5°C ± 3°C
	Y0000258	Diphtheria toxin BRP	1	1 ml	1	See leaflet	See leaflet, 0443	Yes	+5°C ± 3°C
	D2700000	Diphtheria vaccine (adsorbed) BRP	4	32 mg	1	See leaflet	See leaflet, 20706	Yes	-20°C ± 5°C
	Y0000376	Dipivefrine hydrochloride	1	100 mg	1	See leaflet CŒ„H–ÐClNO—	1719	Yes	+5°C ± 3°C
	Y0000394	Dipivefrine for system suitability	1	10 mg	1		1719	Yes	+5°C ± 3°C
	D2750100	Dipotassium clorazepate - reference spectrum	1	n/a	1		0898
	D2800000	Diprophylline	1	100 mg	1		0486	Yes	+5°C ± 3°C
	D2850000	Dipyridamole	1	50 mg	1		1199	Yes	+5°C ± 3°C
	Y0000802	Dipyridamole for peak identification	2	2.04 mg	1		1199	Yes	+5°C ± 3°C
	D2880000	Dirithromycin	1	100 mg	1	See leaflet C÷œHŸ‡NœOŒ÷	1313	Yes	+5°C ± 3°C
	D2900000	Disodium edetate	1	100 mg	1		0232	Yes	+5°C ± 3°C
	D2920000	Disopyramide	1	100 mg	1		1006	Yes	+5°C ± 3°C
	D2922000	Disopyramide phosphate	1	100 mg	1		1005	Yes	+5°C ± 3°C
	D2950000	Disulfiram	1	100 mg	1		0603	Yes	+5°C ± 3°C
	D2953000	Dithranol	3	55 mg	1		1007	Yes	+5°C ± 3°C
	D2953025	Dithranol impurity C	4	15 mg	1	See leaflet; 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione	1007	Yes	+5°C ± 3°C
	D2953050	Dithranol impurity D	4	20 mg	1	1-hydroxyanthracen-9(10H)-one	1007	Yes	+5°C ± 3°C
	D2954000	Dobutamine hydrochloride	1	100 mg	1		1200	Yes	+5°C ± 3°C
	Y0001239	Dobutamine impurity mixture	1	0.1 mg	1		1200	Yes	-20°C ± 5°C
	Y0001133	Docetaxel trihydrate	3	160 mg	1	See leaflet C÷–H—–NOŒ÷.3HœO ; Batch 2 is valid until 31 July 2017	2449, 2593	Yes	+5°C ± 3°C
	Y0001155	Docetaxel for system suitability	2	10 mg	1		2449.2593	Yes	+5°C ± 3°C
	Y0001452	Docetaxel impurity E	1	15 mg	1	5ß,20-epoxy-4-(acetyloxy)-1,7ß,10ß,13¶-tetrahydroxy-9-oxotax-11-en-2¶-yl benzoate (10-desacetyl-baccatin III)	2593	Yes	+5°C ± 3°C
	D2954600	Docosahexaenoic acid ethyl ester	5	150 mg	1	See leaflet ; Batch 4 is valid until 31 July 2016	20429	Yes	-20°C ± 5°C
	Y0001567	Docusate sodium	1	10 mg	1		1418	Yes	+5°C ± 3°C
	Y0000365	Dodecyl gallate	1	30 mg	1		2078	Yes	+5°C ± 3°C
	D2955000	Domperidone	3	120 mg	1		1009	Yes	+5°C ± 3°C
New	D2957000	Domperidone maleate	2	150 mg	1	Batch 1 is valid until 30 November 2017	1008	Yes	+5°C ± 3°C
	D2960000	Dopamine hydrochloride	2	20 mg	1		0664.1200	Yes	+5°C ± 3°C
	Y0000612	Dopexamine dihydrochloride	1	10 mg	1		1748	Yes	+5°C ± 3°C
	Y0000613	Dopexamine impurity B	1	10 mg	1	2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol	1748	Yes	-20°C ± 5°C
	Y0000614	Dopexamine impurity F	1	10 mg	1	4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol	1748	Yes	-20°C ± 5°C
	Y0000726	Dorzolamide hydrochloride	1	50 mg	1		2359	Yes	+5°C ± 3°C
	Y0000727	Dorzolamide impurity A	2	5 mg	1	(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2- sulphonamide 7,7-dioxide	2359	Yes	+5°C ± 3°C
	Y0000750	Dorzolamide for system suitability	1	5 mg	1		2359	Yes	+5°C ± 3°C
	D2962000	Dosulepin hydrochloride	1	100 mg	1		1314	Yes	+5°C ± 3°C
	D2962005	Dosulepin impurity A	2	30 mg	1	(E)-3-(5-oxo-5λ4-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N- dimethylpropan-1-amine	1314	Yes	+5°C ± 3°C
	D2963000	Doxapram hydrochloride	1	50 mg	1		1201	Yes	+5°C ± 3°C
	Y0000208	Doxapram impurity B	2	10 mg	1	(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one	1201	Yes	+5°C ± 3°C
	Y0000553	Doxazosin mesilate	1	60 mg	1	See leaflet	2125	Yes	+5°C ± 3°C
	Y0000551	Doxazosin impurity D	1	10 mg	1	6,7-dimethoxyquinazoline-2,4(1H,3H)-dione	2125	Yes	+5°C ± 3°C
	Y0000552	Doxazosin impurity F	2	15 mg	1	2-chloro-6,7-dimethoxyquinazolin-4-amine	2125	Yes	+5°C ± 3°C
	Y0000838	Doxepin hydrochloride	1	5 mg	1		1096	Yes	+5°C ± 3°C
	Y0000851	Doxepin for system suitability	1	1 mg	1		1096	Yes	+5°C ± 3°C
	D2975000	Doxorubicin hydrochloride	7	150 mg	1	See leaflet CœŸH–ÐClNOŒŒ ; Batch 6 is valid until 30 September 2016	0714,0662,1 590	Yes	-20°C ± 5°C
	D3000000	Doxycycline hyclate	6	50 mg	1	see leaflet	0272, 0820	Yes	+5°C ± 3°C
New	Y0001714	Doxycycline for system suitability	3	10 mg	1	Batch 2 is valid until 30 September 2017	0272.0820	Yes	+5°C ± 3°C
	Y0001562	Doxylamine hydrogen succinate	1	60 mg	1		1589	Yes	+5°C ± 3°C
	Y0000163	Doxylamine hydrogen succinate - reference spectrum	1	n/a	1		1589
	Y0001492	Doxylamine for system suitability	3	110 mg	1	Batch 2 is valid until 31 December 2016	1589	Yes	+5°C ± 3°C
	D3100000	Droperidol	3	150 mg	1		1008,1009,1 010, 1172	Yes	+5°C ± 3°C
	Y0001105	Drospirenone	1	60 mg	1	See leaflet Cœ÷H–ÐO–	2404	Yes	+5°C ± 3°C
	Y0001115	Drospirenone impurity E	1	0.06 mg	1	3-oxo-6α,7α,15α,16α-tetrahydro-3′H,3″H dicyclopropa[6,7:15,16]pregn-4- ene-21,17-carbolactone (17-epidrospirenone)	2404	Yes	+5°C ± 3°C
	Y0001718	Drospirenone for peak identification	1	10 mg	1		2404	Yes	+5°C ± 3°C
	Y0001453	Duloxetine hydrochloride	2	120 mg	1	See leaflet CŒ‡HœÐClNOS	2594	Yes	+5°C ± 3°C
	Y0001455	Duloxetine impurity A	2	10 mg	1	(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine	2594	Yes	+5°C ± 3°C
	Y0001454	Duloxetine for system suitability	1	40 mg	1		2594	Yes	+5°C ± 3°C
New	Y0001598	Dutasteride	2	150 mg	1	See leaflet ; Batch 1 is valid until 30 November 2017	2641	Yes	+5°C ± 3°C
	Y0001603	Dutasteride for system suitability	1	10 mg	1		2641	Yes	+5°C ± 3°C
	Y0001004	Dydrogesterone	1	50 mg	1	See leaflet CœŒHœ‡Oœ	2357	Yes	+5°C ± 3°C
	Y0001005	Dydrogesterone impurity A	1	6 mg	1	9β,10α-pregna-4,6,8(14)-triene-3,20-dione	2357	Yes	+5°C ± 3°C
	Y0001006	Dydrogesterone impurity B	1	5 mg	1	pregna-4,6-diene-3,20-dione	2357	Yes	+5°C ± 3°C
New	Y0001887	E1 Colistimethate sodium for peak identification	1	5 mg	1		0319, 20702	Yes	+5°C ± 3°C
New	Y0001886	E2 Colistimethate sodium for peak identification	1	5 mg	1		0319, 20702	Yes	+5°C ± 3°C
	Y0000249	Ebastine - reference spectrum	1	n/a	1		2015
	Y0000247	Ebastine impurity C	1	10 mg	1	4-(diphenylmethoxy)piperidine	2015	Yes	+5°C ± 3°C
	Y0000248	Ebastine impurity D	1	10 mg	1	1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one	2015	Yes	+5°C ± 3°C
	Y0001236	Econazole	1	10 mg	1		2049	Yes	+5°C ± 3°C
	Y0000254	Econazole for system suitability	1	20 mg	1		0665.2049	Yes	+5°C ± 3°C
	E0050000	Econazole nitrate	3	100 mg	1		0513,0665,0 921, 0935, 1017,1018	Yes	+5°C ± 3°C
	Y0001738	Edrophonium chloride	1	10 mg	1		2106	Yes	+5°C ± 3°C
	E0085000	Eicosapentaenoic acid ethyl ester	4	200 mg	1	See leaflet CœœH–÷Oœ	20429	Yes	-20°C ± 5°C
	Y0000537	Emedastine difumarate	1	10 mg	1		2242	Yes	+5°C ± 3°C
	Y0000512	Emedastine impurity E	1	10 mg	1	1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole	2242	Yes	+5°C ± 3°C
	E0100000	Emetine hydrochloride	2	100 mg	1		0081,0093, 0094,1530,1 875	Yes	+5°C ± 3°C
	Y0001837	Emodin	1	15 mg	1	see leaflet CŒ—HŒÐO—	2724	Yes	+5°C ± 3°C
	E0109000	Enalapril maleate	3	15 mg	1		1420	Yes	+5°C ± 3°C
	E0110000	Enalapril for system suitability	2	10 mg	1	Batch 1 is valid until 31 August 2016	1420	Yes	+5°C ± 3°C
New	Y0001853	Enalapril impurity mixture A	2	0.024 mg	1	Batch 1 is valid until 31 October 2017	1420	Yes	+5°C ± 3°C
	Y0001829	Enalapril impurity G	1	15 mg	1	(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid	1420		+5°C ± 3°C
	Y0000615	Enalaprilat dihydrate	1	100 mg	1		1749	Yes	+5°C ± 3°C
	Y0000678	Enalaprilat impurity G	1	0.005 mg	1	(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2 (1H)-yl]-4-phenylbutanoic acid	1749	Yes	+5°C ± 3°C
	Y0000629	Enalaprilat for system suitability	1	10 mg	1		1749	Yes	+5°C ± 3°C
	E0150000	Endotoxin standard BRP	5	10 mg	1	See leaflet	20614, 20630	Yes	-20°C ± 5°C
	Y0000136	Enilconazole	1	60 mg	1		1720	Yes	+5°C ± 3°C
	Y0000137	Enilconazole impurity E	1	20 mg	1	(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol	1720	Yes	+5°C ± 3°C
	E0180000	Enoxaparin sodium	5	200 mg	1		1097	Yes	+5°C ± 3°C
New	E0180500	Enoxolone	3	220 mg	1	Batch 2 is valid until 30 September 2017	1511	Yes	+5°C ± 3°C
	Y0001259	Enrofloxacin	1	5 mg	1		2229	Yes	+5°C ± 3°C
	Y0001160	Enrofloxacin for system suitability	1	10 mg	1		2229	Yes	+5°C ± 3°C
	Y0001249	Entacapone	1	160 mg	1	See leaflet CŒ÷HŒ—N–O—	2574	Yes	+5°C ± 3°C
	Y0001250	Entacapone impurity A	1	10 mg	1	(2Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide	2574	Yes	+5°C ± 3°C
	Y0001800	Entecavir monohydrate	1	160 mg	1	see leaflet CŒœHŒ—N—O–,HœO	2815	Yes	+5°C ± 3°C
	Y0001802	Entecavir impurity F	2	10 mg	1	Batch 1 is valid until 31 May 2017	2815	Yes	+5°C ± 3°C
	Y0001801	Entecavir for system suitability	1	1 mg	1		2815	Yes	+5°C ± 3°C
	E0200000	Enterokinase BRP	2	200 mg	1	Batch 1 is valid until 30 June 2016	0350	Yes	+5°C ± 3°C
	E0300000	Ephedrine hydrochloride - * Drug Precursor	3	150 mg	1	See leaflet	0487,0488,0 489,1367,24	Yes	+5°C ± 3°C
	E0305000	Ephedrine hydrochloride (racemic) - * Drug Precursor	1	50 mg	1		0715	Yes	+5°C ± 3°C
	E0400000	4-Epianhydrotetracycline hydrochloride	7	25 mg	1	See leaflet ; Batch 6 is valid until 31 July 2017	0210,0211,1 654	Yes	+5°C ± 3°C
	Y0001139	Epinastine hydrochloride	1	20 mg	1		2411	Yes	+5°C ± 3°C
	Y0001128	Epinastine for system suitability	1	10 mg	1		2411	Yes	+5°C ± 3°C
	E0550000	Epirubicin hydrochloride	6	100 mg	1	See leaflet CœŸH–ÐClNOŒŒ	0662,0714,1 590	Yes	-20°C ± 5°C
	E0600000	4-Epitetracycline hydrochloride	9	30 mg	1	Batch 8 is valid until 30 June 2016	0210,0211,1 654	Yes	+5°C ± 3°C
	Y0001704	Eplerenone	1	75 mg	1	see leaflet Cœ÷H–ÐOÿ	2765	Yes	+5°C ± 3°C
	Y0001706	Eplerenone for peak identification	1	10 mg	1		2765	Yes	+5°C ± 3°C
	Y0001705	Eplerenone for system suitability	1	10 mg	1		2765	Yes	+5°C ± 3°C
	P1609010	trans-Epoxyphytomenadione	3	5 mg	1		1036	Yes	+5°C ± 3°C
	E0850010	Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP	2	1 mg	3	See leaflet; Common standard OIE Strain A/eq/Newmarket/77	See leaflet, 0249	Yes	-20°C ± 5°C
	E0850021	Eq Influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP	2	1 mg	3	See leaflet; Common standard OIE Strain A/eq/Newmarket/1/93	See leaflet, 0249	Yes	-20°C ± 5°C
	Y0000712	Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP	1	1 mg	3	See leaflet	See leaflet, 0249	Yes	-20°C ± 5°C
	E0850022	Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP	2	1 mg	3	See leaflet; Common standard OIE Strain A/eq/Newmarket/2/93	See leaflet, 0249	Yes	-20°C ± 5°C
	Y0000052	Equilin	1	15 mg	1	See leaflet CŒ‡HœÐOœ	1512	Yes	-20°C ± 5°C
	Y0001325	Equisetum palustre	1	200 mg	1		1825	Yes	+5°C ± 3°C
	E0900000	Ergocalciferol	9	150 mg	1	See leaflet; Vitamin D2 ; Batch 8 is valid until 30 June 2016	0082,0574,0 575, 0598,1192,1 193, 2398	Yes	-20°C ± 5°C
	Y0001375	Ergocalciferol for system suitability	1	10 mg	1		0082	Yes	-20°C ± 5°C
	E1000000	Ergometrine maleate - * Drug Precursor	2	50 mg	1		0223	Yes	+5°C ± 3°C
	E1100000	Ergosterol	6	20 mg	1	See leaflet Cœ‡H÷÷O ; Batch 5 is valid until 30 June 2016	0082	Yes	-20°C ± 5°C
	Y0001851	Ergotamine for system suitability - * Drug precursor	1	10 mg	1		0224	Yes	-20°C ± 5°C
	E1200000	Ergotamine tartrate - * Drug Precursor	2	100 mg	1		0224, 0551	Yes	+5°C ± 3°C
	Y0000051	Erysipelas ELISA coating antigen BRP	1	0.4 mg	1	See leaflet	See leaflet, 0064	Yes	-20°C ± 5°C
	Y0000177	Erythritol	1	1000 mg	1	See leaflet C÷HŒÐO÷	1803	Yes	+5°C ± 3°C
	E1400000	Erythromycin estolate	1	100 mg	1		0552	Yes	+5°C ± 3°C
	E1500000	Erythromycin ethylsuccinate	2	10 mg	1		0274	Yes	+5°C ± 3°C
	E1500800	Erythromycin stearate	1	50 mg	1		0490	Yes	+5°C ± 3°C
	Y0001848	Erythromycin lactobionate	1	15 mg	1		1098	Yes	+5°C ± 3°C
	Y0001912	Erythromycin A	4	250 mg	1	see leaflet	0179, 0274, 0293, 0490, 0552, 1098	Yes	-20°C ± 5°C
	E1310000	Erythromycin B	4	50 mg	1	See leaflet	0179,0274,0 490, 0552,1098	Yes	-20°C ± 5°C
	Y0001849	Erythromycin stearate for impurity S identification	1	15 mg	1		0490	Yes	+5°C ± 3°C
	E1320000	Erythromycin C	6	25 mg	1	See leaflet ; Batch 5 is valid until 31 August 2017	0179,0274,0 490, 0552,1098	Yes	-20°C ± 5°C
	Y0001845	Erythromycin ethylsuccinate for impurity P identification	1	15 mg	1		0274	Yes	+5°C ± 3°C
	Y0001846	Erythromycin for impurity M identification	1	15 mg	1		0179	Yes	-20°C ± 5°C
	E1300000	Erythromycin for microbiological assay	5	100 mg	1	See leaflet ; Batch 4 is valid until 30 November 2016	20702	Yes	-20°C ± 5°C
	Y0001847	Erythromycin for system suitability	1	15 mg	1		0179, 0552, 0274, 1098, 0490	Yes	-20°C ± 5°C
New	E1515000	Erythropoietin BRP	4	15 mg	1	see leaflet	1316	Yes	-20°C ± 5°C
	Y0001725	Erythropoietin for physicochemical tests	1	0.1 mg	3		1316	Yes	-20°C ± 5°C
	Y0001844	Escitalopram	1	10 mg	1		2758	Yes	+5°C ± 3°C
	Y0001797	Escitalopram for system suitability	1	15 mg	1		2733	Yes	+5°C ± 3°C
	Y0001796	Escitalopram oxalate	1	10 mg	1		2733	Yes	+5°C ± 3°C
	Y0001611	Esculetin	1	25 mg	1	See leaflet C„HÿO÷	2452	Yes	+5°C ± 3°C
	Y0001612	Esculin	1	25 mg	1	See leaflet CŒ—HŒÿO„	2452	Yes	+5°C ± 3°C
	Y0000324	Esketamine hydrochloride - reference spectrum	1	n/a	1		1742
	Y0000338	Esketamine impurity D - * narc	1	10 mg	1	(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)	1742	Yes	+5°C ± 3°C
	Y0001660	Esomeprazole magnesium dihydrate	1	15 mg	1		2787	Yes	+5°C ± 3°C
	Y0001028	Esomeprazole magnesium trihydrate	2	5 mg	1		2372	Yes	+5°C ± 3°C
	Y0000749	Essential oil	2	1000 mg	1		2098	Yes	+5°C ± 3°C
	E1600000	Estradiol benzoate	2	250 mg	1		0139	Yes	+5°C ± 3°C
	Y0000852	Estradiol benzoate for system suitability	1	10 mg	1		0139	Yes	+5°C ± 3°C
	E1620000	Estradiol hemihydrate	3	100 mg	1		0821.1203	Yes	+5°C ± 3°C
	Y0000314	Estradiol for peak identification	2	10 mg	1	Batch 1 is valid until 30 November 2016	0821	Yes	+5°C ± 3°C
	Y0000046	Estradiol valerate	2	120 mg	1	See leaflet Cœ–H–œO–	1614	Yes	+5°C ± 3°C
	Y0001823	Estradiol valerate for system suitability	2	10 mg	1		1614		+5°C ± 3°C
	E1680000	Estriol	3	50 mg	1	Batch 2 is valid until 31 March 2017	1203	Yes	+5°C ± 3°C
	E1680005	Estriol impurity A	2	20 mg	1	See leaflet; estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol (9,11- didehydroestriol)	1203	Yes	+5°C ± 3°C
	E1700000	Estrone	5	20 mg	1	See leaflet	1512.0140	Yes	+5°C ± 3°C
	E1800000	Etacrynic acid	1	100 mg	1		0457	Yes	+5°C ± 3°C
	Y0001263	Etacrynic acid for system suitability	1	10 mg	1		0457	Yes	+5°C ± 3°C
	E1830000	Etamsylate	2	10 mg	1		1204	Yes	+5°C ± 3°C
	E1840000	Ethacridine lactate monohydrate	1	50 mg	1		1591	Yes	+5°C ± 3°C
	E1850000	Ethambutol hydrochloride	3	250 mg	1		0553	Yes	+5°C ± 3°C
	Y0000803	Ethambutol for system suitability	2	10 mg	1	Batch 1 is valid until 31 October 2016	0553	Yes	+5°C ± 3°C
	A1202800	Ethanol (anhydrous) - reference spectrum	1	n/a	1		1318
	E1860100	Ethanol 96% - reference spectrum	1	n/a	1		1317
	E1900000	Ethinylestradiol	5	200 mg	1	See leaflet	0140, 0821, 0940, 0926	Yes	+5°C ± 3°C
	Y0001124	Ethinylestradiol for system suitability	2	1.0124 mg	1		0140	Yes	+5°C ± 3°C
	E2000000	Ethionamide	1	100 mg	1		0141	Yes	+5°C ± 3°C
	Y0001686	Ethionamide for system suitability	1	10 mg	1		0141	Yes	+5°C ± 3°C
	E2150000	Ethosuximide	1	30 mg	1		0764	Yes	+5°C ± 3°C
	E2250000	Ethosuximide impurity A	4	30 mg	1	(2RS)-2-ethyl-2-methylbutanedioic acid	0764	Yes	+5°C ± 3°C
	E2195000	Ethyl acetate - reference spectrum	1	n/a	1		0899
	Y0000617	Ethyl indole-3-carboxylate	1	10 mg	1		2102	Yes	+5°C ± 3°C
	E2425000	Ethyl parahydroxybenzoate	3	150 mg	1	See leaflet C„HŒÐO–	0409,0431,0 900, 1262,1263,2 134	Yes	+5°C ± 3°C
	Y0001633	Ethylcellulose	1	100 mg	1		0822	Yes	+5°C ± 3°C
	E2202000	1-N-Ethylgaramine sulfate	3	50 mg	1	See leaflet	1351	Yes	+5°C ± 3°C
	E2205500	1,1'-Ethylidenebistryptophan	7	0.002 mg	2	See leaflet Cœ÷HœÿN÷O÷ ; Batch 5 is valid until 30 June 2017	1272.1383	Yes	+5°C ± 3°C
	E2300000	Ethylmorphine hydrochloride - reference spectrum	1	n/a	1		0491
	E2400000	Ethylnicotinamide	1	150 mg	1		0233	Yes	+5°C ± 3°C
	Y0000572	Etidronate disodium	1	10 mg	1		1778	Yes	+5°C ± 3°C
	E2450000	Etifenin	1	25 mg	2		0585	Yes	+5°C ± 3°C
	E2451000	Etilefrine hydrochloride	2	75 mg	1		1205	Yes	+5°C ± 3°C
	E2451010	Etilefrine impurity A	1	20 mg	1	2-(ethylamino)-1-(3-hydroxyphenyl)ethanone (etilefrone)	1205	Yes	+5°C ± 3°C
	E2470000	Etodolac	1	60 mg	1		1422	Yes	+5°C ± 3°C
	E2470050	Etodolac impurity H	1	10 mg	1	2-(7-ethyl-1H-indol-3-yl)ethanol	1422	Yes	+5°C ± 3°C
	Y0000768	Etodolac for peak identification	2	0.41 mg	1		1422	Yes	+5°C ± 3°C
	E2499900	Etofenamate	1	40 mg	1		1513	Yes	+5°C ± 3°C
	E2499914	Etofenamate impurity G	2	25 mg	1	2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate	1513	Yes	+5°C ± 3°C
	E2499901	Etofenamate for peak identification	2	20 mg	1		1513	Yes	+5°C ± 3°C
	E2500000	Etofylline	1	100 mg	1		0486	Yes	+5°C ± 3°C
	E2503000	Etomidate	2	50 mg	1		1514	Yes	+5°C ± 3°C
	E2503004	Etomidate impurity B	1	25 mg	1	methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate (metomidate)	1514	Yes	+5°C ± 3°C
	E2600000	Etoposide	7	150 mg	1	See leaflet	0823	Yes	+5°C ± 3°C
	Y0001365	Etoposide for system suitability	1	10 mg	1		0823	Yes	+5°C ± 3°C
	Y0001747	Exemestane	1	70 mg	1	see lealet CœÿH–‡O÷	2766	Yes	+5°C ± 3°C
	Y0001605	Eucommia bark HRS	1	2100 mg	1		2412	Yes	+5°C ± 3°C
	E5000000	Eugenol	2	500 µl	1		1100	Yes	+5°C ± 3°C
	Y0001756	Exemestane for system suitability	1	10 mg	1		2766	Yes	+5°C ± 3°C
	Y0001908	Evodiamine	1	15 mg	1	see leaflet	2718	Yes	+5°C ± 3°C
	F0005000	Famotidine	2	100 mg	1		1012	Yes	+5°C ± 3°C
	Y0000409	Famotidine impurity D	2	10 mg	1	3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]prop*	1012	Yes	+5°C ± 3°C
	Y0000382	Famotidine for system suitability	2	15 mg	1		1012	Yes	+5°C ± 3°C
	Y0000556	Feban	2	150 mg	1	See leaflet	2176	Yes	+5°C ± 3°C
	Y0000660	Feban for system suitability	1	10 mg	1		2176	Yes	+5°C ± 3°C
	Y0000731	Felbinac	1	10 mg	1		2304	Yes	+5°C ± 3°C
	Y0000732	Felbinac impurity A	1	20 mg	1	4-acetyl biphenyl	2304	Yes	+5°C ± 3°C
	F0030000	Felodipine	2	120 mg	1		1013	Yes	+5°C ± 3°C
	Y0000415	Felypressin	1	0.994 mg	1	See leaflet C÷ÿHÿ—NŒ–OŒŒSœ	1634	Yes	-20°C ± 5°C
	F0040000	Fenbendazole	3	150 mg	1		1208.1458	Yes	+5°C ± 3°C
	F0040010	Fenbendazole impurity A	1	20 mg	1	methyl(1§-benzimidazol-2-yl)carbamate	1208	Yes	+5°C ± 3°C
	F0040020	Fenbendazole impurity B	1	25 mg	1	methyl (5-chloro-1H-benzimidazol-2-yl)carbamate	1208	Yes	+5°C ± 3°C
	F0041000	Fenbufen	1	100 mg	1		1209	Yes	+5°C ± 3°C
	F0048000	Fenofibrate	3	100 mg	1	See leaflet CœÐHœŒClO÷	1322	Yes	+5°C ± 3°C
	F0048005	Fenofibrate impurity A	4	15 mg	1	(4-chlorophenyl)(4-hydroxyphenyl)methanone	1322	Yes	+5°C ± 3°C
	F0048010	Fenofibrate impurity B	4	10 mg	1	2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)	1322	Yes	+5°C ± 3°C
	F0048035	Fenofibrate impurity G	4	25 mg	1	1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] oxy]-2-methylpropanoate	1322	Yes	+5°C ± 3°C
	F0050000	Fenoterol hydrobromide	3	50 mg	1		0901	Yes	+5°C ± 3°C
	Y0000756	Fenoterol for peak identification	1	1.2 mg	1		0901	Yes	+5°C ± 3°C
	F0054990	* - reference spectrum	1	n/a	1		1210
	F0055000	* citrate - reference spectrum	1	n/a	1		1103
New	Y0001509	* for system suitability - * narc	3	15 mg	1	Batch 2 is valid until 31 October 2017	1210.1103	Yes	+5°C ± 3°C
	F0060000	Fenticonazole nitrate	1	50 mg	1		1211	Yes	+5°C ± 3°C
	F0060040	Fenticonazole impurity D	2	0.01 mg	1	(¢£)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenylsufanyl)benzyl] imidazolium nitrate	1211	Yes	+5°C ± 3°C
	F0100000	Ferrous gluconate	1	100 mg	1		0493	Yes	+5°C ± 3°C
	Y0001013	Ferulic acid	1	20 mg	1	See leaflet CŒÐHŒÐO÷	1834.2558	Yes	+5°C ± 3°C
	Y0000789	Fexofenadine hydrochloride	1	60 mg	1	See leaflet C–œH÷ÐClNO÷	2280	Yes	+5°C ± 3°C
	Y0000751	Fexofenadine impurity A	2	5 mg	1	2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2- methylpropanoic acid ; Batch 1 is valid until 28 February 2017	2280	Yes	+5°C ± 3°C
	Y0000752	Fexofenadine impurity B	1	0.01 mg	1	2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl] phenyl]-2-methylpropanoic acid	2280	Yes	+5°C ± 3°C
	Y0000753	Fexofenadine impurity C	1	5 mg	1	(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl) phenyl]butan-1-ol	2280	Yes	+5°C ± 3°C
	Y0001173	Filgrastim	2	0.2 mL	1	See leaflet	2206	Yes	-80°C ± 10°C
	Y0000090	Finasteride	3	120 mg	1	See leaflet	1615	Yes	+5°C ± 3°C
	Y0001604	Finasteride for peak identification	1	15 mg	1		1615	Yes	+5°C ± 3°C
	Y0000736	Flavoxate hydrochloride	1	10 mg	1		1692	Yes	+5°C ± 3°C
	Y0000737	Flavoxate impurity A	1	10 mg	1	3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid	1692	Yes	+5°C ± 3°C
	Y0000738	Flavoxate impurity B	1	10 mg	1	ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate	1692	Yes	+5°C ± 3°C
	F0120000	Flecainide acetate	2	10 mg	1		1324	Yes	+5°C ± 3°C
	F0120005	Flecainide impurity A	4	20 mg	1	(8aRS)-3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a- hexahydroimidazo[1,5-a]pyridine ; Batch 3 is valid until 31 March 2017	1324	Yes	+5°C ± 3°C
	F0120010	Flecainide impurity B	1	25 mg	1	(RS)-(piperidin-2-yl)methanamine	1324	Yes	+5°C ± 3°C
	Y0001274	Flecainide for system suitability	1	10 mg	1		1324	Yes	+5°C ± 3°C
	Y0001606	Fleeceflower root HRS	1	300 mg	1		2433	Yes	+5°C ± 3°C
	Y0000138	Flubendazole	1	25 mg	1		1721	Yes	+5°C ± 3°C
	Y0000139	Flubendazole for system suitability	1	20 mg	1		1721	Yes	+5°C ± 3°C
	Y0000892	Flucloxacillin magnesium octahydrate	1	5 mg	1		2346	Yes	+5°C ± 3°C
	Y0000889	Flucloxacillin impurity C	1	5 mg	1	(2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylic acid (6-aminopenicillanic acid)	2346	Yes	+5°C ± 3°C
	Y0000890	Flucloxacillin impurity D	1	5 mg	1	3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid	2346	Yes	+5°C ± 3°C
	Y0000891	Flucloxacillin impurity E	1	5 mg	1	(2S,5R,6R)-6-[[[(2S,5R,6R)-6-[[[3-(2-chloro-6-fluorophenyl)-5- methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0]hept-2-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0]heptane-2-carboxylic acid (6-APA flucloxacillin amide)	2346	Yes	-20°C ± 5°C
	F0150000	Flucloxacillin sodium	8	250 mg	1	See leaflet CŒ„HŒÿClFN–NaO—S ; Batch 7 is valid until 30 April 2017	0661,0663,0 668,2346	Yes	-20°C ± 5°C
	Y0000557	Fluconazole	2	50 mg	1		2287	Yes	+5°C ± 3°C
	Y0000573	Fluconazole impurity B	3	10 mg	1	See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 - triazol-1-yl)propan-2-ol	2287	Yes	+5°C ± 3°C
	Y0000574	Fluconazole impurity C	3	5 mg	2	1,1'-(1,3-phenylene)di-1H-1,2,4-triazole ; Batch 2 is valid until 31 August 2016	2287	Yes	+5°C ± 3°C
	Y0000558	Fluconazole for peak identification	1	10 mg	1		2287	Yes	+5°C ± 3°C
	F0175000	Flucytosine	2	50 mg	1	Batch 1 is valid until 31 August 2016	0766	Yes	+5°C ± 3°C
	Y0001262	Flucytosine for system suitability	1	0.3 mg	1		0766	Yes	+5°C ± 3°C
	Y0000419	Fludarabine phosphate	3	120 mg	1	see leaflet	1781	Yes	+5°C ± 3°C
	Y0001536	Fludarabine for system suitability	1	15 mg	1		1781	Yes	+5°C ± 3°C
	F0180000	Fludrocortisone acetate	2	100 mg	1		0767	Yes	+5°C ± 3°C
	F0188000	Flumazenil - reference spectrum	1	n/a	1		1326
	Y0000335	Flumazenil impurity B	2	5 mg	1	ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4] benzodiazepine-3-carboxylate	1326	Yes	+5°C ± 3°C
	F0189000	Flumequine	1	60 mg	1		1517	Yes	+5°C ± 3°C
	F0189020	Flumequine impurity B	2	0.1 mg	1	ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j] quinolizine-2-carboxylate	1517	Yes	+5°C ± 3°C
	F0188500	Flumetasone pivalate	2	100 mg	1	Batch 1 is valid until 31 May 2017	1327	Yes	+5°C ± 3°C
	F0189900	Flunarizine dihydrochloride	3	100 mg	1		0816	Yes	+5°C ± 3°C
	Y0000265	Flunarizine dihydrochloride - reference spectrum	1	n/a	1		1722
	Y0000266	Flunarizine dihydrochloride for system suitability	1	20 mg	1		1722	Yes	+5°C ± 3°C
	F0190000	Flunitrazepam - * psy	2	100 mg	1		1280	Yes	+5°C ± 3°C
	Y0000169	Flunitrazepam - reference spectrum	1	n/a	1		0717
	Y0000443	Flunixin meglumine	1	10 mg	1		1696	Yes	+5°C ± 3°C
	Y0000444	Flunixin impurity B	1	10 mg	1	2-methyl-3-(trifluoromethyl)aniline	1696	Yes	+5°C ± 3°C
	Y0000445	Flunixin impurity C	2	55 mg	1	ethyl 2-chloropyridine-3-carboxylate	1696	Yes	+5°C ± 3°C
	F0200000	Fluocinolone acetonide	5	110 mg	1	see leaflet	0494	Yes	+5°C ± 3°C
	Y0001711	Fluocinolone acetonide for peak identification	1	10 mg	1		0494	Yes	+5°C ± 3°C
	Y0001710	Fluocinolone acetonide for system suitability	1	10 mg	1		0494	Yes	+5°C ± 3°C
	F0230000	Fluocortolone pivalate	1	100 mg	1		1212	Yes	+5°C ± 3°C
	Y0000796	Fluorescein	1	120 mg	1	See leaflet CœÐHŒœO—	2348	Yes	+5°C ± 3°C
	Y0000804	Fluorescein impurity C	1	0.01 mg	1	2-(2,4-dihydroxybenzoyl)benzoic acid	2348	Yes	+5°C ± 3°C
	F0245000	Fluoresceine sodium - reference spectrum	1	n/a	1		1213
	F0250000	Fluorouracil	3	40 mg	1	Batch 2 is valid until 30 November 2016	0611.0766	Yes	+5°C ± 3°C
	Y0000762	Fluorouracil impurity A	1	10 mg	1	pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)	0611	Yes	+5°C ± 3°C
	Y0000763	Fluorouracil impurity B	1	15 mg	1	dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)	0611	Yes	+5°C ± 3°C
	Y0000764	Fluorouracil impurity C	1	10 mg	1	pyrimidine-2,4(1H,3H)-dione (uracil)	0611	Yes	+5°C ± 3°C
	Y0000765	Fluorouracil impurity F	1	10 mg	1	2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)	0611	Yes	+5°C ± 3°C
	Y0000791	Fluorouracil impurity mixture	2	0.0002 mg	1	Batch 1 is valid until 30 June 2017	0611	Yes	+5°C ± 3°C
	F0253000	Fluoxetine hydrochloride	5	250 mg	1	See leaflet	1104	Yes	+5°C ± 3°C
	F0253020	Fluoxetine impurity B	6	10 mg	1	N-methyl-3-phenylpropan-1-amine	1104	Yes	+5°C ± 3°C
	F0253030	Fluoxetine impurity C	4	5 mg	1	(3RS)-N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine	1104	Yes	+5°C ± 3°C
	Y0000064	Flupentixol dihydrochloride	1	100 mg	1	See leaflet	1693	Yes	+5°C ± 3°C
	Y0000067	Flupentixol impurity D	2	15 mg	1	2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl] piperazin-1-yl]ethoxy]ethanol	1693	Yes	+5°C ± 3°C
	Y0000078	Flupentixol impurity F	2	25 mg	1	See leaflet Cœ–Hœ—F–NœOS; mixture of 2-[4-[(E)-3-[(9RS)-2- (trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]piperazin-1-yl]ethanol and 2-[4-[(Z)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]	1693	Yes	+5°C ± 3°C
	F0260000	Fluphenazine decanoate	3	100 mg	1	Batch 2 is valid until 31 January 2017	1014.1015	Yes	+5°C ± 3°C
	F0280000	Fluphenazine dihydrochloride	2	50 mg	1		0904.1014	Yes	+5°C ± 3°C
	Y0000708	Fluphenazine impurity mixture	1	0.07 mg	1		0904	Yes	+5°C ± 3°C
	Y0000009	Fluphenazine enantate	3	100 mg	1	Batch 2 is valid until 31 January 2017	1014.1015	Yes	+5°C ± 3°C
	Y0000298	Fluphenazine octanoate	4	20 mg	1		1014.1015	Yes	+5°C ± 3°C
	Y0000299	Fluphenazine sulfoxide	2	15 mg	1	Batch 1 is valid until 31 December 2016	0904,1014,1 015	Yes	+5°C ± 3°C
	Y0000211	Flurazepam monohydrochloride - reference spectrum	1	n/a	1		0905
	F0285200	Flurbiprofen	1	50 mg	1		1519	Yes	+5°C ± 3°C
	F0285202	Flurbiprofen impurity A	2	25 mg	1	(2RS)-2-(biphenyl-4-yl)propanoic acid	1519	Yes	+5°C ± 3°C
	Y0000236	Fluspirilene	1	20 mg	1		1723	Yes	+5°C ± 3°C
	Y0000375	Fluspirilene impurity C	1	10 mg	1	8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8- triazaspiro[4.5]decan-4-one	1723	Yes	+5°C ± 3°C
	F0285600	Flutamide	2	100 mg	1	See leaflet	1423	Yes	+5°C ± 3°C
	Y0001591	Flutamide for system suitability	1	10 mg	1		1423	Yes	+5°C ± 3°C
	Y0000284	Fluticasone propionate	4	100 mg	1	See leaflet Cœ—H–ŒF–O—S ; Batch 3 is valid until 31 October 2016	1750	Yes	+5°C ± 3°C
	Y0001754	Fluticasone propionate for impurity C identification	1	5 mg	1		1750		+5°C ± 3°C
	Y0000221	Fluticasone impurity D	3	5 mg	1	6α,9-difluoro-11β-hydroxy-16α-methyl-17- [(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate	1750	Yes	+5°C ± 3°C
	Y0001755	Fluticasone propionate for impurity G identification	1	5 mg	1		1750	Yes	+5°C ± 3°C
	F0290000	Flutrimazole	1	100 mg	1		1424	Yes	+5°C ± 3°C
	F0290010	Flutrimazole impurity B	1	60 mg	1	(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol	1424	Yes	+5°C ± 3°C
	Y0001090	Fluvastatin sodium	1	110 mg	1		2333	Yes	+5°C ± 3°C
	Y0001082	Fluvastatin for system suitability	1	0.5 mg	1		2333	Yes	+5°C ± 3°C
	Y0000854	Fluvoxamine maleate	1	5 mg	1		1977	Yes	+5°C ± 3°C
	Y0000853	Fluvoxamine for system suitability	1	1.004 mg	1		1977	Yes	+5°C ± 3°C
	Y0000916	Fluvoxamine impurity D	1	10 mg	1	5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one	1977	Yes	+5°C ± 3°C
	Y0000386	Foeniculin for peak identification	1	100 mg	1	Anise oil	0804	Yes	+5°C ± 3°C
	F0300000	Folic acid	8	300 mg	2	See leaflet CŒ„HŒ„NŸOÿ	0067	Yes	+5°C ± 3°C
	Y0001242	Folic acid impurity A	1	15 mg	1	(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-L- glutamic acid)	0067	Yes	+5°C ± 3°C
	Y0001243	Folic acid impurity D	3	70 mg	1	4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid)	0067	Yes	+5°C ± 3°C
	Y0001629	Follitropin	1	0.2 mL	1	See leaflet	2285, 2286	Yes	-20°C ± 5°C
	Y0001627	Follitropin for peptide mapping and glycan analysis	1	0.5 mL	1		2285	Yes	-20°C ± 5°C
	F0372000	Formoterol fumarate dihydrate	2	10 mg	1		1293.1724	Yes	+5°C ± 3°C
	Y0000339	Formoterol for impurity I identification	2	10 mg	1		1724	Yes	+5°C ± 3°C
	Y0000340	Formoterol fumarate for system suitability	2	10 mg	1		1724	Yes	+5°C ± 3°C
	F0380000	Formylfolic acid	3	30 mg	1	See leaflet CœÐHŒ„NŸOŸ; 10-Formylfolic acid	0978.1606	Yes	-20°C ± 5°C
	F0389000	Foscarnet sodium hexahydrate	1	50 mg	1		1520	Yes	+5°C ± 3°C
	F0389004	Foscarnet impurity B	1	10 mg	1	disodium (ethoxyoxydophosphanyl)formate	1520	Yes	+5°C ± 3°C
	Y0001222	Foscarnet impurity D	1	50 mg	1	ethyl (diethoxyphosphoryl)formate	1520	Yes	+5°C ± 3°C
	Y0001213	Foscarnet impurity mixture	1	0.012 mg	1		1520	Yes	+5°C ± 3°C
	Y0000782	Fosfomycin calcium	1	10 mg	1		1328	Yes	+5°C ± 3°C
	F0399950	Fosfomycin sodium - reference spectrum	1	n/a	1		1329
	F0400000	Fosfomycin trometamol	3	1500 mg	1	See leaflet	1425	Yes	+5°C ± 3°C
	Y0001227	Fosinopril sodium	1	60 mg	1		1751	Yes	+5°C ± 3°C
	Y0001228	Fosinopril impurity A	1	5 mg	1	(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl] pyrrolidine-2-carboxylic acid	1751	Yes	+5°C ± 3°C
	Y0001229	Fosinopril impurity B	1	5 mg	1	(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy) propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	1751	Yes	+5°C ± 3°C
	Y0001230	Fosinopril impurity C	1	10 mg	1	mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy) propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4- phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	1751	Yes	+5°C ± 3°C
	Y0001231	Fosinopril impurity D	1	10 mg	1	(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4- phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	1751	Yes	+5°C ± 3°C
	Y0001232	Fosinopril impurity I	1	5 mg	1	[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl] acetic acid	1751	Yes	+5°C ± 3°C
	Y0001233	Fosinopril impurity K	1	5 mg	1	(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic acid	1751	Yes	+5°C ± 3°C
	Y0001212	Fosinopril impurity mixture	1	0.02 mg	1		1751	Yes	+5°C ± 3°C
	F0450000	Framycetin sulfate	7	25 mg	2	See leaflet ; Batch 6 is valid until 28 February 2017	0180,0197,2 0702	Yes	-20°C ± 5°C
	F0550000	Fructose	1	100 mg	1		0188, 0924	Yes	+5°C ± 3°C
	Y0001399	Fulvestrant	1	120 mg	1	See leaflet C–œH÷ŸF—O–S	2443	Yes	+5°C ± 3°C
	Y0001413	Fulvestrant for system suitability	1	40 mg	1		2443	Yes	+5°C ± 3°C
	F0600000	Fumaric acid	3	120 mg	1		0365,0902,1 190	Yes	+5°C ± 3°C
	F0700000	Furosemide	2	100 mg	1		0391.2185	Yes	+5°C ± 3°C
	F0702000	Furosemide impurity A	4	5 mg	1	2-chloro-4-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid	0391	Yes	+5°C ± 3°C
	Y0001493	Furosemide for peak identification	2	10 mg	1		0391	Yes	+5°C ± 3°C
	Y0001411	Fusidic acid	1	10 mg	1		0798	Yes	-20°C ± 5°C
	Y0001394	Fusidic acid for peak identification	1	5 mg	1		0798.0848	Yes	-20°C ± 5°C
	Y0001384	Fusidic acid impurity mixture	2	0.048 mg	1		0798.0848	Yes	-20°C ± 5°C
	Y0001280	Gabapentin	2	300 mg	1	See leaflet C„HŒŸNOœ ; Batch 1 is valid until 31 December 2016	2173	Yes	+5°C ± 3°C
	Y0001281	Gabapentin impurity A	1	20 mg	1	2-azaspiro[4.5]decan-3-one	2173	Yes	+5°C ± 3°C
	Y0001348	Gabapentin impurity B	2	20 mg	1	(1-cyanocyclohexyl)acetic acid	2173	Yes	-20°C ± 5°C
	Y0001349	Gabapentin impurity D	1	10 mg	1	[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid	2173	Yes	+5°C ± 3°C
	Y0001803	Gadobutrol monohydrate	1	210 mg	1	See leaflet CŒ‡H–ŒGdN÷O„,HœO	2735	Yes	+5°C ± 3°C
	Y0001804	Gadobutrol for peak identification	1	20 mg	1		2735	Yes	+5°C ± 3°C
	Y0001875	Gadodiamide	1	300 mg	1	see leaflet	2225	Yes	+5°C ± 3°C
	Y0001876	Gadodiamide impurity A	1	15 mg	1	see leaflet; hydrogen[3,6-bis(carboxylatomethyl)-9-[(methylcarbamoyl) methyl]-3,6,9-triazaundecanedioato-κ3N3,N6,N9-gadolinate](1-) (Gd-DTPA- MMA)	2225	Yes	+5°C ± 3°C
	Y0001877	Gadodiamide impurity B	1	15 mg	1	see leaflet; dihydrogen[3,6,9-tris(carboxylatomethyl)-3,6,9- triazaundecanedioato-κ3N3,N6,N9-gadolinate](2-) (Gd-DTPA),	2225	Yes	+5°C ± 3°C
	G0049000	Galactitol	2	50 mg	1		1381	Yes	+5°C ± 3°C
	G0050000	Galactose	3	100 mg	1	See leaflet CÿHŒœ0ÿ ; Batch 2 is valid until 30 June 2016	1215	Yes	+5°C ± 3°C
	Y0001279	Galantamine hydrobromide	1	10 mg	1		2366	Yes	+5°C ± 3°C
	Y0001190	Galantamine natural for system suitability	1	10 mg	1		2366	Yes	+5°C ± 3°C
	Y0001201	Galantamine racemic mixture	1	10 mg	1		2366	Yes	+5°C ± 3°C
	Y0001191	Galantamine synthetic for system suitability	2	5 mg	1	Batch 1 is valid until 30 June 2017	2366	Yes	+5°C ± 3°C
	G0150000	Gammacyclodextrin	2	60 mg	1	See leaflet C÷‡H‡ÐOŒÐ	1070.1487	Yes	+5°C ± 3°C
	Y0001129	Ganciclovir	1	220 mg	1		1752	Yes	+5°C ± 3°C
	Y0001144	Ganciclovir impurity mixture	1	0.005 mg	1		1752	Yes	+5°C ± 3°C
	Y0001813	Gefitinib	1	100 mg	1	See leaflet CœœHœ÷ClFN÷O–	2866	Yes	+5°C ± 3°C
	Y0001809	Gefitinib for system suitability	1	0.351 mg	1		2866	Yes	+5°C ± 3°C
	Y0000675	Gemcitabine hydrochloride	1	50 mg	1	See leaflet	2306	Yes	+5°C ± 3°C
	Y0000676	Gemcitabine impurity A	1	20 mg	1	4-aminopyrimidin-2(1H)-one (cytosine)	2306	Yes	+5°C ± 3°C
	Y0001682	Gemcitabine impurity C	1	5 mg	1	1-(2-deoxy-2,2-difluoro-β-D-erythro-pentofuranosyl)pyrimidin-2,4(1H,3H)- dione (2′-deoxy-2′,2′-difluorouridine) (β-uridine)	2306	Yes	+5°C ± 3°C
	Y0000513	Gemfibrozil	1	5 mg	1		1694	Yes	+5°C ± 3°C
	Y0000514	Gemfibrozil for system suitability	2	0.196 mg	1		1694	Yes	+5°C ± 3°C
	Y0001835	Geniposide	1	15 mg	1	See leaflet CŒŸHœ÷OŒÐ	2565	Yes	+5°C ± 3°C
	G0200000	Gentamicin sulfate	14	25 mg	2	see leaflet ; Batch 9 is valid until 28 February 2017	0331.20702	Yes	-20°C ± 5°C
	Y0001363	Gentamicin for peak identification	2	10 mg	1		0331	Yes	-20°C ± 5°C
	Y0001112	Gestodene	2	100 mg	1	see leaflet	1726	Yes	+5°C ± 3°C
New	Y0001116	Gestodene impurity I	2	0.01 mg	1	13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5α,17α-pregn-15-en-20-yn-3- one (5-methoxy-gestodene) ; Batch 1 is valid until 31 October 2017	1726	Yes	+5°C ± 3°C
	Y0001110	Gestodene for system suitability	1	10 mg	1		1726	Yes	+5°C ± 3°C
	Y0001012	Ginkgo dry extract for peak identification	2	150 mg	1		1827	Yes	-20°C ± 5°C
New	Y0001010	Ginkgolic Acids	3	50 mg	1	See leaflet ; Batch 2 is valid until 30 November 2017	1827	Yes	-20°C ± 5°C
	Y0001029	Ginseng dry extract HRS	1	500 mg	1		2356	Yes	-20°C ± 5°C
	Y0001347	Ginsenoside Rb1	2	30 mg	1	See leaflet C—÷H„œOœ– ; Batch 1 is valid until 30 September 2017	2356	Yes	+5°C ± 3°C
	G0300000	Gitoxin	3	30 mg	1	Batch 2 is valid until 31 July 2016	0078.2168	Yes	+5°C ± 3°C
	G0325000	Glibenclamide	3	100 mg	1		0718	Yes	+5°C ± 3°C
	G0325010	Glibenclamide impurity A	4	10 mg	1	5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide ; Batch 3 is valid until 28 February 2017	0718	Yes	+5°C ± 3°C
	Y0000242	Glibenclamide impurity B	3	10 mg	1	methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulphonyl] carbamate ; Batch 2 is valid until 31 December 2016	0718	Yes	+5°C ± 3°C
	Y0001511	Glibenclamide for peak identification	1	30 mg	1		0718	Yes	+5°C ± 3°C
	Y0001406	Glucosamine hydrochloride	1	15 mg	1		2446	Yes	+5°C ± 3°C
	G0326000	Gliclazide	2	20 mg	1		1524	Yes	+5°C ± 3°C
	G0326004	Gliclazide impurity B	4	50 mg	1	2-nitroso-octahydrocyclopenta[c]pyrrole ; Batch 3 is valid until 31 August 201	1524	Yes	+5°C ± 3°C
	G0326012	Gliclazide impurity F	5	50 mg	1	1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl] urea	1524	Yes	+5°C ± 3°C
	Y0001685	Glucosamine sulfate potassium chloride	1	10 mg	1		2708	Yes	+5°C ± 3°C
	Y0000515	Glimepiride	2	110 mg	1	See leaflet	2223	Yes	+5°C ± 3°C
	Y0001742	Glimepiride for impurity A identification	1	5 mg	1		2223	Yes	+5°C ± 3°C
	Y0000516	Glimepiride for system suitability	4	0.012 mg	1	Batch 3 is valid until 28 February 2017	2223	Yes	+5°C ± 3°C
	G0340000	Glipizide	1	50 mg	1		0906	Yes	+5°C ± 3°C
	G0342000	Glipizide impurity A	1	10 mg	1	5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide	0906	Yes	+5°C ± 3°C
	Y0000523	Glipizide impurity C	1	10 mg	1	ethyl [2-[4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl]ethyl] carbamate	0906	Yes	+5°C ± 3°C
	Y0000643	Glipizide impurity D	1	10 mg	1	6-methyl-N-[2-(4-sulphamoylfenyl)ethyl]pyrazine-2-carboxamide	0906	Yes	+5°C ± 3°C
	Y0001140	Glipizide impurity mixture	1	0.002 mg	1		0906	Yes	+5°C ± 3°C
	Y0001407	Glucosamine sulfate sodium chloride	1	15 mg	1		2447	Yes	+5°C ± 3°C
	Y0001381	Glucosamine for system suitability	2	3 mg	1	Batch 1 is valid until 30 September 2017	2446,2447,2 708	Yes	+5°C ± 3°C
	Y0001745	Glucose monohydrate	1	750 mg	1	See leaflet CÿHŒœOÿ,HœO	0177,0178,0 209	Yes	+5°C ± 3°C
	G0355000	Glutamic acid	2	50 mg	1		0750,0797,1 445, 2076	Yes	+5°C ± 3°C
	Y0000517	Glutathione	1	10 mg	1		1670	Yes	+5°C ± 3°C
	G0360000	Glutethimide - * psy	1	50 mg	1		1291	Yes	+5°C ± 3°C
	G0400000	Glycerol (85 per cent) - reference spectrum	1	n/a	1		0496.0497
	Y0001391	Glycerol formal	1	20 mg	2		1671	Yes	+5°C ± 3°C
	Y0000794	Glycerol monocaprylate	1	400 mg	1		2213	Yes	+5°C ± 3°C
	Y0000795	Glycerol monocaprylocaprate	2	500 mg	1		2392	Yes	+5°C ± 3°C
	G0400006	Glycerol monolinoleate	1	2000 mg	1		1429	Yes	+5°C ± 3°C
	G0400007	Glycerol mono-oleate	2	2500 mg	1		1430	Yes	+5°C ± 3°C
	G0400008	Glycerol monostearate 40-55	4	2000 mg	1	Batch 3 is valid until 31 March 2017	0495	Yes	+5°C ± 3°C
	Y0001786	Glyceryl trinitrate for system suitability	1	0.5 mL	1		1331	Yes	+5°C ± 3°C
	G0400100	Glyceryl trinitrate solution	3	0.5 mL	1		1331.1355	Yes	+5°C ± 3°C
	G0400101	Glyceryl trinitrate - reference spectrum	1	n/a	1		1331
	G0450000	Glycine	3	50 mg	1		0614, 0813	Yes	+5°C ± 3°C
	Y0001308	Glycopyrronium bromide	1	10 mg	1		1783	Yes	+5°C ± 3°C
	Y0001358	Glycopyrronium impurity N	1	10 mg	1	See leaflet CŒ„Hœ‡BrNO–; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2- phenylacetyl)oxy]-1,1-dimethylpyrrolidinium	1783	Yes	+5°C ± 3°C
	Y0000433	Ammonium glycyrrhizate	2	70 mg	1		1772	Yes	+5°C ± 3°C
	Y0001309	Glycopyrronium for peak identification	1	10 mg	1		1783	Yes	+5°C ± 3°C
	G0460000	Glycyrrhizate (monoammonium)	4	300 mg	1	see leaflet	0277, 2378	Yes	+5°C ± 3°C
	G0525000	Gonadorelin	5	5 mg	1	See leaflet C——HŸ—NŒŸOŒ–	0827	Yes	-20°C ± 5°C
	Y0000125	Goserelin	3	2 mg	1	See leaflet C—„H‡÷NŒ‡OŒ÷ ; Batch 2 is valid until 30 November 2016	1636	Yes	-20°C ± 5°C
	Y0000126	Gosereline - reference spectrum	1	n/a	1		1636
	Y0001473	Goserelin for NMR identification	1	14 mg	1		1636	Yes	-20°C ± 5°C
	Y0000194	Goserelin validation mixture	2	1 mg	1	Supplied with the Ph. Eur. reference chromatogram	1636	Yes	-20°C ± 5°C
	Y0000019	4-D-Ser-goserelin	1	0.1 mg	1		1636	Yes	-20°C ± 5°C
	G0550000	Gramicidin	1	250 mg	1	See leaflet	0907,1662,2 0702	Yes	+5°C ± 3°C
	Y0000396	Granisetron hydrochloride	2	120 mg	1	See leaflet	1695	Yes	+5°C ± 3°C
	Y0000477	Granisetron impurity A	3	1 mg	1	2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H- indazole-3-carboxamide	1695	Yes	+5°C ± 3°C
	Y0000478	Granisetron impurity B	3	1 mg	1	N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3- carboxamide	1695	Yes	+5°C ± 3°C
	Y0000395	Granisetron impurity E	3	15 mg	2	(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine	1695	Yes	+5°C ± 3°C
	G0600000	Griseofulvin	2	50 mg	1		0182	Yes	+5°C ± 3°C
	Y0000619	Guaiacol	2	1500 mg	1	See leaflet CŸH‡Oœ	1978	Yes	+5°C ± 3°C
	G0700000	Guaifenesin	1	100 mg	1		0615	Yes	+5°C ± 3°C
	Y0000117	Halofantrine hydrochloride	1	125 mg	1	See leaflet CœÿH–ŒCl–F–NO	1979	Yes	+5°C ± 3°C
	Y0000118	Halofantrine impurity C	1	10 mg	1	[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol	1979	Yes	+5°C ± 3°C
	H0100000	Haloperidol	2	60 mg	1		0616.1178	Yes	+5°C ± 3°C
	Y0001518	Haloperidol for peak identification	2	20 mg	1		0616	Yes	+5°C ± 3°C
	Y0001517	Haloperidol for system suitability	1	25 mg	1		0616	Yes	+5°C ± 3°C
	H0100100	Haloperidol decanoate	1	60 mg	1		1397.1431	Yes	+5°C ± 3°C
	H0150000	Halothane - reference spectrum	2	n/a	1		0393
New	Y0000673	Harpagoside	2	1.05 mg	1	See leaflet Cœ÷H–ÐOŒŒ ; Batch 1 is valid until 30 November 2017	1095, 1871	Yes	+5°C ± 3°C
	H0200000	Heparin sodium BRP	3	2 ml	1	See leaflet	0569, 20705	Yes	+5°C ± 3°C
	Y0001283	Heparin sodium for NMR identification	1	30 mg	1		0333	Yes	+5°C ± 3°C
	Y0001287	Heparin calcium for NMR identification	1	30 mg	1		0332	Yes	+5°C ± 3°C
	Y0001282	Heparin for physico-chemical analysis	2	300 mg	1		0332, 0333	Yes	+5°C ± 3°C
	H0185000	Heparin Low-Molecular-Mass for assay BRP	9	1 mg	5	See leaflet	0828	Yes	+5°C ± 3°C
New	H0190000	Heparin Low-Molecular-Mass for calibration CRS	4	10 mg	1	See leaflet ; Batch 3 is valid until 30 November 2017	0828	Yes	+5°C ± 3°C
	H0205010	Hepatitis A vaccine (inactivated, adsorbed) Type B BRP	2	0.5 ml	3	See leaflet; Please contact us for information on the type needed for your use	See leaflet, 20714	Yes	+5°C ± 3°C
	Y0001192	Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP	2	1 mL	1	To be stored below -50°C	20714,1526, 1935, 1107	Yes	-80°C ± 10°C
	Y0001624	Hepatitis A virus Coating Reagent for ELISA - BRR	1	1 mL	1			Yes	-20°C ± 5°C
	Y0001623	Set of Hepatitis A virus Detection Antibodies for ELISA - BRR	3	275 µL	1	See leaflet	20714	Yes	-20°C ± 5°C
	Y0001872	Hepatitis A virus RNA for NAT testing BRP	1	45 mg	5	See leaflet	1646	Yes	-20°C ± 5°C
	Y0000389	Hepatitis B vaccine (rDNA) BRP method A (thiomersal free)	2	0.5 ml	2	See leaflet; Ph. Eur. BRPs are established in the context of specific methods. The method used to establish this BRP (refer to leaflet) is no longer available. Reference to the BRP has therefore been removed from the relevant monograph and general chapter of the Ph. Eur. and upon depletion of stocks this BRP will not be replaced. Users are encouraged to find alternative reference material to address their future needs.	See leaflet, 20715	Yes	+5°C ± 3°C
	H0210010	Hepatitis B vaccine (rDNA) BRP method B	2	1 ml	2	See leaflet; Ph. Eur. BRPs are established in the context of specific methods. The method used to establish this BRP (refer to leaflet) is no longer available. Reference to the BRP has therefore been removed from the relevant monograph and general chapter of the Ph. Eur. and upon depletion of stocks this BRP will not be replaced. Users are encouraged to find alternative reference material to address their future needs.	See leaflet, 1056	Yes	+5°C ± 3°C
	H0215000	Hepatitis C Virus RNA for NAT testing BRP	1	40 mg	5	See leaflet; For plasma pool testing by NAT	See leaflet, 20621	Yes	-20°C ± 5°C
	Y0001873	Hepatitis E virus RNA for NAT testing BRP	1	45 mg	1	See leaflet	1646	Yes	-20°C ± 5°C
New	Y0000063	Heptaminol hydrochloride	2	150 mg	1		1980	Yes	+5°C ± 3°C
	Y0000057	Heptaminol impurity A	2	20 mg	1	See leaflet C‡HŒŸN; (2RS)-6-methylhept-5-en-2-amine	1980	Yes	+5°C ± 3°C
	Y0001203	Hesperidin	1	20 mg	1	See leaflet Cœ‡H–÷OŒ—	2430	Yes	+5°C ± 3°C
	H0330000	Hexamidine diisetionate	2	20 mg	1		1436	Yes	+5°C ± 3°C
	H0325000	Hexetidine	2	100 mg	1		1221	Yes	+5°C ± 3°C
	H0420000	Hexylresorcinol	1	100 mg	1		1437	Yes	+5°C ± 3°C
	Y0001746	Hexylresorcinol for system suitability	1	1 mg	1		1437	Yes	-20°C ± 5°C
	H0500000	Hide powder	4	500 mg	1		20814	Yes	+5°C ± 3°C
	Y0001779	Histamine	1	15 mg	1		2671	Yes	-20°C ± 5°C
	H0600000	Histamine dihydrochloride	3	250 mg	1	Batch 2 is valid until 30 April 2017	0143	Yes	+5°C ± 3°C
	H0750000	Histidine	3	25 mg	1		0911	Yes	+5°C ± 3°C
	H0755000	Histidine hydrochloride monohydrate	2	100 mg	1		0910.2671	Yes	+5°C ± 3°C
	H0800000	Homatropine hydrobromide	1	100 mg	1		0500.0720	Yes	+5°C ± 3°C
	H0830000	Homatropine methylbromide	1	25 mg	1		0720	Yes	+5°C ± 3°C
	H0837000	L-Homocysteine thiolactone hydrochloride - reference spectrum	1	n/a	1		1617
	Y0001383	Homatropine methylbromide for system suitability	1	5 mg	1		0720	Yes	+5°C ± 3°C
	Y0001290	Honokiol	1	20 mg	1	See leaflet CŒ‡HŒ‡Oœ	2567.2568	Yes	-20°C ± 5°C
	H0900000	Human albumin for electrophoresis BRP	3	50 mg	1	See leaflet ; Batch 2 is valid until 31 March 2017	0255	Yes	-20°C ± 5°C
	Y0000219	Human anti-D immunoglobulin BRP	1	40 mg	1	See leaflet	See leaflet, 20713	Yes	-20°C ± 5°C
	Y0000667	Human coagulation factor VII concentrate BRP	2	25 mg	2	See leaflet	See leaflet, 20710	Yes	-20°C ± 5°C
	Y0001663	Human coagulation factor VIIa (rDNA)	1	42 mg	1	See leaflet	2534	Yes	-20°C ± 5°C
	H0920000	Human coagulation factor VIII concentrate BRP	5	37 mg	3	See leaflet	20704	Yes	-20°C ± 5°C
	H0920500	Human coagulation factor IX concentrate BRP	3	30 mg	3	See leaflet; Common standard with FDA and WHO (4th IS) ; Batch 2 is valid until 31 October 2016	2.7.11	Yes	-20°C ± 5°C
	Y0001659	Human coagulation factor IX (rDNA)	1	10 mg	1	see leaflet	2522	Yes	-20°C ± 5°C
	Y0000191	Human glucagon	2	2.94 mg	2	See leaflet CŒ—–Hœœ—N÷–O÷„S	1635	Yes	-20°C ± 5°C
	H0950000	Human hepatitis A immunoglobulin BRP	1	10 mg	3	See leaflet	See leaflet, 0338, 0769, 1646	Yes	-20°C ± 5°C
	Y0001414	Human Hepatitis B immunoglobulin BRP	1	100 mg	1	See leaflet	0722, 1016	Yes	-20°C ± 5°C
	Y0001504	Human immunoglobulin BRP (ACA and Molecular size)	1	6000 mg	1		See leaflet, 0338, 0918	Yes	+5°C ± 3°C
	Y0001512	Human Immunoglobulin BRP (Fc Function and Molecular size)	2	5000 mg	1	See leaflet ; Batch 1 is valid until 30 September 2016	See leaflet, 0338, 0918	Yes	+5°C ± 3°C
	Y0000488	Human immunoglobulin (molecular size) BRP	1	700 mg	3	Each vial contains 0.7 gram of immunoglobulin G	See leaflet, 0338, 0918,1928	Yes	+5°C ± 3°C
	H1000000	Human immunoglobulin for electrophoresis BRP	3	50 mg	1	See leaflet	0338.0918	Yes	+5°C ± 3°C
	H1005000	Human Plasma Pools for NAT validation	1	3502 mg	1	Set of 103 plasma pool samples	See leaflet, 20621	Yes	-20°C ± 5°C
	H1100000	Human rabies immunoglobulin BRP	1	170 mg	3	See leaflet	See leaflet, 0723	Yes	-20°C ± 5°C
	H1110000	Human tetanus immunoglobulin BRP	1	87 mg	1	See leaflet	0398	Yes	-20°C ± 5°C
	Y0000502	Human vaccinia immunoglobulin	1	1 ml	3	See leaflet	See leaflet	Yes	-20°C ± 5°C
	H1115000	Hyaluronidase BRP	2	50 mg	1	See leaflet ; Batch 1 is valid until 31 October 2016	0912	Yes	+5°C ± 3°C
	H1120000	Hydralazine hydrochloride	1	20 mg	1		0829	Yes	+5°C ± 3°C
	Y0001151	Hydrastine hydrochloride	2	25 mg	1	See leaflet CœŒHœœClNOÿ ; Batch 1 is valid until 31 May 2017	1831.2500	Yes	-20°C ± 5°C
New	H1200000	Hydrochlorothiazide	8	300 mg	1	See leaflet CŸH‡ClN–O÷Sœ ; Batch 7 is valid until 30 November 2017	0394	Yes	+5°C ± 3°C
	Y0001494	Hydrochlorothiazide for peak identification	3	10 mg	1	Batch 2 is valid until 30 November 2016	0394	Yes	+5°C ± 3°C
	Y0000646	Hydrocodone hydrogen tartrate 2.5-hydrate - * narc	1	10 mg	1		1784	Yes	+5°C ± 3°C
	Y0000710	Hydrocodone for peak identification - * narc	1	10 mg	1		1784	Yes	+5°C ± 3°C
	H1300000	Hydrocortisone	8	100 mg	1		0335	Yes	+5°C ± 3°C
	Y0001092	Hydrocortisone for peak identification	2	5 mg	1		0335	Yes	+5°C ± 3°C
	H1400000	Hydrocortisone acetate	9	125 mg	1	See leaflet	0321,0334,0 335, 0734,0767	Yes	+5°C ± 3°C
	Y0001482	Hydrocortisone acetate for peak identification	2	15 mg	1	Batch 1 is valid until 30 November 2016	0334	Yes	+5°C ± 3°C
	H1425000	Hydrocortisone hydrogen succinate	2	100 mg	1		0768	Yes	-20°C ± 5°C
	H1426000	Hydrogenated wool fat	1	250 mg	1		0969	Yes	+5°C ± 3°C
	Y0000446	Hydromorphone hydrochloride - * narc	1	10 mg	1		2099	Yes	+5°C ± 3°C
	B0650000	Hydrous benzoyl peroxide - reference spectrum	2	n/a	1	Batch 1 is valid until 30 November 2017	0704
	H1428000	Hydroxocobalamin	1	10 mg	1		0913,0914,0 915	Yes	-20°C ± 5°C
	Y0000119	Hydroxycarbamide	2	360 mg	1	See leaflet	1616	Yes	+5°C ± 3°C
	Y0001841	Hydroxychloroquine for system suitability	1	15 mg	1		2849	Yes	+5°C ± 3°C
	Y0001839	Hydroxychloroquine sulfate	1	70 mg	1	see leaflet CŒ‡HœÿClN–O.HœSO÷	2849	Yes	+5°C ± 3°C
	H1429400	Hydroxyethyl salicylate	1	125 mg	1		1225	Yes	+5°C ± 3°C
	Y0001322	Hydroxyethyl starch (high Mw)	1	800 mg	1	See leaflet	1785	Yes	+5°C ± 3°C
	Y0001277	Hydroxyethyl starch (medium MW)	1	1200 mg	1	See leaflet	1785	Yes	+5°C ± 3°C
	H1430000	D-alpha-(4-Hydroxy-phenyl)glycine	1	50 mg	1	(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A	0813	Yes	+5°C ± 3°C
	Y0000186	Hydroxypropylbetadex	2	200 mg	1		1804	Yes	+5°C ± 3°C
	Y0001720	Hydroxypropylcellulose	1	150 mg	1		0337, 2083	Yes	+5°C ± 3°C
	Y0001798	Low-substituted hydroxypropylcellulose	1	100 mg	1		2083	Yes	+5°C ± 3°C
	H1435000	Hydroxyzine hydrochloride	3	600 mg	1		0916.1086	Yes	+5°C ± 3°C
	Y0000011	Hymecromone	1	100 mg	1		1786	Yes	+5°C ± 3°C
	Y0000012	Hymecromone impurity A	1	25 mg	1	benzene-1,3-diol (resorcinol)	1786	Yes	+5°C ± 3°C
	Y0000013	Hymecromone impurity B	2	25 mg	1	7-hydroxy-2-methyl-4H-1-benzopyran-4-one.	1786	Yes	+5°C ± 3°C
	Y0000483	Hyoscine	1	10 mg	1		2167	Yes	+5°C ± 3°C
	Y0000484	Hyoscine impurity A	1	15 mg	1	(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)	2167	Yes	+5°C ± 3°C
	H1450000	Hyoscine butylbromide	2	20 mg	1		0737	Yes	+5°C ± 3°C
	Y0000447	Hyoscine butylbromide impurity E	1	10 mg	1	(1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3- hydroxy-2-phenylpropanoate (N-butylhyoscine)	0737	Yes	+5°C ± 3°C
	H1500000	Hyoscine hydrobromide	1	50 mg	1		0106.0500	Yes	+5°C ± 3°C
	Y0000448	Hyoscine hydrobromide impurity B	1	10 mg	1	(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2- phenylpropanoate (norhyoscine)	0106	Yes	+5°C ± 3°C
	H1600000	Hyoscyamine sulfate	1	100 mg	1		0501, 2489	Yes	+5°C ± 3°C
	Y0000449	Hyoscyamine impurity E	1	10 mg	1	(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscyamine)	0501	Yes	+5°C ± 3°C
	Y0000915	Hypromellose phthalate	1	10 mg	1		347	Yes	+5°C ± 3°C
	I0020000	Ibuprofen	5	250 mg	1		0721	Yes	+5°C ± 3°C
	B1220000	Ibuprofen impurity B	9	1.15 mL	1	See leaflet; (2RS)-2-(4-Butylphenyl)propanoic acid	0721	Yes	+5°C ± 3°C
	Y0000140	Ibuprofen impurity F	2	5 mg	1	3-[4-(2-methylpropyl)phenyl]propanoic acid	0721	Yes	+5°C ± 3°C
	Y0000881	Ibuprofen for peak identification	7	0.09 mg	1	Batch 6 is valid until 31 March 2017	0721	Yes	+5°C ± 3°C
	I0050000	Idoxuridine	1	50 mg	1		0669	Yes	+5°C ± 3°C
	I0060000	Ifosfamide	1	50 mg	1	See leaflet CŸHŒ—ClœNœOœP	1529	Yes	+5°C ± 3°C
	I0060100	Ifosfamide - reference spectrum	1	n/a	1		1529
	I0060002	Ifosfamide impurity A	4	100 mg	2	3-[(2-chloroethyl)amino]propyl dihydrogen phosphate	1529	Yes	-20°C ± 5°C
	I0060004	Ifosfamide impurity B	2	40 mg	1	bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate	1529	Yes	+5°C ± 3°C
	I0060010	Ifosfamide impurity E	1	20 mg	2	3-chloro-N-(2-chloroethyl)propan-1-amine	1529	Yes	+5°C ± 3°C
	I0060012	Ifosfamide impurity F	2	10 mg	1	(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide	1529	Yes	+5°C ± 3°C
	Y0001691	Imatinib mesilate	2	120 mg	1	see leaflet C–ÐH–—NŸSO÷ ; Batch 1 is valid until 31 May 2017	2736	Yes	+5°C ± 3°C
	Y0001695	Imatinib impurity A	1	0.03 mg	1	(2E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-ene-1-one	2736	Yes	-20°C ± 5°C
	Y0001693	Imatinib impurity F	3	10 mg	1	4-methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine ; Batch 2 is valid until 31 July 2016	2736	Yes	+5°C ± 3°C
	Y0001694	Imatinib impurity H	1	130 mg	1	1-(pyridin-3-yl)ethan-1-one	2736	Yes	+5°C ± 3°C
	Y0001692	Imatinib for system suitability	1	5 mg	1		2736	Yes	+5°C ± 3°C
	I0086000	Imidazole	2	60 mg	1		0757,1424, 2270	Yes	+5°C ± 3°C
	I0090000	Imipenem	3	70 mg	1	See leaflet	1226	Yes	-20°C ± 5°C
	I0100000	Imipramine hydrochloride	2	50 mg	1		0029, 0408, 0889,1787	Yes	+5°C ± 3°C
	Y0001689	Immunoglobulin (anti-A, anti-B antibodies test) Negative control	1	50 mg	1		20620	Yes	-20°C ± 5°C
	Y0001688	Immunoglobulin (anti-A, anti-B antibodies test) Positive control	1	46 mg	1		20620	Yes	-20°C ± 5°C
	Y0000893	Imipramine for system suitability	1	10 mg	1		0029	Yes	+5°C ± 3°C
	Y0001153	Immunoglobulin for anti-A, anti-B antibodies limit test BRP	1	45 mg	1		20620	Yes	-20°C ± 5°C
	Y0000540	Immunoglobulin panel for anti-D antibodies test BRP	1	2000 mg	1		See leaflet, 20626	Yes	-20°C ± 5°C
	Y0001205	Imperatorin	1	20 mg	1	See leaflet CŒÿHŒ÷O÷	2556	Yes	+5°C ± 3°C
	I0150000	Indapamide	5	150 mg	1	See leaflet CŒÿHŒÿClN–O–S	1108	Yes	+5°C ± 3°C
	Y0001828	Indapamide Impurity C	1	25 mg	1	(2RS)-2-methyl-2,3-dihydro-1H-indol-1-amine	1108	Yes	+5°C ± 3°C
	I0150020	Indapamide impurity B	4	5 mg	1	4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide	1108	Yes	+5°C ± 3°C
	Y0001752	Indigo	1	15 mg	1	see leaflet CŒÿHŒÐNœOœ	2727	Yes	+5°C ± 3°C
	Y0000788	Indinavir	1	100 mg	1	see leaflet	2214	Yes	+5°C ± 3°C
	Y0000880	Indinavir sulfate - reference spectrum	1	n/a	1		2214
	Y0000746	Indinavir for system suitability	1	20 mg	1		2214	Yes	+5°C ± 3°C
	I0200000	Indometacin	3	70 mg	1	Batch 2 is valid until 18 January 2017	0092,0922,1 686	Yes	+5°C ± 3°C
	Y0001640	Indometacine impurity mixture	1	0.002 mg	1		0092	Yes	+5°C ± 3°C
	Y0000349	Insulin aspart	2	8 mg	1	See leaflet	2084	Yes	-20°C ± 5°C
	I0305000	Insulin (bovine)	3	7.99 mg	1	See leaflet Cœ—÷H–ŸŸNÿ—OŸ—Sÿ	0854.1637	Yes	-20°C ± 5°C
New	Y0001542	Insulin glargine	2	50 mg	1	See leaflet ; Batch 1 is valid until 30 November 2017	2571	Yes	-20°C ± 5°C
	Y0001544	Insulin glargine for peak identification	1	3.2 mg	1		2571	Yes	-20°C ± 5°C
	I0310000	Insulin (human)	4	8 mg	1	see leaflet	0838, 0854, 1637, 1638	Yes	-20°C ± 5°C
	Y0000348	Insulin lispro	2	5.75 mg	1	See leaflet Cœ—ŸH–‡–Nÿ—OŸŸSÿ	2085	Yes	-20°C ± 5°C
	I0320000	Insulin (porcine)	4	9 mg	1	See leaflet Cœ—ÿH–‡ŒNÿ—OŸÿSÿ; For qualitative use see insulin porcine for system suitability CRS Y0001717	0854.1638	Yes	-20°C ± 5°C
	Y0001717	Insulin porcine for system suitability	2	9 mg	1	For intended use: see leaflet.	0838,0854,1 637, 1638	Yes	-20°C ± 5°C
	I0320301	Interferon alfa-2b	6	200 µL	1	About 9.74 mg per mL	1110	Yes	-80°C ± 10°C
	Y0001101	Interferon beta-1a	3	0.6 mL	1	See leaflet	1639	Yes	-80°C ± 10°C
	I0320330	Interferon gamma-1b	2	0.5 mL	2	about 1 mg per ml	1440	Yes	-80°C ± 10°C
	Y0001664	Interferon gamma-1b for system suitability	1	0.6 mg	1		1440	Yes	-20°C ± 5°C
	I0328000	Iobenguane sulfate	3	25 mg	1	See leaflet ; Batch 2 is valid until 31 May 2017	1111,1112,11 13,2351	Yes	+5°C ± 3°C
	Y0000839	Iobenguane sulfate - reference spectrum	1	n/a	1		2351
	Y0001294	Iodixanol	1	60 mg	1		2215	Yes	+5°C ± 3°C
	Y0001292	Iodixanol impurity C	1	10 mg	1	5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl] amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodobenzene-1,3-dicarboxamide	2215	Yes	+5°C ± 3°C
	Y0001291	Iodixanol impurity E	1	10 mg	1	5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6- triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide	2215	Yes	+5°C ± 3°C
	Y0001293	Iodixanol impurity H	1	10 mg	1	5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl) carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl] carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl] amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodobenzene-1,3-dicarboxamide	2215	Yes	+5°C ± 3°C
	I0320800	Iohexol	2	150 mg	1		1114	Yes	+5°C ± 3°C
	I0320810	Iohexol impurity A	1	50 mg	1	5-(acetylamino)-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3- dicarboxamide	1114	Yes	+5°C ± 3°C
	I0320820	Iohexol impurity J	1	125 mg	1	5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3- dicarboxamide	1114.2215	Yes	+5°C ± 3°C
	Y0000672	Iohexol for peak identification	1	10 mg	1		1114	Yes	+5°C ± 3°C
	I0329000	Iopamidol	1	50 mg	1		1115	Yes	+5°C ± 3°C
	I0329010	Iopamidol impurity A	2	15 mg	1	5-amino-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6- triiodobenzene-1,3-dicarboxamide ; Batch 1 is valid until 31 October 2016	1115, 1754	Yes	+5°C ± 3°C
New	Y0000406	Iopamidol impurity H	2	15 mg	1	4-chloro-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2- hydroxypropanoyl]amino]-2,6-diiodobenzene-1,3-dicarboxamide ; Batch 1 is valid until 23 September 2017	1115	Yes	+5°C ± 3°C
	I0330000	Iopanoic acid	1	100 mg	1		0700	Yes	+5°C ± 3°C
	Y0001297	Iopentol	1	10 mg	1		2215	Yes	+5°C ± 3°C
	Y0001020	Iopromide	1	100 mg	1	See leaflet CŒ‡Hœ÷I–N–O‡	1753	Yes	+5°C ± 3°C
	Y0001077	Iopromide impurity A	1	0.125 mg	1	5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide	1753	Yes	+5°C ± 3°C
	Y0001021	Iopromide for system suitability 1	1	5 mg	1		1753	Yes	+5°C ± 3°C
	Y0001022	Iopromide for system suitability 2	1	5 mg	1		1753	Yes	+5°C ± 3°C
	Y0000555	Iotrolan	1	100 mg	1	See leaflet	1754	Yes	+5°C ± 3°C
	Y0000658	Iotrolan for system suitability	1	5 mg	1		1754	Yes	+5°C ± 3°C
	Y0000141	Ioxaglic acid	2	125 mg	1		2009	Yes	+5°C ± 3°C
	Y0000142	Ioxaglic acid impurity A	1	20 mg	1	3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid	2009	Yes	+5°C ± 3°C
	I0360000	Ipratropium bromide	5	120 mg	1		0919	Yes	+5°C ± 3°C
	I0361000	Ipratropium impurity B	3	10 mg	1	(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1- methylethyl)-8-azoniabicyclo[3.2.1]octane	0919	Yes	+5°C ± 3°C
	Y0000276	Ipratropium impurity A	3	15 mg	1	(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1] octane ; Batch 2 is valid until 31 August 2017	0919	Yes	+5°C ± 3°C
	Y0001166	Irbesartan	1	60 mg	1		2465	Yes	+5°C ± 3°C
	Y0001156	Irbesartan impurity A	3	10 mg	1	1-(pentanoylamino)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl] cyclopentane-1-carboxamide	2465	Yes	+5°C ± 3°C
	Y0001831	Irinotecan for peak identification	1	1 mg	1		2675	Yes	+5°C ± 3°C
	Y0001830	Irinotecan for system suitability 1	1	1.51 mg	1		2675	Yes	+5°C ± 3°C
	Y0001833	Irinotecan for system suitability 2	1	10 mg	1		2675	Yes	+5°C ± 3°C
	Y0001832	Irinotecan hydrochloride trihydrate	1	170 mg	1	see leaflet C––H–„ClN÷Oÿ,3HœO	2675	Yes	+5°C ± 3°C
	Y0001616	Irisflorentin	1	15 mg	1	See leaflet CœÐHŒ‡O‡	2561	Yes	+5°C ± 3°C
	I0375000	Isoconazole	1	200 mg	1		1018	Yes	+5°C ± 3°C
	I0380000	Isoconazole nitrate	1	200 mg	1		1017	Yes	+5°C ± 3°C
	I0400000	Isoemetine hydrobromide	1	25 mg	1		0081	Yes	+5°C ± 3°C
	Y0000858	Isoflurane	2	1.4 mL	1		1666	Yes	+5°C ± 3°C
	Y0000037	Isoflurane - reference spectrum	1	n/a	1		1673
	I0460000	Isoleucine	2	30 mg	1		0770	Yes	+5°C ± 3°C
	I0465000	Isomalt	5	3000 mg	1	See leaflet	1531	Yes	+5°C ± 3°C
	Y0000070	Isomaltooligosaccharide	1	0.9 mg	1		1506	Yes	+5°C ± 3°C
	I0500000	Isoniazid	1	100 mg	1		0146	Yes	+5°C ± 3°C
	I0599990	Isoprenaline hydrochloride	1	50 mg	1		1332	Yes	+5°C ± 3°C
	Y0001577	Isoprenaline impurity A	1	15 mg	1	1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone	1332	Yes	+5°C ± 3°C
	I0600000	Isoprenaline sulfate	3	510 mg	1		0502	Yes	+5°C ± 3°C
	Y0001728	Isopropyl alcohol	1	100 mg	1		0970	Yes	+5°C ± 3°C
	I0725000	Isopropyl hexadecanoate	2	100 mg	1	See leaflet CŒ„H–‡Oœ	0839	Yes	+5°C ± 3°C
	Y0001907	Isopropyl isostearate	1	0.5 mL	1		2867	Yes	+5°C ± 3°C
	I0750000	Isopropyl tetradecanoate	4	2 ml	1	See leaflet CŒŸH–÷Oœ	0725	Yes	+5°C ± 3°C
	Y0001568	Isoquercitroside	1	15 mg	1	See leaflet CœŒHœÐOŒœ	2528	Yes	+5°C ± 3°C
	Y0001836	Isorhynchophylline	1	15 mg	1	see leaflet	2729	Yes	-20°C ± 5°C
	I0775000	Isosorbide dinitrate	4	350 mg	1	See leaflet CÿH‡NœO‡ ; Batch 3 is valid until 28 February 2017	1117.1118	Yes	+5°C ± 3°C
	I0775010	Isosorbide mononitrate	5	150 mg	1	See leaflet CÿH„NOÿ; Isosorbide-5-nitrate. Can only be sent by road. ; Batch 4 is valid until 30 September 2017	1117.1118	Yes	+5°C ± 3°C
	I0775020	Isosorbide-2-nitrate	3	50 mg	1		1117.1118	Yes	+5°C ± 3°C
	I0800000	Isotretinoin	5	50 mg	1		0693.1019	Yes	+5°C ± 3°C
	Y0001218	Isotretinoin for peak identification	2	10 mg	1		1019	Yes	+5°C ± 3°C
	I0900000	Isoxsuprine hydrochloride	1	50 mg	1		1119	Yes	+5°C ± 3°C
	Y0000366	Isradipine	1	125 mg	1	See leaflet CŒ„HœŒN–O—	2110	Yes	+5°C ± 3°C
	Y0000367	Isradipine impurity D	1	5 mg	1	methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl) -2,6-dimethylpyridine-3,5-dicarboxylate	2110	Yes	+5°C ± 3°C
	I7000000	Itraconazole	3	20 mg	1		1335	Yes	+5°C ± 3°C
New	Y0001100	Itraconazole for system suitability	3	25 mg	1	Batch 2 is valid until 31 October 2017	1335	Yes	+5°C ± 3°C
	I8000010	Ivermectin	2	150 mg	1	See leaflet	1336	Yes	+5°C ± 3°C
	Y0001592	Ivy leaf dry extract HRS	1	70 mg	1	See leaflet	2148	Yes	-20°C ± 5°C
	Y0000041	Josamycin	2	150 mg	1	See leaflet	1982,1983,2 0702	Yes	-20°C ± 5°C
	Y0001315	Josamycin for peak identification	1	25 mg	1		1983	Yes	+5°C ± 3°C
	Y0000042	Josamycin propionate	3	150 mg	1	See leaflet ; Batch 2 is valid until 31 January 2017	1982,1983,2 0702	Yes	-20°C ± 5°C
	K0100000	Kanamycin B sulfate	3	20 mg	1		0032,0033,0 645	Yes	+5°C ± 3°C
	K0200000	Kanamycin monosulfate	3	150 mg	1	See leaflet CŒ‡H–‡N÷OŒ—S,HœO	0032,0033,0 053, 0485,0645,1 289, 1290,20702	Yes	+5°C ± 3°C
	Y0000450	Ketamine hydrochloride - * narc	1	10 mg	1		1020	Yes	+5°C ± 3°C
New	K0551000	Ketamine impurity A	3	20 mg	1	1-(2-chloro-N-methylbenzimidoyl)cyclopentanol ; Batch 2 is valid until 30 September 2017	1020.1742	Yes	+5°C ± 3°C
	Y0000246	Ketobemidone hydrochloride - reference spectrum	1	n/a	1		1746
	Y0000244	Ketobemidone impurity B	1	5 mg	1	1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone	1746	Yes	+5°C ± 3°C
	Y0000245	Ketobemidone impurity C	1	5 mg	1	1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one	1746	Yes	+5°C ± 3°C
	K0600000	Ketoconazole	2	150 mg	1		0921.1270	Yes	+5°C ± 3°C
	K2000000	Ketoprofen	2	50 mg	1		0922,1157,1 209	Yes	+5°C ± 3°C
	K2000010	Ketoprofen impurity A	5	10 mg	1	1-(3-benzoylphenyl)ethanone	0922	Yes	+5°C ± 3°C
	K2000015	Ketoprofen impurity C	4	15 mg	1	3-[(1RS)-1-carboxyethyl]benzoic acid ; Batch 3 is valid until 31 May 2017	0922	Yes	+5°C ± 3°C
New	Y0000486	Ketorolac trometamol	2	10 mg	1	Batch 1 is valid until 31 December 2017	1755	Yes	+5°C ± 3°C
	Y0000626	Ketorolac trometamol for peak identification	2	5 mg	1		1755	Yes	+5°C ± 3°C
	Y0001619	Ketotifen hydrogen fumarate	1	10 mg	1		1592	Yes	+5°C ± 3°C
	Y0000161	Ketotifen impurity G	5	0.0225 mg	1	4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b) thiophen-9,10-dione	1592	Yes	+5°C ± 3°C
	Y0001617	Ketotifen for peak identification	1	15 mg	1		1592	Yes	+5°C ± 3°C
	Y0001200	Kudzuvine root dry extract	1	200 mg	1	See leaflet	2434.2483	Yes	-20°C ± 5°C
	L0050000	Labetalol hydrochloride	2	120 mg	1	See leaflet CŒ„Hœ—ClNœO–	0923	Yes	+5°C ± 3°C
	Y0001548	Labetalol impurity A	1	10 mg	1	mixture of 4 stereoisomers of 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3- phenylpropyl)amino]ethyl]benzoic acid	0923	Yes	+5°C ± 3°C
	L0129000	Lactitol monohydrate	2	60 mg	1	See leaflet CŒœHœ÷OŒŒ	1337	Yes	+5°C ± 3°C
New	Y0000257	Lactobionic acid	2	100 mg	1	Batch 1 is valid until 30 September 2017	1647	Yes	+5°C ± 3°C
	A1206000	Lactose (anhydrous)	2	30 mg	1	Batch 1 is valid until 31 July 2016	1061	Yes	+5°C ± 3°C
	Y0001750	Lactose monohydrate	1	100 mg	1		0187	Yes	+5°C ± 3°C
	L0130000	Lactulose	4	3000 mg	1	See leaflet	0924.1230	Yes	+5°C ± 3°C
	Y0001510	Lactulose for peak identification	1	2600 mg	1		0924	Yes	+5°C ± 3°C
	Y0000425	Lamivudine	2	150 mg	1	See leaflet C‡HŒŒN–O–S ; Batch 1 is valid until 31 July 2017	2217	Yes	+5°C ± 3°C
	Y0000518	Lamivudine for system suitability 1	1	10 mg	1		2217	Yes	+5°C ± 3°C
	Y0000426	Lamivudine for system suitability 2	2	10.3 mg	1		2217	Yes	+5°C ± 3°C
	Y0001030	Lamotrigine	1	10 mg	1		1756	Yes	+5°C ± 3°C
	Y0001032	Lamotrigine impurity E	1	15 mg	1	2,3-dichlorobenzoic acid	1756	Yes	+5°C ± 3°C
	Y0001031	Lamotrigine for peak identification	1	20 mg	1		1756	Yes	+5°C ± 3°C
	Y0001085	Lamotrigine for system suitability	2	10 mg	1		1756	Yes	+5°C ± 3°C
	Y0000773	Lansoprazole	1	60 mg	1		2219	Yes	+5°C ± 3°C
	Y0000774	Lansoprazole for peak identification	2	1.01 mg	1		2219	Yes	+5°C ± 3°C
	Y0001765	Laudanosine	1	15 mg	1		2763	Yes	+5°C ± 3°C
	Y0001474	Lauric acid	1	1500 mg	1	see leaflet	1848, 2579	Yes	+5°C ± 3°C
	Y0000654	Leflunomide	1	100 mg	1	See leaflet	2330	Yes	+5°C ± 3°C
	Y0000487	Leflunomide impurity A	2	25 mg	1	4-(trifluoromethyl)aniline	2330	Yes	+5°C ± 3°C
	Y0000674	Leflunomide for peak identification	1	1 mg	1		2330	Yes	+5°C ± 3°C
	Y0000685	Letrozole	1	70 mg	1	See leaflet CŒŸHŒŒN—	2334	Yes	+5°C ± 3°C
	L0375000	Leucine	2	50 mg	1		0771.0874	Yes	+5°C ± 3°C
	L0376000	Leuprorelin	5	1 mg	1	See leaflet C—„H‡÷NŒÿOŒœ	1442	Yes	-20°C ± 5°C
	L0376001	Leuprorelin - reference spectrum	1	n/a	1		1442
	Y0000048	Levamisole - reference spectrum	1	n/a	1		1728
	L0380000	Levamisole hydrochloride	1	50 mg	1		0726	Yes	+5°C ± 3°C
	Y0000047	Levamisole hydrochloride for system suitability	5	15 mg	1		0726.1728	Yes	+5°C ± 3°C
	Y0001253	Levetiracetam	3	120 mg	1	See leaflet ; Batch 2 is valid until 31 March 2017	2535	Yes	+5°C ± 3°C
	Y0001254	Levetiracetam impurity A	3	10 mg	1	(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid	2535	Yes	+5°C ± 3°C
	Y0001255	Levetiracetam impurity B	2	15 mg	1	(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide	2535	Yes	+5°C ± 3°C
	Y0001256	Levetiracetam impurity C	2	15 mg	1	pyridin-2-ol	2535	Yes	+5°C ± 3°C
	Y0001257	Levetiracetam impurity D	3	15 mg	1	(2R)-2-(2-oxopyrrolidin-1-yl)but* ((R)-etiracetam)	2535	Yes	+5°C ± 3°C
	L0390000	Levocabastine hydrochloride	1	125 mg	1		1484	Yes	+5°C ± 3°C
	Y0001636	Levocabastine for system suitability 1	1	5.028 mg	1		1484	Yes	+5°C ± 3°C
	Y0001637	Levocabastine for system suitability 2	1	5.005 mg	1		1484	Yes	+5°C ± 3°C
	L0399900	Levocarnitine	3	125 mg	1		1339	Yes	+5°C ± 3°C
	L0399905	Levocarnitine impurity A	4	50 mg	1	(E)- or (Z)-4-(trimethylammonio)but-2-enoate	1339	Yes	+5°C ± 3°C
	L0400000	Levodopa	3	20 mg	1	Batch 2 is valid until 31 May 2017	0038	Yes	+5°C ± 3°C
	L0420000	Levodropropizine	1	60 mg	1		1535	Yes	+5°C ± 3°C
	L0420002	Levodropropizine impurity A	3	25 mg	1	(2R)-3-(4-phenylpiperazin-1-yl)propan-1,2-diol (dextrodropropizine)	1535	Yes	+5°C ± 3°C
	Y0001033	Levodropropizine impurity B	1	50 mg	1	1-phenylpiperazine	1535	Yes	+5°C ± 3°C
	Y0001048	Levodropropizine impurity C	1	300 mg	1	[(2RS)-oxiran-2-yl]methanol (glycidol)	1535	Yes	-20°C ± 5°C
	L0500000	Levomepromazine hydrochloride	1	100 mg	1		0505	Yes	+5°C ± 3°C
	L0505000	Levomepromazine maleate	1	50 mg	1		0925	Yes	+5°C ± 3°C
	L0551000	Levonorgestrel	2	30 mg	1		0926	Yes	+5°C ± 3°C
	Y0001379	Levonorgestrel impurity B	2	15 mg	1	13-ethyl-17-hydroxy-18,19-dinor-17α-pregn-5(10)-en-20-yn-3-one	0926	Yes	+5°C ± 3°C
	Y0001431	Levonorgestrel for system suitability 1	2	10 mg	1		0926	Yes	+5°C ± 3°C
	Y0001618	Levonorgestrel for system suitability 2	1	10 mg	1		0926	Yes	+5°C ± 3°C
	L0570000	Levothyroxine sodium	4	100 mg	1	see leaflet	0401.0728	Yes	-20°C ± 5°C
	Y0001382	Levothyroxine for peak identification	1	10 mg	1		0401	Yes	-20°C ± 5°C
	L0595000	Lidocaine	2	10 mg	1		0727	Yes	+5°C ± 3°C
	L0600000	Lidocaine hydrochloride	3	40 mg	1		0227,1242,1 363	Yes	+5°C ± 3°C
	L0650000	Lincomycin hydrochloride	4	100 mg	1	See leaflet	0582,0583,0 996	Yes	+5°C ± 3°C
	Y0001393	Lincomycin hydrochloride for system suitability	2	10 mg	1		0583	Yes	-20°C ± 5°C
	L0700000	Liothyronine sodium	8	60 mg	1	See leaflet	0401.0728	Yes	-20°C ± 5°C
	Y0000860	Liothyronine for peak identification	1	0.0046 mg	1		0728	Yes	-20°C ± 5°C
	L0702000	Lisinopril dihydrate	2	50 mg	1		1120	Yes	+5°C ± 3°C
	Y0001234	Lisinopril impurity F	2	0.01 mg	1	(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino] hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)	1120	Yes	+5°C ± 3°C
	Y0001701	Lisinopril for peak identification	1	10 mg	1		1120	Yes	+5°C ± 3°C
	Y0001709	Lisinopril for system suitability A	1	10 mg	1		1120	Yes	+5°C ± 3°C
	L0720000	Lithium clavulanate	8	125 mg	1	See leaflet; 1 mg of C‡H‡LiNO— corresponds to 1.157 mg of C‡H‡KNO— ; Batch 6 is valid until 31 January 2017	1140.1653	Yes	+5°C ± 3°C
New	L0720800	Lithocholic acid	3	60 mg	1	Batch 2 is valid until 31 October 2017	1189.1275	Yes	+5°C ± 3°C
	Y0000112	Lobeline hydrochloride	1	50 mg	1		1988	Yes	+5°C ± 3°C
	L0745000	Lomustine	2	50 mg	1		0928	Yes	+5°C ± 3°C
	Y0001438	Long pepper for system suitability HRS	1	600 mg	1		2477, 2453	Yes	+5°C ± 3°C
	L0750000	Loperamide hydrochloride	2	50 mg	1		0921,0929,1 729	Yes	+5°C ± 3°C
	Y0000322	Loperamide hydrochloride for system suitability	2	15 mg	1		0929	Yes	+5°C ± 3°C
	Y0000341	Loperamide oxide monohydrate	1	20 mg	1		1729	Yes	+5°C ± 3°C
	Y0001498	Lopinavir	1	200 mg	1	See leaflet C–ŸH÷‡N÷O—	2615	Yes	+5°C ± 3°C
	Y0001506	Lopinavir for peak identification	1	10 mg	1		2615	Yes	+5°C ± 3°C
	Y0001505	Lopinavir for system suitability	1	10 mg	1		2615	Yes	+5°C ± 3°C
	Y0000688	Loratadine	4	60 mg	1	Batch 3 is valid until 31 August 2016	2124	Yes	+5°C ± 3°C
	Y0000604	Loratadine impurity F	1	10 mg	1	ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-yl]piperidine-1-carboxylate	2124	Yes	+5°C ± 3°C
	Y0000605	Loratadine impurity H	2	50 mg	1	ethyl 4-oxopiperidine-1-carboxylate ; Batch 1 is valid until 30 November 2016	2124	Yes	+5°C ± 3°C
	Y0000603	Loratadine for system suitability	2	15 mg	1	Batch 1 is valid until 31 December 2016	2124	Yes	+5°C ± 3°C
	L0750500	Lorazepam - * psy	2	15 mg	1		1121	Yes	+5°C ± 3°C
	Y0000718	Lorazepam impurity D	2	10 mg	1	(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3- dione	1121	Yes	+5°C ± 3°C
	Y0000576	Lorazepam for system suitability - * psy	2	0.8 mg	1		1121	Yes	+5°C ± 3°C
	Y0001062	Losartan potassium	2	50 mg	1	Batch 1 is valid until 30 April 2017	2232	Yes	+5°C ± 3°C
New	Y0001072	Losartan impurity D	4	10 mg	1	2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 3 is valid until 30 November 2017	2232	Yes	+5°C ± 3°C
	Y0001076	Losartan for system suitability	3	0.0015 mg	1		2232	Yes	+5°C ± 3°C
	L0790000	Lovastatin	4	60 mg	1	See leaflet Cœ÷H–ÿO— ; Batch 3 is valid until 31 July 2017	1538.1563	Yes	-20°C ± 5°C
	Y0001136	Lovastatin for peak identification	1	20 mg	1		1538	Yes	-20°C ± 5°C
	Y0001284	Lufenuron	1	140 mg	1	See leaflet CŒŸH‡ClœF‡NœO–	2177	Yes	+5°C ± 3°C
	Y0001261	Lufenuron for peak identification	1	0.4028 mg	1		2177	Yes	+5°C ± 3°C
	Y0001265	Lufenuron impurity G	1	15 mg	1	2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl phenyl carbonate	2177	Yes	+5°C ± 3°C
	L0800000	Lynestrenol	1	50 mg	1		0558	Yes	+5°C ± 3°C
	Y0001034	Lynestrenol for peak identification	1	20 mg	1		0558	Yes	+5°C ± 3°C
	Y0000397	Lysine acetate	2	60 mg	1		2114	Yes	+5°C ± 3°C
	L0900000	Lysine hydrochloride	3	50 mg	1		0930, 1654	Yes	+5°C ± 3°C
	Y0001369	Macrogol 30 dipolyhydroxystearate	1	100 mg	1		2584	Yes	+5°C ± 3°C
	Y0000745	Macrogol 40 sorbitol heptaoleate	1	20 mg	1		2396	Yes	+5°C ± 3°C
	Y0001684	High-molecular-mass macrogol CRS	1	10 mg	1		2444	Yes	+5°C ± 3°C
	Y0001157	Macrogol polyvinyl alcohol grafted copolymer	1	400 mg	1		2523	Yes	+5°C ± 3°C
	M0088000	Magnesium aspartate dihydrate	1	60 mg	1		1445	Yes	+5°C ± 3°C
	Y0001289	Magnolol	1	20 mg	1	See leaflet CŒ‡HŒ‡Oœ	2567.2568	Yes	-20°C ± 5°C
	M0120000	Malathion	3	250 mg	1	See leaflet CŒÐHŒ„OÿPSœ	1343	Yes	-20°C ± 5°C
	M0120005	Malathion impurity A	3	15 mg	1	see leaflet; diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butanedioate (isomalathion)	1343	Yes	-20°C ± 5°C
	M0120010	Malathion impurity B	3	10 mg	1	diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon)	1343	Yes	-20°C ± 5°C
	M0100000	Maleic acid	2	100 mg	1		0365.0925	Yes	+5°C ± 3°C
	Y0000143	Malic acid - reference spectrum	1	n/a	1		2080
	M0160000	Maltitol	4	1200 mg	1	See leaflet CŒœHœ÷OŒŒ	1235.1236	Yes	+5°C ± 3°C
	Y0001751	Mangiferin	1	15 mg	1	see leaflet CŒ„HŒ‡OŒŒ	2661	Yes	+5°C ± 3°C
	M0200000	Mannitol	5	1200 mg	1	See leaflet CÿHŒ÷Oÿ	0435,0559,1 381, 1531	Yes	+5°C ± 3°C
	M0206000	Maprotiline hydrochloride	1	100 mg	1		1237	Yes	+5°C ± 3°C
	M0206040	Maprotiline impurity D	1	25 mg	1	3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylprop-2-en-1-amine (dehydromaprotiline)	1237	Yes	+5°C ± 3°C
	Y0000819	Marbofloxacin	1	10 mg	1		2233	Yes	+5°C ± 3°C
	Y0000820	Marbofloxacin for peak identification	1	20 mg	1		2233	Yes	+5°C ± 3°C
	M0210000	Measles vaccine (live) BRP	1	400 mg	1	See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of each vial is 80 mg.	1057,0213,2 442	Yes	-20°C ± 5°C
	M0215000	Mebendazole	1	20 mg	1		1208,1254, 0845	Yes	+5°C ± 3°C
	Y0000144	Mebendazole for system suitability	1	20 mg	1		0845	Yes	+5°C ± 3°C
	Y0001086	Mebrofenin	1	120 mg	1		2393	Yes	+5°C ± 3°C
	M0220000	Meclozine dihydrochloride	2	150 mg	1		0622	Yes	+5°C ± 3°C
	Y0001310	Meclozine impurity B	1	15 mg	1	(RS)-(4-chlorophenyl)phenylmethanol	0622	Yes	+5°C ± 3°C
	Y0001311	Meclozine impurity H	1	15 mg	1	1-[(RS)-(4-chlorophenyl)phenylmethyl]piperazine	0622	Yes	+5°C ± 3°C
	Y0001770	Medronate for radiochemical purity testing	1	5 mg	1		0641	Yes	+5°C ± 3°C
	M0240000	Medronic acid	2	20 mg	1		2350	Yes	+5°C ± 3°C
	Y0001107	Medronic acid impurity A	2	60 µL	1	see leaflet C„HœŒO–P; Tris(1-methylethoxy)phosphane	2350	Yes	-20°C ± 5°C
	Y0001106	Medronic acid impurity B	1	40 µl	1	Tetrakis(1-methylethyl)methylenediphosphonate	2350	Yes	-20°C ± 5°C
	M0250000	Medroxyprogesterone acetate	3	100 mg	1		0673	Yes	+5°C ± 3°C
	Y0001484	Medroxyprogesterone acetate for peak identification	1	25 mg	1		0673	Yes	+5°C ± 3°C
	Y0000598	Medroxyprogesterone acetate for system suitability	2	10 mg	1		0673	Yes	-20°C ± 5°C
	M0252600	Mefenamic acid	2	50 mg	1		1240	Yes	+5°C ± 3°C
	Y0001081	Mefenamic acid impurity A	1	100 mg	1	2,3-dimethylaniline	1240	Yes	+5°C ± 3°C
	M0253000	Mefloquine hydrochloride	2	100 mg	1		1241	Yes	+5°C ± 3°C
	Y0001514	Megestrol acetate	1	120 mg	1	See leaflet Cœ÷H–œO÷	1593	Yes	+5°C ± 3°C
	Y0001594	Megestrol acetate for impurity K identification	1	0.01 mg	1		1593	Yes	+5°C ± 3°C
	Y0001507	Megestrol acetate for peak identification	1	25 mg	1		1593	Yes	+5°C ± 3°C
New	Y0001524	Megestrol acetate for system suitability	2	50 mg	1	Batch 1 is valid until 31 October 2017	1593	Yes	+5°C ± 3°C
	Y0001209	Meglumine	1	10 mg	1		2055	Yes	+5°C ± 3°C
	Y0001670	Meldonium dihydrate	1	10 mg	1		2624	Yes	+5°C ± 3°C
	Y0001671	Meldonium impurity A	1	25 mg	1	N,N-dimethylmethanaminium	2624	Yes	+5°C ± 3°C
	Y0001672	Meldonium impurity B	1	25 mg	1	1,1,1-trimethylhydrazin-1-ium	2624	Yes	+5°C ± 3°C
	Y0001673	Meldonium impurity C	1	25 mg	1	see leaflet CŸHŒŸNœOœBr; 2-(3-methoxy-3-oxopropyl)-1,1,1- trimethylhydrazin-1-ium	2624	Yes	+5°C ± 3°C
	Y0001674	Meldonium impurity D	1	25 mg	1	see leaflet C‡HŒ„NœOœBr; 2-(3-ethoxy-3-oxopropyl)-1,1,1-trimethylhydrazin-1- ium	2624	Yes	+5°C ± 3°C
	Y0001675	Meldonium impurity E	1	25 mg	1	see leaflet C„HœŒBrNœOœ; 1,1,1-trimethyl-2-[3-(1-methylethoxy)-3-oxopropyl] hydrazin-1-ium	2624	Yes	+5°C ± 3°C
	Y0001676	Meldonium impurity F	1	25 mg	1	see leaflet C—HŒÐNœO; 1,1-dimethyl-4,5-dihydro-1H-pyrazol-1-ium-3-olate	2624	Yes	+5°C ± 3°C
	Y0001080	Meloxicam	1	50 mg	1		2373	Yes	+5°C ± 3°C
	Y0001035	Meloxicam impurity A	2	5 mg	1	ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide	2373	Yes	+5°C ± 3°C
	Y0001036	Meloxicam impurity B	2	5 mg	1	5-methylthiazol-2-amine	2373	Yes	+5°C ± 3°C
	Y0001037	Meloxicam impurity C	3	10 mg	1	N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide	2373	Yes	+5°C ± 3°C
	Y0001039	Meloxicam impurity D	3	5 mg	1	N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide	2373	Yes	+5°C ± 3°C
	Y0001158	Melphalan hydrochloride	2	100 mg	1	see leaflet ; Batch 1 is valid until 28 February 2017	1698	Yes	+5°C ± 3°C
	Y0001513	Melphalan - reference spectrum	1	1 uc	1		1698
	Y0001457	Melphalan for system suitability	1	10 mg	1		1698	Yes	+5°C ± 3°C
	M0300000	Menadione	1	100 mg	1		0507	Yes	+5°C ± 3°C
	M0350000	Menthol	5	150 mg	1		0619.0623	Yes	+5°C ± 3°C
	M0370000	Mepivacaine hydrochloride	1	100 mg	1		1242	Yes	+5°C ± 3°C
	M0370020	Mepivacaine impurity B	1	60 mg	1	(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide	1242		+5°C ± 3°C
	M0400000	Meprobamate - * psy	1	100 mg	1		0407.1689	Yes	+5°C ± 3°C
	M0500000	Mepyramine maleate	1	1000 mg	1		0278	Yes	+5°C ± 3°C
	Y0000679	Mepyramine impurity A	1	10 mg	1	N-(4-methoxybenzyl)pyridin-2-amine	0278	Yes	+5°C ± 3°C
	Y0000680	Mepyramine impurity C	1	10 mg	1	pyridin-2-amine	0278	Yes	+5°C ± 3°C
	Y0001252	Meropenem trihydrate	1	110 mg	1	See leaflet	2234	Yes	+5°C ± 3°C
	Y0000297	Mesalazine	2	125 mg	1		1699.1993	Yes	+5°C ± 3°C
	Y0001563	Mesalazine impurity A	2	15 mg	1	4-aminophenol ; Batch 1 is valid until 30 September 2017	1699	Yes	+5°C ± 3°C
	Y0001569	Mesalazine impurity C	1	15 mg	1	2-aminophenol	1699	Yes	+5°C ± 3°C
	Y0001574	Mesalazine for system suitability	4	10 mg	1	Batch 3 is valid until 31 October 2016	1699	Yes	+5°C ± 3°C
	Y0001040	Mesityl oxide	2	100 mg	1	see leaflet CÿHŒÐO ; Batch 1 is valid until 31 July 2017	2358	Yes	+5°C ± 3°C
	Y0000337	Mesna - reference spectrum	1	n/a	1		1674
	Y0000316	Mesna impurity C	1	10 mg	1	2-(acetylsulfanyl)ethanesulfonic acid	1674	Yes	+5°C ± 3°C
	Y0000317	Mesna impurity D	1	10 mg	1	2,2'-(disulfanediyl)bis(ethanesulfonic acid)	1674	Yes	+5°C ± 3°C
	Y0000227	Meso-rich exametazime	1	0.5 mg	1		1925	Yes	+5°C ± 3°C
	Y0000097	Mesterolone	2	120 mg	1	See leaflet CœÐH–œOœ	1730	Yes	+5°C ± 3°C
	Y0000096	Mesterolone impurity A	1	30 mg	1	17ß-hydroxy-1α-methylandrost-4-en-3-one	1730	Yes	+5°C ± 3°C
	M0600000	Mestranol	1	100 mg	1		0509	Yes	+5°C ± 3°C
	Y0000301	Metacresol - reference spectrum	1	n/a	1		2077
	M0600900	Metamizole sodium	4	10 mg	1		1346	Yes	+5°C ± 3°C
	M0600905	Metamizole impurity A	4	15 mg	1	4-(formylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one	1346	Yes	+5°C ± 3°C
	Y0001481	Metamizole impurity E	3	0.01 mg	1	[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino] methanesulfonic acid (4-N-desmethylmetamizole).	1346	Yes	+5°C ± 3°C
	M0605000	Metformin hydrochloride	3	50 mg	1		0931	Yes	+5°C ± 3°C
	Y0001590	Metformin impurity A	1	25 mg	1	Cyanoguanidine	0931	Yes	+5°C ± 3°C
	Y0001600	Metformin impurity F	2	2 mL	1	N-methylmethanamine (dimethylamine)	0931	Yes	+5°C ± 3°C
	Y0001820	Methacrylic acid - methylmethacrylate copolymer (1:1)	1	120 mg	1		1127	Yes	+5°C ± 3°C
	Y0001821	Methacrylic acid - methylmethacrylate copolymer (1:2)	1	120 mg	1		1130	Yes	+5°C ± 3°C
	Y0000770	Methacrylic acid-ethyl acrylate copolymer (1:1) - type A	1	200 mg	1		1128	Yes	+5°C ± 3°C
	Y0000323	Methacrylic acid-ethyl acrylate copolymer (1:1) - type B	1	200 mg	1		1128	Yes	+5°C ± 3°C
	M0610030	Methacrylic acid-ethylacrylate copolymer (1:1), dispersion 30%-ref.sp	1	n/a	1		1129
	M0800000	Methadone hydrochloride - reference spectrum	1	n/a	1		0408.1787
	Y0000428	Methanol - reference spectrum	1	n/a	1		1989
	Y0000754	Methenamine	1	10 mg	1		1545	Yes	+5°C ± 3°C
	M0960000	Methionine	2	50 mg	1		0788.1027	Yes	+5°C ± 3°C
	M0950000	DL-Methionine	1	50 mg	1		0624	Yes	+5°C ± 3°C
	M1000000	Methotrexate	7	100 mg	1	See leaflet CœÐHœœN‡O—	0560	Yes	+5°C ± 3°C
New	Y0000663	Methotrexate impurity C	3	10 mg	1	(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino] benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine) ; Batch 2 is valid until 31 October 2017	0560	Yes	+5°C ± 3°C
	M1000008	Methotrexate impurity D	4	10 mg	1	4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic acid (N10-methylpteroic acid) ; Batch 3 is valid until 31 October 2016	0560	Yes	+5°C ± 3°C
	Y0000664	Methotrexate impurity E	1	10 mg	1	4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino- N10-methylpteroic acid, APA)	0560	Yes	+5°C ± 3°C
	Y0000602	Methotrexate for peak identification	1	20 mg	1		0560	Yes	+5°C ± 3°C
	Y0001668	Methotrexate for system suitability	1	100 mg	1		0560	Yes	+5°C ± 3°C
	M1470000	Methyl 2-(4-chlorophenoxy)-2-methylpropionate	1	0.5 ml	1		0318	Yes	+5°C ± 3°C
	M1556000	Methyl 12-hydroxystearate	2	100 mg	1		1497	Yes	+5°C ± 3°C
	Y0001488	Methyl methacrylate	1	50 mg	1		1975	Yes	+5°C ± 3°C
	Y0000398	Methyl nicotinate	1	25 mg	1		2129	Yes	+5°C ± 3°C
	M1650000	Methyl parahydroxybenzoate	4	150 mg	1	See leaflet	0409,1262,2 134,1999	Yes	+5°C ± 3°C
	M1770180	Methyl ricinoleate	3	125 mg	1	Batch 2 is valid until 30 September 2016	0051.2367	Yes	+5°C ± 3°C
	M1770200	Methyl stearate	3	100 mg	1		0051,1497, 2367	Yes	+5°C ± 3°C
	M1300000	Methylatropine bromide	1	100 mg	1		0919	Yes	+5°C ± 3°C
	M1500000	Methyldopa	2	50 mg	1		0045	Yes	+5°C ± 3°C
	Y0001083	Methyldopa for system suitability	2	0.024 mg	1	Batch 1 is valid until 31 May 2017	0045	Yes	+5°C ± 3°C
	Y0001374	Racemic methyldopa	1	5 mg	1		0045	Yes	+5°C ± 3°C
	M1550000	Methylene chloride	3	5 mL	1		0932	Yes	+5°C ± 3°C
	Y0000776	Methylergometrine maleate	1	10 mg	1		1788	Yes	+5°C ± 3°C
	Y0000777	Methylergometrine for system suitability	1	0.53 mg	1		1788	Yes	+5°C ± 3°C
	M1625000	Methylnitrosoindoline	3	110 mg	1		1108	Yes	+5°C ± 3°C
	Y0001017	Methylphenidate hydrochloride - * narc	1	40 mg	1		2235	Yes	+5°C ± 3°C
	Y0001490	Methylphenidate impurity C	1	10 mg	1	(2RS)-2-phenyl-2-[(2RS)-piperidin-2-yl]acetamide	2235	Yes	+5°C ± 3°C
	Y0000910	Methylphenidate impurity mixture	1	0.04 mg	1		2235	Yes	+5°C ± 3°C
	M1700000	Methylphenobarbital - * psy	1	500 mg	1		0189	Yes	+5°C ± 3°C
	M1750000	Methylprednisolone	3	120 mg	1	See leaflet	0312.0561	Yes	-20°C ± 5°C
	Y0001799	Methylprednisolone for system suitability A	1	10 mg	1		0561	Yes	-20°C ± 5°C
	M1755000	Methylprednisolone acetate	2	110 mg	1	See leaflet Cœ÷H–œOÿ	0933	Yes	+5°C ± 3°C
	Y0001736	Methylprednisolone acetate for peak identification	1	0.01 mg	1		0933	Yes	+5°C ± 3°C
	Y0001760	Methylprednisolone acetate for system suitability	1	10 mg	1		0933	Yes	+5°C ± 3°C
	M1755200	Methylprednisolone hydrogen succinate	3	60 mg	1	See leaflet CœÿH–÷O‡	0768.1131	Yes	+5°C ± 3°C
	Y0001759	Methylprednisolone hydrogen succinate for peak identification	1	10 mg	1		1131	Yes	+5°C ± 3°C
	M1755220	Methylprednisolone hydrogen succinate for performance test	2	20 mg	1	Batch 1 is valid until 31 August 2017	1131	Yes	+5°C ± 3°C
	Y0001376	2-methylpyrazine	1	100 mg	1		2446,2447,2 708	Yes	+5°C ± 3°C
	Y0000190	N-Methylpyrrolidone - reference spectrum	1	n/a	1		1675
	Y0000418	Methylrosanilinium chloride	1	40 mg	1		1990	Yes	+5°C ± 3°C
	Y0000407	Methylrosanilinium for system suitability	1	10 mg	1		1990	Yes	+5°C ± 3°C
	M1800000	Methyltestosterone	2	10 mg	1	Batch 1 is valid until 28 February 2017	0410	Yes	+5°C ± 3°C
	Y0000861	Methyltestosterone for system suitability	1	10 mg	1		0410	Yes	+5°C ± 3°C
	M1800900	Methylthioninium chloride	2	130 mg	1	See leaflet CŒÿHŒ‡ClN–S,xHœO	1132	Yes	+5°C ± 3°C
	Y0001744	Methylthioninium for system suitability	1	15 mg	1		1132	Yes	+5°C ± 3°C
	M1808000	Metixene hydrochloride	1	75 mg	1		1347	Yes	+5°C ± 3°C
	M1824990	Metoclopramide	1	100 mg	1		1348	Yes	+5°C ± 3°C
	M1825000	Metoclopramide hydrochloride	2	50 mg	1		0674,0856,1 303	Yes	+5°C ± 3°C
	M1824995	Metoclopramide impurity A	2	25 mg	1	4-(acetylamino)-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide	1348	Yes	+5°C ± 3°C
New	M1825010	Metoclopramide impurity E	2	40 mg	1	N,N-diethylethane-1,2-diamine ; Batch 1 is valid until 31 October 2017	1575	Yes	+5°C ± 3°C
	Y0000701	Metolazone	1	80 mg	1	See leaflet CŒÿHŒÿClN–O–S	1757	Yes	+5°C ± 3°C
	Y0000702	Metolazone for system suitability	1	10 mg	1		1757	Yes	+5°C ± 3°C
	Y0000171	Metoprolol succinate - reference spectrum	1	n/a	1		1448
	M1830000	Metoprolol tartrate	2	60 mg	1		1028	Yes	+5°C ± 3°C
	Y0000145	Metoprolol impurity A	4	5 mg	1	(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol ; Batch 3 is valid until 31 July 2016	1028.1448	Yes	+5°C ± 3°C
	M1845000	Metrifonate	1	100 mg	1		1133	Yes	+5°C ± 3°C
	M1850000	Metronidazole	2	50 mg	1		0675.0934	Yes	+5°C ± 3°C
	Y0000087	Metronidazole impurity A	3	10 mg	1	2-methyl-4-nitroimidazole	0675, 0934	Yes	+5°C ± 3°C
	M1851000	Metronidazole benzoate	1	50 mg	1		1424	Yes	+5°C ± 3°C
	Y0000069	Metronidazole benzoate - reference spectrum	1	n/a	1		0934
	M1860000	Mexiletine hydrochloride	1	100 mg	1		1029	Yes	+5°C ± 3°C
	Y0000202	Mexiletine impurity C	3	10 mg	1	see leaflet CœœH–œNœOœ; 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy] dipropan-2-amine ; Batch 2 is valid until 31 July 2017	1029	Yes	+5°C ± 3°C
	Y0000203	Mexiletine impurity D	1	2 mg	1	(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine	1029	Yes	+5°C ± 3°C
	M1875000	Mianserin hydrochloride	3	100 mg	1		0846	Yes	+5°C ± 3°C
	Y0001041	Mianserin impurity B	1	10 mg	1	(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazi,2-a] azepine-8-sulfonic acid	0846	Yes	+5°C ± 3°C
	Y0000862	Mianserin for system suitability	1	1.01 mg	1		0846	Yes	+5°C ± 3°C
	M1880000	Miconazole	1	70 mg	1		0935	Yes	+5°C ± 3°C
	M1900000	Miconazole nitrate	2	100 mg	1		0513.1148	Yes	+5°C ± 3°C
	M2200000	Midazolam - * psy	3	50 mg	1	Batch 2 is valid until 28 February 2017	0936.1065	Yes	+5°C ± 3°C
	Y0000562	Midazolam impurity C	3	0.08 mg	1	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4] benzodiazepine-3-carboxylic acid	0936	Yes	+5°C ± 3°C
	Y0000599	Midazolam for system suitability - * psy	3	1 mg	1		0936	Yes	+5°C ± 3°C
	Y0001882	Milbemycin oxime for system suitability	1	10 mg	1		2536	Yes	+5°C ± 3°C
New	Y0001893	Milbemycin oxime	1	100 mg	1		2536	Yes	+5°C ± 3°C
	Y0001687	Milk thistle dry extract HRS	2	120 mg	1	See leaflet	1860.2071	Yes	-20°C ± 5°C
	Y0001878	Minocycline for system suitability	1	10 mg	1		1030	Yes	+5°C ± 3°C
	M2280000	Minocycline hydrochloride	3	125 mg	1	See leaflet Cœ–Hœ‡ClN–OŸ; The reference standard M2280000 will be deleted from the monograph 07/2017 :1030 on 2017/06/30 and will be replaced by Minocycline hydrochloride Y0001930.	1030	Yes	+5°C ± 3°C
	M2300000	Minoxidil	1	50 mg	1		0937	Yes	+5°C ± 3°C
	Y0001432	Minoxidil for system suitability	1	10 mg	1		0937	Yes	+5°C ± 3°C
	Y0000705	Mirtazapine	1	10 mg	1		2338	Yes	+5°C ± 3°C
	Y0000721	Mirtazapine for system suitability	1	10 mg	1		2338	Yes	+5°C ± 3°C
	Y0000490	Misoprostol	3	60 mg	1	See leaflet CœœH–‡O—	1731	Yes	-20°C ± 5°C
	Y0001162	Misoprostol for system suitability	1	5 mg	1		1731	Yes	-20°C ± 5°C
	Y0000378	Mitomycin	2	120 mg	1	See leaflet CŒ—HŒ‡N÷O—	1655	Yes	+5°C ± 3°C
	M2305000	Mitoxantrone hydrochloride	4	60 mg	1	See leaflet	1243	Yes	+5°C ± 3°C
	M2305005	Mitoxantrone impurity A	4	5 mg	1	1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino] anthracene-9,10-dione ; Batch 3 is valid until 30 June 2017	1243	Yes	+5°C ± 3°C
	Y0000635	Modafinil	1	110 mg	1	See leaflet CŒ—HŒ—NOœS	2307	Yes	+5°C ± 3°C
	Y0000636	Modafinil for system suitability	1	0.1 mg	1		2307	Yes	+5°C ± 3°C
	Y0000251	Molgramostim	1	0.3 ml	1	13.45 mg protein per ml Cÿ–„HŒÐÐŸNŒŸŒOŒ„ÿS‡	1641	Yes	-80°C ± 10°C
	Y0000821	Molsidomine	1	5 mg	1		1701	Yes	+5°C ± 3°C
	Y0000822	Molsidomine impurity B	1	10 mg	1	4-nitrosomorpholine	1701	Yes	+5°C ± 3°C
	Y0000823	Molsidomine impurity D	1	10 mg	1	morpholine-4-carbaldehyde	1701	Yes	+5°C ± 3°C
	M2900000	Mometasone furoate	3	60 mg	1	Batch 2 is valid until 31 July 2016	1449	Yes	+5°C ± 3°C
	Y0001436	Monukast dicyclohexylamine	2	150 mg	1	See leaflet	2583	Yes	+5°C ± 3°C
	Y0001433	Monukast racemate	3	0.1 mg	1	Batch 2 is valid until 31 July 2016	2583	Yes	+5°C ± 3°C
	Y0001434	Monukast sodium	2	20 mg	1		2583	Yes	+5°C ± 3°C
	Y0001435	Monukast for peak identification	3	20 mg	1		2583	Yes	+5°C ± 3°C
	Y0000028	Moran hydrogen tartrate	2	50 mg	1		1546	Yes	+5°C ± 3°C
	Y0000451	Morphine hydrochloride trihydrate - * narc	3	25 mg	1	See leaflet ; Batch 2 is valid until 30 November 2016	1839, 1840, 0777, 1841, 0097	Yes	+5°C ± 3°C
	Y0000452	Morphine sulfate - * narc	1	40 mg	1		1244.1784	Yes	+5°C ± 3°C
	Y0000830	Morphine for system suitability - * narc	3	15 mg	1		1244, 0097	Yes	+5°C ± 3°C
	Y0000772	Moxidectin	3	70 mg	1	See leaflet	1656	Yes	-20°C ± 5°C
	Y0000747	Moxidectin for system suitability	2	10 mg	1		1656	Yes	+5°C ± 3°C
	Y0000703	Moxifloxacin hydrochloride	3	120 mg	1	See leaflet CœŒHœ—ClFN–O÷ ; Batch 2 is valid until 30 June 2016	2254	Yes	+5°C ± 3°C
	Y0000717	Moxifloxacin for peak identification	2	10 mg	1		2254	Yes	+5°C ± 3°C
	Y0000226	Moxonidine	2	50 mg	1	See leaflet C„HŒœClN—O ; Batch 1 is valid until 30 June 2017	1758	Yes	+5°C ± 3°C
	Y0000222	Moxonidine impurity A	1	10 mg	1	4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine (6- chloromoxonidine)	1758	Yes	+5°C ± 3°C
	M3600000	Mumps vaccine (live) BRP	1	165 mg	1	See leaflet	0538,1057, 2442	Yes	-80°C ± 10°C
	M3805000	Mupirocin - reference spectrum	1	n/a	1		1450
	M3805500	Mupirocin calcium - reference spectrum	1	n/a	1		1451
	M3806000	Mupirocin lithium	2	100 mg	1	See leaflet CœÿH÷–O„Li	1450.1451	Yes	+5°C ± 3°C
	Y0000489	Mycophenolate mofetil	3	30 mg	1		1700	Yes	+5°C ± 3°C
	Y0000519	Mycophenolate mofetil for peak identification	6	10 mg	1	Batch 5 is valid until 31 July 2016	1700	Yes	+5°C ± 3°C
	Y0001810	Mycophenolate sodium	1	200 mg	1	See leaflet CŒŸHœÐOÿNa	2813	Yes	+5°C ± 3°C
	Y0000692	Mycoplasma fermentans BRP	1	1 ml	1		20607	Yes	-80°C ± 10°C
	Y0000690	Mycoplasma hyorhinis BRP	1	1 ml	1		20607	Yes	-80°C ± 10°C
	Y0000691	Mycoplasma orale BRP	1	1 ml	1		20607	Yes	-80°C ± 10°C
	Y0000689	Mycoplasma synoviae BRP	1	1 ml	1		20607	Yes	-80°C ± 10°C
	Y0000485	Myo-inositol	1	1020 mg	1	See leaflet	1805	Yes	+5°C ± 3°C
	N0020000	Nabumetone	1	60 mg	1	See leaflet CŒ—HŒÿOœ	1350	Yes	+5°C ± 3°C
New	N0020020	Nabumetone impurity D	3	10 mg	1	(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one ; Batch 2 is valid until 31 October 2017	1350	Yes	+5°C ± 3°C
	N0020030	Nabumetone impurity F	5	10 mg	1	See leaflet; 6,6'-dimethoxy-2,2'-binaphthalenyl	1350	Yes	+5°C ± 3°C
	Y0000146	Nadolol	1	100 mg	1		1789	Yes	+5°C ± 3°C
	Y0001215	Nadolol impurity mixture	1	0.01 mg	1		1789	Yes	+5°C ± 3°C
	N0025000	Nadroparin calcium	3	450 mg	1	Batch 2 is valid until 31 July 2017	0828.1134	Yes	+5°C ± 3°C
	Y0000077	Naftidrofuryl - reference spectrum	1	n/a	1		1594
New	Y0000120	Naftidrofuryl impurity A	2	10 mg	1	2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid	1594	Yes	+5°C ± 3°C
	Y0000121	Naftidrofuryl impurity B	2	25 mg	1	ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate	1594	Yes	+5°C ± 3°C
	Y0000331	Naftidrofuryl impurity F	1	10 mg	1	2-(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl) propanoate	1594	Yes	+5°C ± 3°C
	N0050000	Nalidixic acid	1	100 mg	1		0701	Yes	+5°C ± 3°C
	Y0001792	Nalidixic acid impurity C	1	20 mg	1	diethyl (ethoxymethylidene)propanedioate	0701	Yes	+5°C ± 3°C
	N0075000	Naloxone hydrochloride dihydrate	3	100 mg	1	Batch 2 is valid until 28 February 2017	0729.2099	Yes	+5°C ± 3°C
	Y0001571	Naloxone impurity D	2	25 mg	1	7,8-didehydro-4,5α-epoxy-3,14-dihydroxy-17-(prop-2-enyl)morphinan-6-one (7,8-didehydronaloxone)	0729	Yes	+5°C ± 3°C
	Y0000695	Naloxone for peak identification	3	5.1 mg	1	Batch 2 is valid until 31 May 2017	0729	Yes	+5°C ± 3°C
	Y0000400	Naltrexone hydrochloride	2	50 mg	1		1790	Yes	+5°C ± 3°C
	Y0000410	Naltrexone impurity C	1	15 mg	1	17-but-3-enyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one	1790	Yes	+5°C ± 3°C
	Y0000542	Nandrolone decanoate	1	5 mg	1		1992	Yes	-20°C ± 5°C
	Y0000547	Nandrolone decanoate for peak identification	1	10 mg	1		1992	Yes	-20°C ± 5°C
	Y0000548	Nandrolone decanoate for system suitability	1	10 mg	1		1992	Yes	-20°C ± 5°C
	N0080000	Naphazoline hydrochloride	3	50 mg	1		0730.1162	Yes	+5°C ± 3°C
	N0100000	Naphazoline nitrate	2	10 mg	1		0147	Yes	+5°C ± 3°C
	N0200000	Naphazoline impurity A	5	15 mg	1	N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (naphthylacetylethylenediamine)	0147.0730	Yes	+5°C ± 3°C
	N0250000	Naproxen	3	50 mg	1		0731.1702	Yes	+5°C ± 3°C
	Y0000399	Naproxen (racemic)	1	10 mg	1		0731.1702	Yes	+5°C ± 3°C
	Y0000631	Naproxen impurity L	1	10 mg	1	1-(6-methoxynaphthalen-2-yl)ethanone	0731.1702	Yes	+5°C ± 3°C
	Y0001378	Naringin	1	20 mg	1	See leaflet CœŸH–œOŒ÷	2563	Yes	+5°C ± 3°C
	Y0001437	Nateglinide	1	200 mg	1	See leaflet CŒ„HœŸNO–	2575	Yes	+5°C ± 3°C
	Y0001440	Nateglinide impurity A	1	10 mg	1	trans-4-(1-methylethyl)cyclohexanecarboxylic acid	2575	Yes	+5°C ± 3°C
	Y0001441	Nateglinide impurity B	1	15 mg	1	N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (L- phenylalanine isomer)	2575	Yes	+5°C ± 3°C
	Y0001442	Nateglinide impurity C	1	10 mg	1	N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)	2575	Yes	+5°C ± 3°C
	N0300000	Neamine	5	0.5 mg	1	see leaflet	0180.0197	Yes	+5°C ± 3°C
	N0399000	Neohesperidin-dihydrochalcone	2	125 mg	1	See leaflet Cœ‡H–ÿOŒ—	1547	Yes	-20°C ± 5°C
	N0399004	Neohesperidin-dihydrochalcone impurity B	2	10 mg	1	See leaflet Cœ‡H–œOŒ— ; 7-[[2-O-(6-deoxy-¶-L-mannopyranosyl) -ß-D- glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1- benzopyran-4-one (neodiosmin)	1547	Yes	+5°C ± 3°C
	N0400000	Neomycin sulfate	3	50 mg	1	Not to be used for microbiological assay	0032,0033,0 053, 0180,0197,0 485, 0645	Yes	-20°C ± 5°C
	N0401000	Neomycin sulfate for microbiological assay	5	25 mg	1	See leaflet ; Batch 4 is valid until 31 May 2017	20702	Yes	-20°C ± 5°C
	N0500000	Neostigmine bromide	1	50 mg	1		0046	Yes	+5°C ± 3°C
	N0550000	Neostigmine metilsulfate	1	50 mg	1		0626	Yes	+5°C ± 3°C
	Y0001639	Neostigmine impurity A	1	0.0025 mg	1	3-hydroxy-N,N,N-trimethylanilinium	0046.0626	Yes	+5°C ± 3°C
New	Y0001890	Netilmicin for peak identification	1	15 mg	1		1351, 20702	Yes	-20°C ± 5°C
	N0559000	Netilmicin sulfate	1	25 mg	2	See leaflet; The reference standard N0559000 will be deleted from the monograph 07/2017:1351 on 06/30/2017. ; Batch 1 is valid until 30 June 2017	1351.20702	Yes	-20°C ± 5°C
New	Y0001894	Netilmicin sulfate for LC assay	1	25 mg	1	See leaflet	1351, 20702	Yes	-20°C ± 5°C
	Y0000520	Nevirapine (Anhydrous)	1	30 mg	1	See leaflet CŒ—HŒ÷N÷O	2255, 2479	Yes	+5°C ± 3°C
	Y0001499	Nevirapine hemihydrate	1	15 mg	1		2479	Yes	+5°C ± 3°C
	Y0000521	Nevirapine for peak identification	1	0.058 mg	1		2255, 2479	Yes	+5°C ± 3°C
	Y0000388	Newcastle Disease Vaccine (inactivated) BRP	1	40 mg	1	The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated, detection antibody	0870	Yes	-20°C ± 5°C
New	Y0001917	Nicardipine for system suitability	1	10 mg	1		2776	Yes	+5°C ± 3°C
	Y0001373	Nicergoline	1	50 mg	1		1998	Yes	+5°C ± 3°C
	Y0001356	Nicergoline impurity D	1	20 mg	1	5-bromopyridine-3-carboxylic acid	1998	Yes	+5°C ± 3°C
	Y0001362	Nicergoline for peak identification	1	1 mg	1		1998	Yes	+5°C ± 3°C
	Y0001352	Nicergoline for system suitability	1	10 mg	1		1998	Yes	+5°C ± 3°C
	N0560000	Niclosamide (anhydrous)	3	50 mg	1		0679.0680	Yes	+5°C ± 3°C
	Y0001761	Nicorandil	1	5 mg	1		2332	Yes	-20°C ± 5°C
	Y0001762	Nicorandil impurity A	1	5 mg	1	2-[(pyridin-4-ylcarbonyl)amino]ethyl nitrate	2332	Yes	-20°C ± 5°C
	N0600000	Nicotinamide	1	50 mg	1		0047	Yes	+5°C ± 3°C
	N0590000	Nicotine - reference spectrum	1	n/a	1		1452.1792
	N0590200	Nicotine ditartrate	5	120 mg	1	See leaflet CŒÐHŒ÷Nœ x 2 C÷HÿOÿ ; Batch 4 is valid until 30 November 2016	1792	Yes	+5°C ± 3°C
	Y0001425	Nicotine ditartrate dihydrate	1	15 mg	1		2599	Yes	+5°C ± 3°C
	Y0001023	Nicotine for system suitability	4	1 mg	1	Batch 3 is valid until 31 October 2016	1452, 1792, 2599	Yes	-20°C ± 5°C
	N0700000	Nicotinic acid	1	100 mg	1		0459	Yes	+5°C ± 3°C
	Y0001268	Nicotinic acid impurity mixture	1	0.12 mg	1		0459	Yes	+5°C ± 3°C
	N0750000	Nifedipine	1	50 mg	1		0627.1013	Yes	+5°C ± 3°C
	N0750010	Nifedipine impurity A	1	25 mg	1	Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (nitrophenylpyridine analogue)	0627	Yes	+5°C ± 3°C
	N0750015	Nifedipine impurity B	1	25 mg	1	Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate (nitrosophenylpyridine analogue)	0627	Yes	+5°C ± 3°C
	Y0000824	Niflumic acid	1	10 mg	1		2115	Yes	+5°C ± 3°C
	Y0000825	Niflumic acid impurity A	1	10 mg	1	2-chloropyridine-3-carboxylic acid	2115	Yes	+5°C ± 3°C
	Y0000826	Niflumic acid impurity B	1	10 mg	1	2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide	2115	Yes	+5°C ± 3°C
	Y0000827	Niflumic acid impurity E	1	15 mg	1	6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid	2115	Yes	+5°C ± 3°C
	Y0000836	Nifuroxazide	1	10 mg	1		1999	Yes	+5°C ± 3°C
	N0800000	Nikethamide	1	1 ml	1		0233	Yes	+5°C ± 3°C
	Y0000829	Nilutamide	1	110 mg	1	See leaflet CŒœHŒÐF–N–O÷	2256	Yes	+5°C ± 3°C
	Y0000894	Nilutamide impurity B	1	5 mg	1	4-nitro-3-(trifluoromethyl)aniline (nifeline)	2256	Yes	+5°C ± 3°C
	N0845000	Nimesulide	2	100 mg	1		1548	Yes	+5°C ± 3°C
	N0845008	Nimesulide impurity D	5	0.004 mg	1	4-nitro-2-phenoxyaniline ; Batch 4 is valid until 31 October 2016	1548	Yes	+5°C ± 3°C
	Y0001237	Nimesulide for peak identification	1	10 mg	1		1548	Yes	+5°C ± 3°C
	N0850000	Nimodipine	2	50 mg	1		1245	Yes	+5°C ± 3°C
	Y0001784	Nimodipine for peak identification	1	15 mg	1		1245	Yes	+5°C ± 3°C
	N0850010	Nimodipine impurity A	4	1 mL	1	2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5- dicarboxylate	1245	Yes	+5°C ± 3°C
	N0900000	Nitrazepam - * psy	2	100 mg	1		0415.0898	Yes	+5°C ± 3°C
	N0905000	Nitrendipine	2	60 mg	1		1246	Yes	+5°C ± 3°C
	N0905005	Nitrendipine impurity A	3	30 mg	1	ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate	1246	Yes	+5°C ± 3°C
	Y0001456	Nitrendipine for peak identification	1	10 mg	1		1246	Yes	+5°C ± 3°C
	N0930000	Nitric oxide - reference spectrum	1	n/a	1		1550
	N0950000	Nitrofural	2	150 mg	1	See leaflet CÿHÿN÷O÷	1135	Yes	+5°C ± 3°C
	Y0001570	Nitrofural impurity B	1	30 mg	1	See leaflet C„H„OŸN; (5-nitrofuran-2-yl)methylene diacetate	1135	Yes	+5°C ± 3°C
	Y0001377	Nitrofural for peak identification	1	0.11 mg	1		1135	Yes	+5°C ± 3°C
	N1000000	Nitrosotriaminopyrimidine	1	50 mg	1		0058	Yes	+5°C ± 3°C
	N1090000	Nizatidine	1	250 mg	1	See leaflet CŒœHœŒN—OœSœ	1453	Yes	+5°C ± 3°C
	N1090060	Nizatidine impurity F	1	10 mg	1	(EZ)-N-methyl-N'-[2-[[[4-[[[2-[[(EZ)-1-(methylamino)-2-nitroethenyl]amino] ethyl]sulfanyl]methyl]thiazol-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1- diamine	1453	Yes	+5°C ± 3°C
	Y0001278	Nizatidine for system suitability	1	10 mg	1		1453	Yes	+5°C ± 3°C
	N1080000	Nomegestrol acetate	2	100 mg	1		1551	Yes	+5°C ± 3°C
	N1080005	Nomegestrol acetate impurity A	2	50 mg	1	6α-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate	1551	Yes	+5°C ± 3°C
	Y0001314	1-nonadecanol	2	425 mg	1		0801,0802,0 847	Yes	+5°C ± 3°C
	Y0000670	Nonivamide	1	10 mg	2	See leaflet CŒŸHœŸNO–	1859,2336,2 337, 2529	Yes	+5°C ± 3°C
	Y0000755	Nonoxinol 9	1	10 mg	1		1454	Yes	+5°C ± 3°C
New	N1100000	Noradrenaline tartrate	7	200 mg	1	Batch 6 is valid until 31 October 2017	0254,0285,0 732, 2303	Yes	+5°C ± 3°C
	Y0000681	Noradrenaline impurity D	2	15 mg	1	4[(1R)-2-ami-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) ; Batch 1 is valid until 31 August 2016	0285.0732	Yes	+5°C ± 3°C
	Y0000682	Noradrenaline impurity E	1	10 mg	1	2-chloro-1-(3,4-dihydroxyphenyl)ethanone	0285.0732	Yes	+5°C ± 3°C
	Y0000686	Noradrenaline impurity F	1	10 mg	1	N-benzyl-1-phenylmethanamine	0285.0732	Yes	+5°C ± 3°C
	N1130000	Norcyclobenzaprine	1	25 mg	1		0941	Yes	+5°C ± 3°C
	N1140000	Nordazepam -* psy	1	50 mg	1	Dipotassium clorazepate impurity B	0898	Yes	+5°C ± 3°C
	N1200000	Norethisterone	3	25 mg	1		0234,1212,0 926	Yes	+5°C ± 3°C
	Y0000522	Norethisterone for system suitability	1	10 mg	1		0234	Yes	-20°C ± 5°C
	N1225000	Norethisterone acetate	2	110 mg	1	See leaflet CœœHœ‡O– ; Batch 1 is valid until 31 December 2016	0850	Yes	+5°C ± 3°C
	Y0001532	Norethisterone acetate for system suitability	1	2.585 mg	1		0850	Yes	+5°C ± 3°C
	N1230000	Norfloxacin	2	20 mg	1	Batch 1 is valid until 20 June 2017	1248	Yes	+5°C ± 3°C
	N1230010	Norfloxacin impurity A	1	20 mg	1	7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid	1460	Yes	+5°C ± 3°C
	Y0001301	Norfloxacin for peak identification	1	10 mg	1		1248	Yes	+5°C ± 3°C
	Y0001015	Norfloxacin for system suitability	3	10 mg	1	Batch 2 is valid until 30 November 2016	1248	Yes	+5°C ± 3°C
	Y0001609	Norflurane - reference spectrum	1	n/a	1
	Y0000724	Norgestimate	1	10 mg	1		1732	Yes	+5°C ± 3°C
	Y0000725	Norgestimate for system suitability	1	5 mg	1		1732	Yes	+5°C ± 3°C
	N1250000	Norgestrel	1	30 mg	1		0940	Yes	+5°C ± 3°C
	N1279000	Norpseudoephedrine hydrochloride - * psy	2	50 mg	1	Cathine hydrochloride	0683	Yes	+5°C ± 3°C
	N1280000	Nortriptyline hydrochloride	2	10 mg	1		0941	Yes	+5°C ± 3°C
	Y0001296	Nortriptyline for system suitability	1	20 mg	1		0941	Yes	+5°C ± 3°C
	N1300000	Noscapine	2	100 mg	1		0102,0515,0 516	Yes	+5°C ± 3°C
	N1400000	Nystatin	7	100 mg	1	See leaflet	0517,1292,2 0702	Yes	-20°C ± 5°C
	O0100900	Octoxinol 10	3	310 mg	1	Batch 2 is valid until 24 June 2017	1553	Yes	+5°C ± 3°C
	Y0000368	Octyl gallate	1	30 mg	1		2057	Yes	+5°C ± 3°C
	O0101000	Octyldodecanol	5	500 mg	1	See leaflet CœÐH÷œO ; Batch 4 is valid until 30 June 2016	1136	Yes	+5°C ± 3°C
	O0120000	Ofloxacin	1	50 mg	1		1455	Yes	+5°C ± 3°C
	O0120010	Ofloxacin impurity A	3	20 mg	1	(3RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4- benzoxazine-6-carboxylic acid (FPA)	1455	Yes	+5°C ± 3°C
	O0120050	Ofloxacin impurity E	4	20 mg	1	(3RS)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid	1455	Yes	+5°C ± 3°C
	Y0001370	Olanzapine	2	200 mg	1	See leaflet	2258	Yes	+5°C ± 3°C
	Y0001392	Olanzapine impurity A	2	5 mg	1	5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile ; Batch 1 is valid until 31 October 2016	2258	Yes	+5°C ± 3°C
	Y0001380	Olanzapine for system suitability	2	10 mg	1	Batch 1 is valid until 31 August 2016	2258	Yes	+5°C ± 3°C
	Y0001204	Oleanolic acid	1	20 mg	2	See leaflet	2463.2472	Yes	+5°C ± 3°C
New	Y0001479	Oleic acid	2	2000 mg	1	See leaflet CŒ‡H–÷Oœ ; Batch 1 is valid until 31 December 2017	2579, 1848	Yes	+5°C ± 3°C
	Y0000805	Oleuropein	2	25 mg	1	See leaflet Cœ—H–œOŒ–	1878	Yes	+5°C ± 3°C
	Y0001405	Olmesartan medoxomil	3	100 mg	1	see leaflet ; Batch 2 is valid until 30 June 2017	2600	Yes	+5°C ± 3°C
	Y0001424	Olmesartan medoxomil for system suitability	3	10 mg	1	Batch 2 is valid until 31 August 2017	2600	Yes	+5°C ± 3°C
	O0146000	Olsalazine sodium	2	70 mg	1		1457	Yes	+5°C ± 3°C
	O0146010	Olsalazine sodium for performance test	1	60 mg	1		1457	Yes	+5°C ± 3°C
	O0150000	Omeprazole	4	50 mg	1	See leaflet	0942,1032,2 372, 2374,2787	Yes	-20°C ± 5°C
	Y0001043	Omeprazole magnesium	1	10 mg	1		2374	Yes	+5°C ± 3°C
	O0151000	Omeprazole impurity D	2	10 mg	1	5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H- benzimidazole (omeprazole sulfone)	0942,1032, 2372, 2374, 2787	Yes	-20°C ± 5°C
	Y0000218	Ondansetron hydrochloride dihydrate	4	200 mg	1	See leaflet CŒ‡HœÐClN–O	2016	Yes	+5°C ± 3°C
	Y0001042	Omeprazole for peak identification	2	10 mg	1	Batch 1 is valid until 31 July 2017	0942, 1032, 2372, 2374, 2787	Yes	-20°C ± 5°C
	Y0001345	Ondansetron impurity A	2	10 mg	1	(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H- carbazol-4-one ; Batch 1 is valid until 31 January 2017	2016	Yes	+5°C ± 3°C
	Y0000195	Ondansetron impurity D	3	15 mg	1	9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one	2016	Yes	+5°C ± 3°C
New	Y0001326	Ondansetron impurity E	2	10 mg	1	1H-imidazole ; Batch 1 is valid until 30 November 2017	2016	Yes	+5°C ± 3°C
	Y0001320	Ondansetron impurity F	1	10 mg	1	2-methyl-1H-imidazole	2016	Yes	+5°C ± 3°C
	Y0001346	Ondansetron impurity G	2	10 mg	1	(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H- carbazol-4-one (C-desmethylondansetron) ; Batch 1 is valid until 30 November 2016	2016	Yes	+5°C ± 3°C
	Y0000197	Ondansetron for LC system suitability	1	10 mg	1		2016	Yes	+5°C ± 3°C
	Y0000196	Ondansetron for TLC system suitability	2	30 mg	1		2016	Yes	+5°C ± 3°C
	Y0001125	Orbifloxacin	1	200 mg	1		2259	Yes	+5°C ± 3°C
	Y0001147	Orbifloxacin impurity mixture	1	0.0008 mg	1		2259	Yes	+5°C ± 3°C
	O0180000	Orciprenaline sulfate	3	100 mg	1	Batch 2 is valid until 31 March 2017	1033.1332	Yes	+5°C ± 3°C
	Y0000895	Orciprenaline for system suitability	1	5 mg	1		1033	Yes	+5°C ± 3°C
	Y0001501	Orientvine stem HRS	1	600 mg	1		2450	Yes	+5°C ± 3°C
	Y0000101	Orphenadrine citrate	1	100 mg	1		1759	Yes	+5°C ± 3°C
	Y0000100	Orphenadrine hydrochloride	1	100 mg	1		1760	Yes	+5°C ± 3°C
	Y0000102	Orphenadrine impurity E	2	60 mg	1	(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (meta- methylbenzyl isomer)	1759.1760	Yes	+5°C ± 3°C
	Y0001181	Orphenadrine for peak identification	2	0.44 mg	1	Batch 1 is valid until 30 June 2016	1759.1760	Yes	+5°C ± 3°C
	Y0001337	Oseltamivir phosphate (impurity B-free)	2	300 mg	1	See leaflet CŒÿH–ŒNœO‡P ; Batch 1 is valid until 30 September 2017	2422	Yes	+5°C ± 3°C
	Y0001338	Oseltamivir impurity A	2	10 mg	1	(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1- carboxylic acid ; Batch 1 is valid until 30 June 2017	2422	Yes	+5°C ± 3°C
	Y0001339	Oseltamivir impurity B	1	10 mg	1	ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate	2422	Yes	+5°C ± 3°C
	Y0001340	Oseltamivir impurity C	2	10 mg	1	See leaflet CŒ÷HœœNœO÷; (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy) cyclohex-1-ene-1-carboxylic acid ; Batch 1 is valid until 31 October 2016	2422	Yes	+5°C ± 3°C
	Y0001341	Oseltamivir impurity H	1	30 mg	1	tributylphosphane oxide	2422	Yes	+5°C ± 3°C
	Y0001207	Osthole	1	20 mg	1	See leaflet CŒ—HŒÿO–	2557	Yes	+5°C ± 3°C
	O0200000	Ouabain	2	150 mg	1	See leaflet Cœ„H÷÷OŒœ	0048	Yes	+5°C ± 3°C
	Y0000638	Oxacillin sodium monohydrate	1	110 mg	1	See leaflet CŒ„HŒ‡N–NaO—S	2260	Yes	+5°C ± 3°C
	Y0000560	Oxacillin for peak identification	1	10 mg	1		2260	Yes	-20°C ± 5°C
	Y0000271	Oxaliplatin	4	250 mg	1	See leaflet C‡HŒ÷NœO÷Pt	2017	Yes	+5°C ± 3°C
	Y0000272	Oxaliplatin impurity B	10	22 mg	1	See leaflet CœÐHœ‡NœOÿPtSœ; (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2- diamineκN,κN′]platinum (diaquodiaminocyclohexaneplatinum) ; Batch 9 is valid until 31 August 2016	2017	Yes	+5°C ± 3°C
	Y0000273	Oxaliplatin impurity C	6	25 mg	1	(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamineκN,κN′][ethanedioato(2-)- κO1,κO2]dihydroxyplatinum	2017	Yes	+5°C ± 3°C
	Y0000274	Oxaliplatin impurity D	5	15 mg	1	(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-κN,κN'][ethanedioato(2-)- κO1,κO2]platinum (S,S-enantiomer of oxaliplatin) ; Batch 4 is valid until 31 July 2016	2017	Yes	+5°C ± 3°C
	O0225000	Oxazepam - * psy	2	50 mg	1		0778	Yes	+5°C ± 3°C
	Y0000543	Oxazepam for peak identification	2	0.008 mg	1		0778	Yes	+5°C ± 3°C
	Y0001576	Oxcarbazepine	1	120 mg	1	See leaflet CŒ—HŒœNœOœ	2577	Yes	+5°C ± 3°C
	Y0001549	Oxcarbazepine impurity mixture	1	0.008 mg	1		2577	Yes	+5°C ± 3°C
	Y0000350	Oxeladin hydrogen citrate	1	50 mg	1		1761	Yes	+5°C ± 3°C
	Y0000404	Oxeladin impurity C	1	10 mg	1	2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate	1761	Yes	+5°C ± 3°C
	Y0000390	Oxeladin impurity D	1	20 mg	1	2-[2-(diethylamino)ethoxy]ethyl (2RS)-2-phenylbutanoate	1761	Yes	+5°C ± 3°C
	O0225800	Oxfendazole CRS	2	50 mg	1		1458	Yes	+5°C ± 3°C
	Y0000224	Oxfendazole impurity B	2	10 mg	1	See leaflet; methyl [5-(phenylsulfonyl)-1H-benzimidazole-2-yl]carbamate	1458	Yes	+5°C ± 3°C
	Y0000225	Oxfendazole with impurity D	1	10 mg	1		1458	Yes	+5°C ± 3°C
	O0260000	Oxibendazole	2	100 mg	1		1386	Yes	+5°C ± 3°C
	Y0001771	Oxidronate for radiochemical purity testing	1	34 mg	1		2376	Yes	+5°C ± 3°C
	Y0000709	Oxitropium bromide	1	50 mg	1		2170	Yes	+5°C ± 3°C
	Y0000715	Oxitropium bromide impurity B	1	15 mg	1	(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9- dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)	2170	Yes	+5°C ± 3°C
	Y0000713	Oxitropium bromide impurity D	1	10 mg	1	(1R,2R,4S,5S,7s,9s)-9-ethyl-9-methyl-7-[(2-phenylacryloyl)oxy]-3-oxa-9- azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine	2170	Yes	+5°C ± 3°C
	O0240000	Oxolinic acid	1	50 mg	1		1353	Yes	+5°C ± 3°C
	O0240005	Oxolinic acid impurity A	1	20 mg	1	8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid	1353	Yes	+5°C ± 3°C
	O0240010	Oxolinic acid impurity B	1	20 mg	1	ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate	1353	Yes	+5°C ± 3°C
	O0250000	Oxprenolol hydrochloride	1	50 mg	1		0628,0876,1 072	Yes	+5°C ± 3°C
	O0270000	Oxybuprocaine hydrochloride	2	100 mg	1		1251	Yes	+5°C ± 3°C
	O0288000	Oxybutynin hydrochloride	2	50 mg	1		1354	Yes	+5°C ± 3°C
	O0288005	Oxybutynin impurity A	4	20 mg	1	See leaflet CœœH–ÿClNO–; 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3- enyl)-2- cyclohexyl-2-hydroxyacetate	1354	Yes	+5°C ± 3°C
	Y0000492	Oxycodone hydrochloride - * narc	1	100 mg	1		1784, 1793	Yes	+5°C ± 3°C
	Y0000453	Oxycodone impurity D	3	50 mg	1	7,8-didehydro-4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6- one (14-hydroxycodeinone)	1793	Yes	+5°C ± 3°C
	O0290000	Oxymetazoline hydrochloride	2	80 mg	1		0943	Yes	+5°C ± 3°C
New	Y0001044	Oxymetazoline impurity A	2	15 mg	1	N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl] acetamide ; Batch 1 is valid until 31 October 2017	0943	Yes	+5°C ± 3°C
	Y0001896	Oxytetracycline	8	100 mg	1	see leaflet; This reference standard is suitable for use with monographs 01/2017:0199 and 01/2017:0198.	0198, 0199	Yes	+5°C ± 3°C
New	Y0001850	Oxytetracycline for system suitability	2	15 mg	1	Batch 1 is valid until 31 October 2017	0198.0199	Yes	+5°C ± 3°C
	O0500000	Oxytetracycline hydrochloride	4	20 mg	1		0198.1030	Yes	+5°C ± 3°C
	O0700000	Oxytocin	5	41 mg	1	see leaflet	0779.0780	Yes	-20°C ± 5°C
	O0770000	Oxytocin/Desmopressin validation mixture	4	20 mg	1		0712,0779,0 780	Yes	-20°C ± 5°C
	Y0000698	Paclitaxel	3	40 mg	1	See leaflet C÷ŸH—ŒNOŒ÷ ; Batch 2 is valid until 31 October 2016	1794	Yes	+5°C ± 3°C
	Y0000699	Paclitaxel impurity C	2	10 mg	1	N-debenzoyl-N-hexanoylpaclitaxel (paclitaxel C)	1794	Yes	+5°C ± 3°C
	Y0000700	Paclitaxel natural for peak identification	1	10 mg	1		1794	Yes	+5°C ± 3°C
	Y0000719	Paclitaxel semi-synthetic for peak identification	2	10 mg	1		1794	Yes	+5°C ± 3°C
	Y0000739	Paclitaxel semi-synthetic for system suitability	2	1.013 mg	1		1794	Yes	+5°C ± 3°C
	Y0001856	Paeoniflorin	1	15 mg	1	see leaflet Cœ–Hœ‡OŒŒ	2424, 2425	Yes	+5°C ± 3°C
	P0090000	Palmitic acid	4	100 mg	1		0229,0882,1 474,1663,20	Yes	+5°C ± 3°C
	Y0000524	Pamidronate disodium pentahydrate	1	10 mg	1		1779	Yes	+5°C ± 3°C
	Y0001632	Pancreas powder (amylase) BRP	4	2000 mg	1	See leaflet	0350	Yes	+5°C ± 3°C
	Y0001631	Pancreas powder (lipase) BRP	4	2000 mg	1	See leaflet	0350	Yes	+5°C ± 3°C
	P0200000	Pancreas powder (protease) BRP	4	2000 mg	1	See leaflet	0350	Yes	+5°C ± 3°C
	P0250000	Pancuronium bromide	2	20 mg	1	Vecuronium impurity B	0681.1769	Yes	+5°C ± 3°C
	Y0000577	Pancuronium bromide for system suitability	1	20 mg	1		0681	Yes	+5°C ± 3°C
	Y0000835	Pantoprazole sodium sesquihydrate	1	20 mg	1		2296	Yes	+5°C ± 3°C
New	Y0001001	Pantoprazole for system suitability	7	0.51 mg	1	Batch 6 is valid until 30 September 2017	2296	Yes	+5°C ± 3°C
	P0270000	Papaverine hydrochloride	1	25 mg	1		0102,0573,0 515	Yes	+5°C ± 3°C
	P0300000	Paracetamol	4	50 mg	1		0049	Yes	+5°C ± 3°C
	Y0001781	Paracetamol for equipment qualification	1	250 mg	1		20248	Yes	+5°C ± 3°C
	Y0000780	Paraffin (hard)	1	10 mg	1		1034	Yes	+5°C ± 3°C
	Y0000058	Paraffin (liquid) - reference spectrum	1	n/a	1		0239.0240
	Y0000913	Paraffin (White soft)	1	10 mg	1		1799	Yes	+5°C ± 3°C
	Y0000912	Paraffin (Yellow soft)	1	10 mg	1		1554	Yes	+5°C ± 3°C
	P0305000	Parnaparin sodium	2	200 mg	1		1252	Yes	+5°C ± 3°C
	Y0000578	Paroxetine hydrochloride (anhydrous)	1	100 mg	1		2283	Yes	+5°C ± 3°C
	Y0000579	Paroxetine hydrochloride (anhydrous) impurity C	1	10 mg	1	(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl) piperidine (N-benzylparoxetine)	2283	Yes	+5°C ± 3°C
	Y0000581	Paroxetine hydrochloride (anhydrous) impurity H	1	10 mg	1	[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol	2283	Yes	+5°C ± 3°C
	Y0000281	Paroxetine hydrochloride hemihydrate	3	200 mg	1	See leaflet CŒ„HœŒClFNO– ; Batch 2 is valid until 31 July 2016	2018.2283	Yes	+5°C ± 3°C
	Y0000233	Paroxetine impurity A	5	15 mg	1	(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-phenylpiperidine (desfluoroparoxetine)	2018.2283	Yes	+5°C ± 3°C
	Y0000256	Paroxetine impurity D	3	10 mg	1	See leaflet; (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl) piperidine ((+)-trans-paroxetine)	2018.2283	Yes	+5°C ± 3°C
	Y0000580	Paroxetine impurity E	1	5 mg	1	(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine (cis-paroxetine)	2283	Yes	+5°C ± 3°C
	Y0000630	Paroxetine for system suitability	1	5 mg	1		2018	Yes	+5°C ± 3°C
	P0309000	Pefloxacin mesilate dihydrate	1	200 mg	1		1460	Yes	+5°C ± 3°C
	P0309020	Pefloxacin impurity B	1	10 mg	1	6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3- carboxylic acid (chlorinated homologue of pefloxacin)	1460	Yes	+5°C ± 3°C
	P0309030	Pefloxacin impurity C	2	0.01 mg	1	1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3- carboxylic acid (isopefloxacin)	1460	Yes	+5°C ± 3°C
	Y0001539	Pemetrexed disodium heptahydrate	2	200 mg	1	See leaflet ; Batch 1 is valid until 30 November 2016	2637	Yes	+5°C ± 3°C
	Y0001538	Pemetrexed for system suitability	1	20 mg	1		2637	Yes	+5°C ± 3°C
	Y0001535	Pemetrexed impurity mixture	2	0.002 mg	1		2637	Yes	+5°C ± 3°C
	P0307000	Penbutolol sulfate	1	100 mg	1		1461	Yes	+5°C ± 3°C
	P0307005	Penbutolol impurity A	2	20 mg	1	See leaflet CŒ‡HœŸNOœ; (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1- dimethylethyl) amino]propan-2-ol	1461	Yes	+5°C ± 3°C
	P0310000	Penicillamine	1	100 mg	1		0566	Yes	+5°C ± 3°C
	P0320000	Penicillamine disulfide	3	100 mg	1	See leaflet CŒÐHœÐNœO÷Sœ; 3,3-(disulphanediyl)bis[(2S)-2-amino-3- methylbutanoic] acid	0566	Yes	+5°C ± 3°C
	P0400100	Pentaerythrityl tetranitrate diluted	2	600 mg	1	See leaflet C—H‡N÷OŒœ	1355	Yes	+5°C ± 3°C
	P0405000	Pentamidine diisetionate	2	30 mg	1		1137.1436	Yes	+5°C ± 3°C
	P0405500	Pentazocine - reference spectrum	1	n/a	1		1462
	P0405510	Pentazocine hydrochloride - reference spectrum	1	n/a	1		1463
	Y0000417	Pentazocine lactate - reference spectrum	1	n/a	1		2000		+5°C ± 3°C
	Y0001051	Pentetate sodium calcium	1	100 mg	1		2353	Yes	+5°C ± 3°C
	P0500000	Pentobarbital - * psy	1	500 mg	1		0200.0419	Yes	+5°C ± 3°C
	P0510000	Pentoxifylline	2	100 mg	1	Batch 1 is valid until 31 January 2017	0851	Yes	+5°C ± 3°C
	Y0000076	Pentoxyverine hydrogen citrate - reference spectrum	1	n/a	1		1621
	Y0000098	Pentoxyverine impurity A	1	10 mg	1	1-phenylcyclopentanecarboxylic acid	1621	Yes	+5°C ± 3°C
	Y0000099	Pentoxyverine impurity B	1	10 mg	1	2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)	1621	Yes	+5°C ± 3°C
	P0525000	Pepsin powder BRP	2	2000 mg	1	See leaflet	0682	Yes	+5°C ± 3°C
	Y0000010	Pergolide mesilate	1	150 mg	1	See leaflet CœÐH–ÐNœO–Sœ	1555	Yes	+5°C ± 3°C
	Y0000238	Perindopril tert-butylamine	3	40	1	Batch 2 is valid until 31 March 2017	2019	Yes	+5°C ± 3°C
	Y0000237	Perindopril impurity A	2	10 mg	1	(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid	2019	Yes	+5°C ± 3°C
	Y0000771	Perindopril for peak identification	1	5 mg	1		2019	Yes	+5°C ± 3°C
	Y0000207	Perindopril for stereochemical purity	2	40 mg	1		2019	Yes	+5°C ± 3°C
	Y0001733	Permethrin (25:75)	1	350 mg	1	see leaflet	1762	Yes	+5°C ± 3°C
	Y0001741	Permethrin for system suitability	2	60 mg	1	Batch 1 is valid until 30 June 2016	1762	Yes	+5°C ± 3°C
	P0550000	Perphenazine	1	100 mg	1		0629.0904	Yes	+5°C ± 3°C
	Y0001045	Perphenazine for system suitability	1	5 mg	1		0629	Yes	+5°C ± 3°C
	Y0000021	Pertussis toxin BRP	1	0.05 mg	2	See leaflet	See leaflet, 1356, 1595, 1931, 1932, 1933, 1934, 2065, 2067, 2329,2764	Yes	-20°C ± 5°C
	P0600000	Pethidine hydrochloride - reference spectrum	1	n/a	1		0420
	P0600002	Pethidine impurity A	2	20 mg	1	1-methyl-4-phenylpiperidine (MPP) ; Batch 1 is valid until 28 February 2017	0420	Yes	+5°C ± 3°C
	P0800000	Phenazone	2	20 mg	1		0421	Yes	+5°C ± 3°C
	Y0001138	Phenazone impurity A	1	20 mg	1	5-methyl-2-phenyl-2,4-dihydro-3§-pyrazol-3-one	0421	Yes	+5°C ± 3°C
	P0850000	Pheniramine maleate	3	250 mg	1	Batch 2 is valid until 30 June 2017	1357, 0977	Yes	+5°C ± 3°C
	Y0001428	Pheniramine impurity A	1	20 mg	1	2-benzylpyridine	1357	Yes	+5°C ± 3°C
	P0900000	Phenobarbital - * psy	5	200 mg	1	See leaflet CŒœHŒœNœO– ; Batch 4 is valid until 30 June 2016	0189,0201,0 630	Yes	+5°C ± 3°C
	Y0001350	Phenobarbital impurity A	1	15 mg	1	See leaflet CŒœHŒ÷N÷O; (5RS)-5-ethyl-2,6-diimino-5- phenyltetrahydropyrimidin-4(1H)-one	0201.0630	Yes	+5°C ± 3°C
	Y0001351	Phenobarbital impurity B	1	15 mg	1	(5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione	0201.0630	Yes	+5°C ± 3°C
	P0950000	Phenoxyethanol	5	1 mL	1	Batch 4 is valid until 31 October 2016	0781	Yes	+5°C ± 3°C
	P1000000	Phenoxymethylpenicillin	2	250 mg	1		0148	Yes	+5°C ± 3°C
	Y0001868	Phenoxymethylpenicillin for system suitability	1	25 mg	1		0148.0149	Yes	+5°C ± 3°C
	P1100000	Phenoxymethylpenicillin potassium	4	250 mg	1	See leaflet CŒÿHŒŸKNœO—S	0113,0114,0 148, 0149	Yes	+5°C ± 3°C
	Y0001127	Phentolamine mesilate	1	10 mg	1		1138	Yes	+5°C ± 3°C
	P1109000	Phentolamine mesilate - reference spectrum	1	n/a	1		1138
	Y0001251	Phentolamine for system suitability	1	10 mg	1		1138	Yes	+5°C ± 3°C
	P1150000	Phenylalanine	4	60 mg	1		0782.2575	Yes	+5°C ± 3°C
	P1200000	Phenylbutazone	1	100 mg	1		0422.1574	Yes	+5°C ± 3°C
New	Y0000147	Phenylbutazone impurity B	2	20 mg	1	4-butyl-4-hydroxy-1,2-diphenylpyrazolidine-3,5-dione ; Batch 1 is valid until 30 September 2017	0422	Yes	+5°C ± 3°C
	P1240000	Phenylephrine	2	60 mg	1		1035	Yes	+5°C ± 3°C
	P1250000	Phenylephrine hydrochloride	3	50 mg	1		0632.1205	Yes	+5°C ± 3°C
New	Y0000683	Phenylephrine hydrochloride for peak identification	5	2.004 mg	1	Batch 4 is valid until 30 November 2017	0632.1035	Yes	+5°C ± 3°C
	Y0000229	Phenylmercuric acetate - reference spectrum	1	n/a	1		2042
	P1255100	Phenylmercuric borate - reference spectrum	1	n/a	1		0103
	P1260000	Phenylpropanolamine hydrochloride - * Drug Precursor	1	50 mg	1	Norephedrin hydrochloride	0683	Yes	+5°C ± 3°C
	P1290000	Phenytoin	1	50 mg	1		1253.1988	Yes	+5°C ± 3°C
	P1300000	Phenytoin sodium	2	250 mg	1		0521	Yes	+5°C ± 3°C
	Y0001167	Phenytoin for system suitability	1	20 mg	1		0521.1253	Yes	+5°C ± 3°C
	Y0000493	Phloroglucinol (anhydrous)	2	220 mg	1		2301.2302	Yes	+5°C ± 3°C
	Y0000761	Pholcodine - * narc	1	10 mg	1		0522	Yes	+5°C ± 3°C
	Y0001865	Pholcodine for impurity G identification - * narc	1	15 mg	1		0522	Yes	+5°C ± 3°C
	Y0000798	Pholcodine for peak identification - * narc	1	10 mg	1		0522	Yes	+5°C ± 3°C
	Y0000766	Phthalic acid	1	20 mg	1	benzene-1,2-dicarboxylic acid	2348	Yes	+5°C ± 3°C
	P1500000	Phthalylsulfathiazole	1	100 mg	1		0352	Yes	+5°C ± 3°C
	P1600000	Physostigmine salicylate	2	100 mg	1		0286	Yes	+5°C ± 3°C
	P1609000	Phytomenadione	4	150 mg	1	see leaflet; Vitamin K1	1036	Yes	+5°C ± 3°C
	Y0001104	Picosulfate for system suitability	2	0.5 mg	1	Batch 1 is valid until 28 February 2017	1031	Yes	+5°C ± 3°C
	P1645000	Picotamide monohydrate	1	125 mg	1		1358	Yes	+5°C ± 3°C
	P1645005	Picotamide impurity A	1	25 mg	1	4-methoxybenzene-1,3-dicarboxylic acid	1358	Yes	+5°C ± 3°C
	Y0001508	Picrotin	1	40 mg	1		2486	Yes	+5°C ± 3°C
	Y0001528	Picrotoxinin	1	40 mg	1	See leaflet CŒ—HŒÿOÿ	2486	Yes	+5°C ± 3°C
	Y0000124	Pidolate impurity B	3	110 mg	1	(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid	1619	Yes	+5°C ± 3°C
	Y0000123	Pidolic acid	2	125 mg	1	Batch 1 is valid until 30 April 2017	1619	Yes	+5°C ± 3°C
	P1650000	Pilocarpine hydrochloride	2	50 mg	1		0633	Yes	+5°C ± 3°C
	P1700000	Pilocarpine nitrate	1	50 mg	1		0104	Yes	+5°C ± 3°C
	Y0000106	Pilocarpine nitrate for system suitability	1	20 mg	1		0104.0633	Yes	+5°C ± 3°C
	Y0000525	Pimobendan	1	10 mg	1		2179	Yes	+5°C ± 3°C
	Y0000401	Pimobendan for system suitability	2	0.1 mg	1	Batch 1 is valid until 31 October 2016	2179	Yes	+5°C ± 3°C
	P1750000	Pimozide	1	150 mg	1		1254	Yes	+5°C ± 3°C
	P1800000	Pindolol	1	100 mg	1		0634.0871	Yes	+5°C ± 3°C
	Y0001520	Pioglitazone hydrochloride	1	120 mg	1	See leaflet CŒ„HœŒClNœO–S	2601	Yes	+5°C ± 3°C
	Y0001519	Pioglitazone for system suitability	1	15 mg	1		2601	Yes	+5°C ± 3°C
	Y0001476	Pipemidic acid trihydrate	1	15 mg	1		1743	Yes	+5°C ± 3°C
	Y0000061	Pipemidic acid trihydrate - reference spectrum	1	n/a	1		1743
	P1890000	Piperacillin	4	100 mg	1	See leaflet Cœ–HœŸN—OŸS	1168.1169	Yes	+5°C ± 3°C
	P1900000	Piperazine adipate	1	250 mg	1		0423	Yes	+5°C ± 3°C
	P2000000	Piperazine citrate	1	250 mg	1		0424	Yes	+5°C ± 3°C
	P2100000	Piperazine hydrate	1	250 mg	1		0425	Yes	+5°C ± 3°C
	Y0001217	Piperine	1	30 mg	1	See leaflet CŒŸHŒ„NO–	2453.2477	Yes	+5°C ± 3°C
	Y0000288	Piracetam	3	150 mg	1	See leaflet CÿHŒÐNœOœ	1733	Yes	+5°C ± 3°C
	Y0000038	Pirenzepine dihydrochloride monohydrate	1	250 mg	1		2001	Yes	+5°C ± 3°C
	P2120000	Piretanide	1	100 mg	1		1556	Yes	+5°C ± 3°C
	Y0001458	Piretanide for system suitability	1	10 mg	1		1556	Yes	+5°C ± 3°C
	Y0001769	Pirfenidone	1	120 mg	1	See Leaflet CŒœHŒŒNO	2856	Yes	+5°C ± 3°C
	P2130000	Piroxicam	3	50 mg	1		0944	Yes	+5°C ± 3°C
	Y0001475	Piroxicam for system suitability	5	15 mg	1	Batch 4 is valid until 31 December 2016	0944	Yes	+5°C ± 3°C
	P2150000	Pivampicillin	1	125 mg	2	See leaflet	0808.0852	Yes	+5°C ± 3°C
	P2152000	Pivmecillinam hydrochloride	2	100 mg	1	See leaflet CœŒH–÷ClN–O—S	1359	Yes	-20°C ± 5°C
	P2152015	Pivmecillinam impurity C	2	10 mg	1	methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl) methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate	1359	Yes	+5°C ± 3°C
	P2155001	Plastic additive 01	1	2 ml	1	(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate	90001,9000 2, 30114	Yes	+5°C ± 3°C
	P2155003	Plastic additive 03	1	100 mg	1	N,N'-ethylenedialc*	90001.30114	Yes	+5°C ± 3°C
	E0800000	Plastic additive 04	1	500 mg	1	Epoxidised soya oil	90001.30114	Yes	+5°C ± 3°C
	P2155005	Plastic additive 05	1	500 mg	1	Epoxidised linseed oil	90001.30114	Yes	+5°C ± 3°C
	P2155008	Plastic additive 08	3	500 mg	1	ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]	30103,3010 4,	Yes	+5°C ± 3°C
	P2155009	Plastic additive 09	3	250 mg	1	See leaflet; pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]	30103,3010 5,	Yes	+5°C ± 3°C
	P2155010	Plastic additive 10	2	250 mg	1	4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1- dimethylethyl)phenol]	30103,3010 5,	Yes	+5°C ± 3°C
	P2155011	Plastic additive 11	2	500 mg	1	Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate	30103,3010 5,	Yes	+5°C ± 3°C
	P2155012	Plastic additive 12	4	250 mg	1	Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R ; Batch 3 is valid until 30 June 2017	30103,3010 5,	Yes	+5°C ± 3°C
	P2155013	Plastic additive 13	2	250 mg	1	1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5- triazine-2,4,6-trione	30103,3010 5, 30106	Yes	+5°C ± 3°C
	P2155014	Plastic additive 14	2	250 mg	1	2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R	30103,3010 5, 30106	Yes	+5°C ± 3°C
	P2155015	Plastic additive 15	2	500 mg	1	Dioctadecyl disulphide	30103,3010 4,	Yes	+5°C ± 3°C
	P2155016	Plastic additive 16	2	250 mg	1	Didodecyl 3,3'-thiodipropionate R	30103,3010 5, 30106	Yes	+5°C ± 3°C
	P2155017	Plastic additive 17	2	250 mg	1	Dioctadecyl 3,3'-thiodipropionate R	30103,3010 5, 30106	Yes	+5°C ± 3°C
	P2155018	Plastic additive 18	2	50 mg	1		30103	Yes	+5°C ± 3°C
	O0140000	Plastic additive 20	1	100 mg	1	Oleamide R	30103,3010 5,	Yes	+5°C ± 3°C
	E1260000	Plastic additive 21	1	100 mg	1	Erucamide R	30103, 30105, 30106,	Yes	+5°C ± 3°C
	P2155022	Plastic additive 22	1	100 mg	1	Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6- tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6- tetramethylpiperidin-1-yl)ethanol	30103	Yes	+5°C ± 3°C
	P2155023	Plastic additive 23	3	200 mg	1	di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris (thio)] triacetate. ; Batch 2 is valid until 28 February 2017	30110.30111	Yes	+5°C ± 3°C
	P2160000	Poliomyelitis vaccine (inactivated) BRP	3	0.6 mL	3	See leaflet ; Batch 2 is valid until 28 February 2017	0214,2066,2 065, 2328,2061,2 067, 1934,2329,2 0720	Yes	-80°C ± 10°C
	P2163920	Poloxamer 124	2	500 mg	1	Batch 1 is valid until 31 March 2017	1464	Yes	+5°C ± 3°C
	P2164009	Poloxamer 188	2	50 mg	1		1464	Yes	+5°C ± 3°C
	P2164020	Poloxamer 237	1	100 mg	1		1464	Yes	+5°C ± 3°C
	P2164021	Poloxamer 338	2	100 mg	1		1464	Yes	+5°C ± 3°C
	P2164030	Poloxamer 407	1	100 mg	1		1464	Yes	+5°C ± 3°C
	Y0001557	Poly (vinyl acetate)	1	100 mg	1		1962	Yes	+5°C ± 3°C
	Y0000792	Poly(vinyl acetate) dispersion 30 per cent	1	1500 mg	1		2152	Yes	+5°C ± 3°C
	Y0001550	Poly(vinyl alcohol)	1	100 mg	1		1961	Yes	+5°C ± 3°C
	P2600000	Poly(vinyl chloride)	1	100 mg	1		90001,9000 2, 30114	Yes	+5°C ± 3°C
	P2170000	Polyacrylate - reference spectrum	1	n/a	1		0733
	Y0001855	Polydatin	1	15 mg	1	see leaflet CœÐHœœO‡	2724	Yes	+5°C ± 3°C
	Y0001860	Polygonum orientale fruit for system suitability	1	510 mg	1		2726	Yes	+5°C ± 3°C
	P2400000	Polymyxin B sulfate	6	25 mg	1	see leaflet	0203	Yes	+5°C ± 3°C
	Y0000355	Polymyxin B sulfate for microbiological assay	2	25 mg	1	See leaflet	20702	Yes	-20°C ± 5°C
	Y0001712	Polyoxypropylene stearyl ether	1	250 mg	1		2602	Yes	+5°C ± 3°C
	Y0000289	Polysorbate 20 - reference spectrum	1	n/a	1		0426
	Y0000290	Polysorbate 40 - reference spectrum	1	n/a	1		1914
	Y0000291	Polysorbate 60 - reference spectrum	1	n/a	1		0427
	Y0000007	Polysorbate 80 - reference spectrum	1	n/a	1		0428
	P2649610	Potassium clavulanate - reference spectrum	1	n/a	1		1140
	Y0001168	Potassium clavulanate impurity G	2	5 mg	1	4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoic acid (N- (hydrogensuccinyl)tyrosine)	1653.1140	Yes	-20°C ± 5°C
	Y0000315	Potassium hydrogen aspartate hemihydrate	1	50 mg	1		2076	Yes	+5°C ± 3°C
	P2650000	Potassium sorbate	2	100 mg	1		0618	Yes	+5°C ± 3°C
	Y0001275	Potassium sucrose octasulfate	1	100 mg	1	See leaflet CŒœHŒ÷K‡O–—S‡	1796	Yes	+5°C ± 3°C
	P2660000	Povidone	2	50 mg	1		0685	Yes	+5°C ± 3°C
	Y0000466	Povidone (iodinated)	1	10 mg	1		1142	Yes	+5°C ± 3°C
	Y0001266	Pramipexole dihydrochloride monohydrate	1	5 mg	1		2416	Yes	+5°C ± 3°C
	Y0001267	Pramipexole impurity D	2	5 mg	1	(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine	2416	Yes	+5°C ± 3°C
	Y0001187	Pramipexole for system suitability	1	15 mg	1		2416	Yes	+5°C ± 3°C
	Y0000215	Pravastatin sodium - reference spectrum	1	n/a	1		2059
	Y0000223	Pravastatin impurity A	5	0.1 mg	1	(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8- [[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl] heptanoic acid (6'-epipravastatin)	2059	Yes	-20°C ± 5°C
	Y0000204	Pravastatin 1,1,3,3-tetramethylbutylamine	2	30 mg	1	See leaflet Cœ–H–ÿOŸ	2059	Yes	-20°C ± 5°C
	P2669000	Prazepam -* psy	1	50 mg	1		1466	Yes	+5°C ± 3°C
	P2670000	Praziquan	3	200 mg	1	See leaflet	0855	Yes	+5°C ± 3°C
	Y0001533	Praziquan for system suitability	1	10 mg	1		0855	Yes	+5°C ± 3°C
	P2680000	Prazosin hydrochloride	2	30 mg	1		0856	Yes	+5°C ± 3°C
	P2698000	Prednicarbate	2	100 mg	1	See leaflet CœŸH–ÿO‡	1467	Yes	+5°C ± 3°C
	Y0001630	Prednicarbate for system suitability A	1	10 mg	1		1467	Yes	+5°C ± 3°C
	P2700000	Prednisolone	8	150 mg	1	See leaflet	0335,0353,0 354, 0735	Yes	+5°C ± 3°C
	Y0001359	Prednisolone for peak identification	1	10 mg	1		0353	Yes	+5°C ± 3°C
	Y0001355	Prednisolone for system suitability	2	10 mg	1		0353	Yes	+5°C ± 3°C
	P2800000	Prednisolone acetate	4	120 mg	1		0734,0736,0 933, 0975,1467,0 334	Yes	+5°C ± 3°C
	Y0000582	Prednisolone acetate for peak identification	1	10 mg	1		0734	Yes	+5°C ± 3°C
	P2804000	Prednisolone hexanoate	1	10 mg	1		1212	Yes	+5°C ± 3°C
	P2805000	Prednisolone pivalate	2	120 mg	1		0734.0736	Yes	+5°C ± 3°C
	P2810000	Prednisolone sodium phosphate	4	100 mg	1		0549,0735,0 810	Yes	+5°C ± 3°C
	P2900000	Prednisone	4	100 mg	1		0354	Yes	+5°C ± 3°C
New	Y0001921	Prednisone for peak identification	1	15 mg	1		0354	Yes	+5°C ± 3°C
New	Y0001920	Prednisone impurity B	1	20 mg	1		0354	Yes	+5°C ± 3°C
	Y0001805	Pregabalin	2	260 mg	1	See leaflet C‡HŒŸNOœ ; Batch 1 is valid until 30 April 2017	2777	Yes	+5°C ± 3°C
	Y0001806	Pregabalin impurity A	1	0.25 mg	1	See leaflet C‡HŒ—NO; (4S)-4-(2-methylpropyl)pyrrolidin-2-one	2777	Yes	+5°C ± 3°C
	Y0001808	Pregabalin impurity D	1	10 mg	1	1-methylethyl (2RS)-2-hydroxy-2-phenylacetate	2777	Yes	+5°C ± 3°C
	P2920000	Pregnenolone isobutyrate	6	200 mg	1		0593,0993,2 397	Yes	-20°C ± 5°C
	Y0000263	Prekallikrein activator in albumin BRP	5	200 mg	3	See leaflet ; Batch 4 is valid until 31 August 2016	See leaflet, 20615	Yes	-20°C ± 5°C
	P2939000	Prilocaine	1	150 mg	1		1362	Yes	+5°C ± 3°C
	P2939060	Prilocaine hydrochloride	1	100 mg	1		1363	Yes	+5°C ± 3°C
	Y0001408	Prilocaine impurity B	1	80 mg	1	2-methylbenzenamine (o-toluidine)	1362.1363	Yes	+5°C ± 3°C
	P2939025	Prilocaine impurity E	1	25 mg	1	(2RS)-N-(4-methylphenyl)-2-(propylamino)prop*	1362.1363	Yes	+5°C ± 3°C
	Y0001681	Prilocaine for peak identification	1	20 mg	1		1363	Yes	+5°C ± 3°C
	P2940000	Primaquine diphosphate	3	500 mg	1		0635	Yes	+5°C ± 3°C
	P2950000	Primidone	2	150 mg	1	See leaflet	0584	Yes	+5°C ± 3°C
	Y0000369	Primidone for peak identification	1	10 mg	1		0584	Yes	+5°C ± 3°C
	P3000000	Probenecid	1	100 mg	1		0243	Yes	+5°C ± 3°C
	P3050000	Procainamide hydrochloride	1	100 mg	1		0567	Yes	+5°C ± 3°C
	P3090000	Procaine benzylpenicillin	4	250 mg	1	See leaflet ; Batch 3 is valid until 30 June 2016	0115	Yes	+5°C ± 3°C
	P3100000	Procaine hydrochloride	1	100 mg	1		0050	Yes	+5°C ± 3°C
	P3200000	Prochlorperazine maleate	1	100 mg	1		0244	Yes	+5°C ± 3°C
New	P3300000	Progesterone	4	120 mg	1	See leaflet ; Batch 3 is valid until 30 September 2017	0429	Yes	+5°C ± 3°C
	Y0001667	Progesterone for impurity H identification	2	20 mg	1	see leaflet ; Batch 1 is valid until 31 January 2017	0429	Yes	+5°C ± 3°C
	Y0001666	Progesterone for peak identification	1	5 mg	1		0429	Yes	+5°C ± 3°C
	Y0001665	Progesterone for system suitability	1	5 mg	1		0429	Yes	+5°C ± 3°C
	Y0001885	Proguanil for system suitability	1	15 mg	1		2002	Yes	+5°C ± 3°C
	Y0001901	Proguanil hydrochloride	1	10 mg	1		2002	Yes	+5°C ± 3°C
	Y0000179	Proguanil hydrochloride - reference spectrum	1	n/a	1		2002
	Y0001909	Proguanil impurity B	1	15 mg	1	4-chloroaniline	2002	Yes	+5°C ± 3°C
	Y0000181	Proguanil impurity C	2	10 mg	1	1,5-bis(4-chlorophenyl)biguanide The reference standard Y0000181 will be deleted from the monograph 01/2008:2002 on 30/06/2017. ; Batch 2 is valid until 30 June 2017	2002	Yes	+5°C ± 3°C
	Y0000182	Proguanil impurity D	2	10 mg	1	1,5-bis(1-methylethyl)biguanide The reference standard Y0000182 will be deleted from the monograph 01/2008:2002 on 30/06/2017 ; Batch 2 is valid until 30 June 2017	2002	Yes	+5°C ± 3°C
	P3350000	Proline	3	60 mg	1		0785	Yes	+5°C ± 3°C
	P3390000	Promazine hydrochloride	2	40 mg	1		0475.1365	Yes	+5°C ± 3°C
	P3400000	Promethazine hydrochloride	2	50 mg	1		0524	Yes	+5°C ± 3°C
	Y0000769	Promethazine impurity D	2	15 mg	1	(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide	0524	Yes	+5°C ± 3°C
	Y0000797	Promethazine for peak identification	2	5 mg	1		0524	Yes	+5°C ± 3°C
	P3490000	Propacetamol hydrochloride - reference spectrum	1	n/a	1		1366
	Y0000455	Propafenone hydrochloride	1	10 mg	1		2103	Yes	+5°C ± 3°C
	Y0000456	Propafenone impurity B	1	10 mg	1	(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3- phenylprop-2-en-1-one	2103	Yes	+5°C ± 3°C
	Y0000278	Propanol - reference spectrum	1	n/a	1		2036
	Y0000016	Propofol	6	650 mg	1	See leaflet	1558	Yes	+5°C ± 3°C
	Y0000018	Propofol impurity J	4	20 mg	1	2,6-bis(1-methylethyl)benzene-1,4-dione	1558	Yes	+5°C ± 3°C
	Y0000017	Propofol for peak identification	3	0.1 ml	1		1558	Yes	+5°C ± 3°C
	P3500000	Propranolol hydrochloride	2	30 mg	1		0568.0923	Yes	+5°C ± 3°C
	P3600000	Propranolol hydrochloride for performance test	3	15 mg	1		0568	Yes	+5°C ± 3°C
	Y0001547	Propylene glycol	1	150 mg	1		1403,1804,2 645	Yes	+5°C ± 3°C
	Y0000318	Propylene glycol dilaurate	1	100 mg	1		2087	Yes	+5°C ± 3°C
	Y0000319	Propylene glycol monolaurate	1	100 mg	1		1915	Yes	+5°C ± 3°C
	P3640000	Propyl gallate	3	50 mg	1		1039	Yes	+5°C ± 3°C
	P3650000	Propyl parahydroxybenzoate	4	150 mg	1	See leaflet CŒÐHŒœO–	0431,0852,1 263	Yes	+5°C ± 3°C
	P3700000	Propylthiouracil	2	30 mg	1		0525	Yes	+5°C ± 3°C
	P3750000	Propyphenazone	4	200 mg	1		0636	Yes	+5°C ± 3°C
	P3760000	Protirelin	3	5.03 mg	2	See leaflet CŒÿHœœNÿO÷	1144	Yes	-20°C ± 5°C
	P3760020	D-His-Protirelin	2	0.1 mg	1	approx. 0.1 mg per vial	1144	Yes	-20°C ± 5°C
	P3800000	Proxyphylline	1	100 mg	1		0526	Yes	+5°C ± 3°C
	P3850000	Pseudoephedrine hydrochloride - * Drug Precursor	3	50 mg	1		0487.1367	Yes	+5°C ± 3°C
	Y0000387	Pseudoisoeugenyl 2-methylbutyrate for peak identification	1	100 mg	1	Star anise oil	2108	Yes	+5°C ± 3°C
	Y0001537	Purified quillaia saponins	1	30 mg	1		1843	Yes	-20°C ± 5°C
	P3900000	Purpureaglycoside A	1	25 mg	1		0117	Yes	+5°C ± 3°C
	P4000000	Purpureaglycoside B	1	25 mg	1		0117	Yes	+5°C ± 3°C
	Y0000402	Pyran embonate	1	10 mg	1		1680	Yes	+5°C ± 3°C
	Y0000403	Pyran impurity A	2	20 mg	1	1-methyl-2-[(Z)-2-(thiophen-2-yl)eth-1-en-1-yl]-1,4,5,6-tetrahydropyrimidine	1680	Yes	+5°C ± 3°C
	Y0001817	Pyran impurity D	1	20 mg	1	1,2-dimethyl-1,4,5,6,-tetrahydropyrimidine	1680	Yes	+5°C ± 3°C
	P4050000	Pyrazinamide	2	30 mg	1		0859	Yes	+5°C ± 3°C
	P4099900	Pyridostigmine bromide	4	30 mg	1	Batch 3 is valid until 31 October 2016	1255	Yes	+5°C ± 3°C
	P4099910	Pyridostigmine impurity A	1	20 mg	1	pyridin-3-yl-dimethylcarbamate	1255	Yes	+5°C ± 3°C
	Y0001486	Pyridostigmine impurity B	1	10 mg	1	3-hydroxy-1-methylpyridinium	1255	Yes	+5°C ± 3°C
	P4100000	Pyridoxine hydrochloride	2	100 mg	1		0245	Yes	+5°C ± 3°C
	Y0001226	Pyridoxine impurity A	3	5 mg	1	6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol	0245	Yes	+5°C ± 3°C
	P4200000	Pyrimethamine	1	250 mg	1		0288	Yes	+5°C ± 3°C
New	Y0000659	Pyrrolidone	2	20 mg	1	Batch 1 is valid until 23 September 2017	2180	Yes	+5°C ± 3°C
	Y0001009	Quercetin dihydrate	3	25 mg	1	See leaflet CŒ—HŒÐOŸ	1827	Yes	+5°C ± 3°C
	Y0001657	Quetiapine fumarate	2	50 mg	1	Batch 1 is valid until 31 August 2017	2541	Yes	+5°C ± 3°C
	Y0001419	Quetiapine for system suitability	3	2.005 mg	1	Batch 2 is valid until 31 July 2016	2541	Yes	+5°C ± 3°C
	Y0001564	Quillaia saponin for assay	1	30 mg	1	See leaflet C÷œHÿ—NOŒÿ; monoammonium glycyrrhizate	1843	Yes	+5°C ± 3°C
	Y0001491	Quinapril hydrochloride	1	30 mg	1		1763	Yes	+5°C ± 3°C
	Y0001502	Quinapril for peak identification	1	5.075 mg	1		1763	Yes	+5°C ± 3°C
	Y0001503	Quinapril for system suitability	1	5.125 mg	1		1763	Yes	+5°C ± 3°C
	Q0100000	Quinidine sulfate	1	300 mg	1		0017,0018,0 019	Yes	+5°C ± 3°C
	Q0200000	Quinine sulfate	2	300 mg	1		0017,0018,0 019	Yes	+5°C ± 3°C
	Y0001783	Rabeprazole sodium hydrate	1	100 mg	1	See leaflet CŒ‡HœÐNaN–O–S	2331.2868		+5°C ± 3°C
	R0100000	Rabies vaccine (inactivated) for veterinary use BRP	5	86 mg	2	See leaflet	0451	Yes	-20°C ± 5°C
	Y0000896	Racecadotril	2	120 mg	1	See leaflet CœŒHœ–NO÷S ; Batch 1 is valid until 31 January 2017	2171	Yes	+5°C ± 3°C
	Y0000897	Racecadotril impurity A	3	1.5 mL	1	ethanethioic acid (thioacetic acid) ; Batch 2 is valid until 31 August 2016	2171	Yes	+5°C ± 3°C
	Y0000898	Racecadotril impurity G	1	10 mg	1	benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate	2171	Yes	+5°C ± 3°C
	Y0000902	Racecadotril for peak identification	1	5 mg	1		2171	Yes	+5°C ± 3°C
	Y0001134	Raloxifene hydrochloride	1	110 mg	1	See leaflet Cœ‡Hœ‡ClNO÷S	2375	Yes	+5°C ± 3°C
	Y0001135	Raloxifene for peak identification	1	10 mg	1		2375	Yes	+5°C ± 3°C
	R0145000	Ramipril	2	20 mg	1		1368	Yes	+5°C ± 3°C
	R0145005	Ramipril impurity A	4	10 mg	1	(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(methoxycarbonyl)-3-phenylpropyl]amino] propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril methyl ester) ; Batch 3 is valid until 30 October 2016	1368	Yes	+5°C ± 3°C
	R0145010	Ramipril impurity B	3	10 mg	1	(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-[(1-methylethoxy)carbonyl]-3-phenylpropyl] amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril isopropyl ester)	1368	Yes	+5°C ± 3°C
	R0145015	Ramipril impurity C	3	10 mg	1	(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)-propyl] amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril)	1368	Yes	+5°C ± 3°C
	R0145020	Ramipril impurity D	4	10 mg	1	ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta [4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine)	1368	Yes	+5°C ± 3°C
	R0150000	Ranitidine hydrochloride	3	100 mg	1		0946.1453	Yes	+5°C ± 3°C
	Y0000416	Ranitidine impurity J	7	0.00025 mg	1	1,1'-N-[methylenebis(sulfanediylethylene)]bis(N'-methyl-2-nitroethene-1,1- diamine) ; Batch 6 is valid until 31 January 2017	0946	Yes	-20°C ± 5°C
	Y0001787	Ranitidine for impurity A identification	1	15 mg	1		0946	Yes	+5°C ± 3°C
	Y0001565	Recombinant Major Allergen rBet v 1	1	0.01025 mg	1	See leaflet	1063	Yes	-20°C ± 5°C
	Y0001566	Recombinant Major Allergen rPhl p 5a	1	0.00856 mg	1	See leaflet	1063	Yes	-20°C ± 5°C
New	Y0001892	* hydrochloride - * narc	1	100 mg	1		2644	Yes	+5°C ± 3°C
	Y0001884	* impurity mixture - *narc	1	15 mg	1		2644	Yes	+5°C ± 3°C
	Y0000457	Repaglinide	1	20 mg	1		2135	Yes	+5°C ± 3°C
	Y0000459	Repaglinide impurity E	3	10 mg	1	2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2- oxoethyl]benzoic acid ; Batch 2 is valid until 31 August 2016	2135	Yes	+5°C ± 3°C
	Y0000458	Repaglinide for system suitability	3	6 mg	1		2135	Yes	+5°C ± 3°C
	R0200000	Reserpine	3	100 mg	1	See leaflet C––H÷ÐNœO„	0528	Yes	+5°C ± 3°C
	R0250000	Residual solvent solution class 1	7	1.4 mL	1	Batch 6 is valid until 31 August 2017	20424	Yes	+5°C ± 3°C
	Y0000767	Resorcinol	1	20 mg	1	benzene-1,3-diol	2348	Yes	+5°C ± 3°C
	Y0001194	Resveratrol	1	20 mg	1	See leaflet CŒ÷HŒœO–	2433	Yes	-20°C ± 5°C
	R0300000	Retinol acetate	7	500 mg	1	See leaflet ; Batch 6 is valid until 31 December 2016	0218,0219,0 220,1192,11 93,2398	Yes	-20°C ± 5°C
	R0290000	Retinol esters	1	100 mg	1		0217,0218,0 219, 0220	Yes	+5°C ± 3°C
	Y0000377	Ribavirin	3	150 mg	2	See leaflet C‡HŒœN÷O— ; Batch 2 is valid until 30 November 2016	2109	Yes	+5°C ± 3°C
	R0600000	Riboflavin	4	130 mg	1	Vitamin B2	0292.0786	Yes	+5°C ± 3°C
	Y0000757	Riboflavin for peak identification	4	0.12 mg	1	Batch 3 is valid until 30 April 2017	0292	Yes	+5°C ± 3°C
	R0630000	Riboflavin sodium phosphate	2	250 mg	1		0786	Yes	+5°C ± 3°C
	Y0000662	Ribonucleic acid	1	100 mg	1	See leaflet	2090	Yes	+5°C ± 3°C
	Y0000149	Rifabutin	2	150 mg	1	See leaflet C÷—HÿœN÷OŒŒ	1657	Yes	+5°C ± 3°C
	Y0000184	Rifabutin impurity A	1	20 mg	1	1-(2-methylpropyl)piperidin-4-one	1657	Yes	+5°C ± 3°C
	R0700000	Rifampicin	2	100 mg	1		0052	Yes	+5°C ± 3°C
	R0800000	Rifampicin quinone	4	100 mg	1		0052	Yes	+5°C ± 3°C
	R1000000	Rifamycin sodium	4	150 mg	1	see leaflet C–ŸH÷ÿNNaOŒœ	0432.20702	Yes	-20°C ± 5°C
	R0900000	Rifamycin B	3	25 mg	1	See leaflet C–„H÷„NOŒ÷; Rifamycin impurity A	0432	Yes	+5°C ± 3°C
	R0950000	Rifamycin S	3	100 mg	1		0432	Yes	+5°C ± 3°C
	Y0001074	Riimin	2	160 mg	1	See leaflet	2362	Yes	+5°C ± 3°C
	Y0001075	Riimin for system suitability	1	10 mg	1		2362	Yes	+5°C ± 3°C
	Y0000250	Rilmenidine dihydrogenophosphate - reference spectru	1	n/a	1		2020
	Y0000187	Rilmenidine for system suitability	1	30 mg	1		2020	Yes	+5°C ± 3°C
	Y0001541	Risedronate sodium 2.5-hydrate	1	15 mg	1		2572	Yes	+5°C ± 3°C
	Y0001558	Risedronate impurity A	1	15 mg	1	See leaflet; [(3RS,6RS and 3R,6S-meso)-2,5-dihydroxy-2,5-dioxo-3,6-bis [(pyridin-3-yl)methyl]-1,4,2λ5,5λ5-dioxadiphosphinane-3,6-diyl]bis (phosphonic acid)	2572	Yes	+5°C ± 3°C
	Y0001540	Risedronate impurity E	1	15 mg	1	[2-(pyridin-3-yl)ethylidene]bis(phosphonic acid)	2572	Yes	+5°C ± 3°C
	R1000600	Risperidone	2	50 mg	1		1559	Yes	+5°C ± 3°C
	Y0001276	Risperidone impurity K	2	0.015 mg	1	3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9- tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)	1559	Yes	+5°C ± 3°C
	Y0000370	Risperidone for system suitability	5	20 mg	1		1559	Yes	+5°C ± 3°C
	Y0000714	Ritonavir	1	80 mg	1	See leaflet C–ŸH÷‡NÿO—Sœ	2136	Yes	+5°C ± 3°C
	Y0000706	Ritonavir for peak identification	1	10 mg	1		2136	Yes	+5°C ± 3°C
	Y0001516	Rivastigmine hydrogen tartrate	2	350 mg	1	See leaflet CŒ‡Hœ‡NœO‡	2629.2630	Yes	+5°C ± 3°C
	Y0001515	Rivastigmine impurity D	1	10 mg	1	3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)- enantiomer)	2629.2630	Yes	+5°C ± 3°C
	Y0001485	Rivastigmine for system suitability	1	1.0114 mg	1		2629.2630	Yes	+5°C ± 3°C
	Y0001302	Rizatriptan benzoate	1	200 mg	1	See leaflet CœœHœ—N—Oœ	2585	Yes	+5°C ± 3°C
	Y0001303	Rizatriptan for system suitability	1	15 mg	1		2585	Yes	+5°C ± 3°C
	R1300000	RK 13 cells	1	1 ml	2	cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines	0162.1057	Yes	Liquid nitrogen
	Y0001580	Rocuronium bromide	1	10 mg	1		1764	Yes	-20°C ± 5°C
	Y0000527	Rocuronium for peak identification	1	10 mg	1		1764	Yes	-20°C ± 5°C
	Y0001773	Ropinirole hydrochloride	1	125 mg	1	See leaflet CŒÿHœ—ClNœO	2604	Yes	+5°C ± 3°C
	Y0001774	Ropinirole impurity A	1	25 mg	1	4-[2-(dipropylamino)ethyl]-1H-indole-2,3-dione	2604	Yes	+5°C ± 3°C
	Y0001775	Ropinirole for peak identification 1	1	15 mg	1		2604	Yes	+5°C ± 3°C
	Y0001776	Ropinirole for peak identification 2	1	15 mg	1		2604	Yes	+5°C ± 3°C
	Y0000742	Ropivacaine hydrochloride monohydrate	1	10 mg	1		2335	Yes	+5°C ± 3°C
	Y0000743	Ropivacaine impurity G	2	5 mg	1	(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)- ropivacaine) ; Batch 1 is valid until 31 March 2017	2335	Yes	+5°C ± 3°C
	Y0000786	Rosmarinic acid	3	50 mg	1	See leaflet CŒ‡HŒÿO‡	1447,2382, 2524,1229, 2723	Yes	+5°C ± 3°C
	Y0001719	Rosuvastatin Calcium	2	100 mg	1	See leaflet C÷÷H—÷CaFœNÿOŒœSœ ; Batch 1 is valid until 30 June 2016	2631	Yes	+5°C ± 3°C
	Y0001721	Rosuvastatin for system suitability	3	15 mg	1	Batch 1 is valid until 30 September 2016 Batch 2 is valid until 31 May 2017	2631	Yes	+5°C ± 3°C
	Y0001722	Rosuvastatin impurity G	2	0.004 mg	1	(3S,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid	2631	Yes	+5°C ± 3°C
	R1500000	Roxithromycin	5	125 mg	1	See leaflet C÷ŒHŸÿNœOŒ—	1146	Yes	+5°C ± 3°C
	Y0000220	Roxithromycin for system suitability	2	10 mg	1		1146	Yes	+5°C ± 3°C
	R2000000	Rubella vaccine (live) BRP	1	90 mg	1	See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of each vial is 18 mg.	1057,0162,2 442	Yes	-80°C ± 10°C
New	Y0001919	Rupatadine for system suitability	1	10 mg	1		2888	Yes	+5°C ± 3°C
New	Y0001922	Rupatadine fumarate	1	10 mg	1		2888	Yes	+5°C ± 3°C
	Y0000494	Ruscogenins	1	10 mg	1	See leaflet	1847	Yes	+5°C ± 3°C
	Y0000105	Rutoside trihydrate	3	100 mg	1	See leaflet CœŸH–ÐOŒÿ	1795,1874,2 184, 2427,2639	Yes	+5°C ± 3°C
	S0040000	Saccharin	1	30 mg	1		0947	Yes	+5°C ± 3°C
	S0050000	Saccharin sodium	2	50 mg	1	Batch 1 is valid until 31 July 2017	0787	Yes	+5°C ± 3°C
	S0100000	Salbutamol	2	50 mg	1		0529.1033	Yes	+5°C ± 3°C
New	Y0000030	Salbutamol impurity B	6	5 mg	1	(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol ; Batch 5 is valid until 31 December 2017	0529	Yes	+5°C ± 3°C
	Y0000071	Salbutamol impurity D	6	10 mg	1	5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2- hydroxybenzaldehyde ; Batch 5 is valid until 30 November 2016	0529.0687	Yes	+5°C ± 3°C
	Y0000031	Salbutamol impurity F	6	10 mg	1	See leaflet; 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol] ; Batch 5 is valid until 31 May 2017	0529.0687	Yes	+5°C ± 3°C
	Y0000034	Salbutamol impurity G	4	10 mg	1	See leaflet CœÐHœ—NO–; 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3- (hydroxymethyl)phenyl]ethanone ; Batch 3 is valid until 31 March 2017	0529	Yes	+5°C ± 3°C
	Y0000032	Salbutamol impurity I	4	0.006 mg	1	(1RS)-2-[(1,1-dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl) phenyl]ethanol	0529	Yes	+5°C ± 3°C
	Y0001186	Salbutamol impurity J	3	0.00045 mg	1	2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl] ethanone (salbutamone) ; Batch 2 is valid until 31 July 2017	0687	Yes	+5°C ± 3°C
	S0150000	Salbutamol sulfate	3	50 mg	1		0687	Yes	+5°C ± 3°C
	Y0001288	Salbutamol sulfate for system suitability	2	10 mg	1		0687	Yes	+5°C ± 3°C
	Y0000669	Salicin	1	50 mg	1	See leaflet CŒ–HŒ‡OŸ	2312.1583	Yes	+5°C ± 3°C
	S0200000	Salicylic acid	2	100 mg	1		0366.1185	Yes	+5°C ± 3°C
	Y0000405	Salicylic acid impurity B	2	10 mg	1	4-hydroxyisophthalic acid	0366	Yes	+5°C ± 3°C
	Y0000422	Salmeterol xinafoate	3	70 mg	1	see leaflet ; Batch 2 is valid until 31 August 2017	1765	Yes	+5°C ± 3°C
	Y0001625	Salmeterol xinafoate for peak identification	1	15 mg	1		1765	Yes	+5°C ± 3°C
	Y0000423	Salmeterol xinafoate for system suitability	2	25 mg	1		1765	Yes	+5°C ± 3°C
	Y0001559	Salvianolic acid B	2	15 mg	1	See leaflet C–ÿH–ÐOŒÿ ; Batch 1 is valid until 15 December 2016	2663	Yes	-20°C ± 5°C
	Y0001052	Santonin	1	20 mg	1	See leaflet	1391.1809	Yes	+5°C ± 3°C
	Y0001049	Saquinavir mesilate	1	70 mg	1	See leaflet C–„H—÷NÿO‡S	2267	Yes	+5°C ± 3°C
	Y0001056	Saquinavir for system suitability	1	0.3033 mg	1		2267	Yes	+5°C ± 3°C
	Y0001483	Saw palmetto extract HRS	1	8000 mg	1		1848, 2579	Yes	-20°C ± 5°C
	Y0001818	Schisandrin	1	15 mg	1	See leaflet Cœ÷H–œOŸ	2428	Yes	+5°C ± 3°C
	Y0000814	Selamectin	2	120 mg	1	see leaflet	2268	Yes	+5°C ± 3°C
	Y0001734	Selamectin for peak identification	1	5 mg	1		2268	Yes	+5°C ± 3°C
	Y0001661	Selamectin impurity B	1	0.005 mg	1	(2aE,2'S,4E,5'S,6S,6'R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)-6'- cyclohexyl-7-[(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)oxy]-20b- hydroxy-20-(hydroxyimino)-5',6,8,19-tetramethyl-5',6,6',7,10,11,14,15,17a, 20,20a,20b-dodecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6] benzodioxacyclooctadecine-13,2'-pyran]-17-one ((5Z,25R)-25-cyclohexyl-4'- O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25- de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a)	2268	Yes	+5°C ± 3°C
New	S0360000	Selegiline hydrochloride	2	50 mg	2	Batch 1 is valid until 30 November 2017	1260	Yes	+5°C ± 3°C
	S0360090	(RS)-Selegiline hydrochloride	2	25 mg	1		1260	Yes	+5°C ± 3°C
	S0400000	Senna extract	1	50 mg	1		0206,0207,0 208, 1261	Yes	-20°C ± 5°C
New	S0450000	Serine	2	50 mg	1	Batch 1 is valid until 31 December 2017	0788	Yes	+5°C ± 3°C
	S0460000	Sertaconazole nitrate	2	125 mg	1		1148	Yes	+5°C ± 3°C
	Y0000828	Sertraline hydrochloride	3	200 mg	1	See leaflet	1705	Yes	+5°C ± 3°C
	Y0001285	Sertraline impurity E	1	15 mg	1	(2R)-hydroxyphenylacetic acid ((R)-mandelic acid)	1705	Yes	+5°C ± 3°C
	Y0000866	Sertraline for peak identification	5	5.4 mg	1	Batch 4 is valid until 31 March 2017	1705	Yes	+5°C ± 3°C
	Y0000867	Sertraline for system suitability	3	6.2 mg	1		1705	Yes	+5°C ± 3°C
	Y0000371	Sestamibi labelling kit	3	22 mg	1		1926	Yes	+5°C ± 3°C
	Y0001046	Sevoflurane	2	1 mL	1		2269	Yes	+5°C ± 3°C
	Y0001578	Sildenafil citrate	1	100 mg	1	See leaflet	2270	Yes	+5°C ± 3°C
	Y0001891	Sildenafil for peak identification	1	15 mg	1		2270	Yes	+5°C ± 3°C
	Y0001579	Sildenafil impurity A	1	10 mg	1	5-[2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2- methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one	2270	Yes	+5°C ± 3°C
	S0500000	Silicone elastomer	3	2000 mg	1		30109	Yes	+5°C ± 3°C
	S0600000	Silicone oil	2	1 mL	1		30108	Yes	+5°C ± 3°C
New	S0650000	Simvastatin	6	200 mg	1	See leaflet ; Batch 5 is valid until 30 November 2017	1563	Yes	-20°C ± 5°C
	Y0001066	Simvastatin for peak identification	1	10 mg	1		1563	Yes	-20°C ± 5°C
	Y0001208	Sinomenine	1	20 mg	1	See leaflet CŒ„Hœ–NO÷	2450	Yes	+5°C ± 3°C
	S0660000	Sisomicin sulfate	3	60 mg	1	See leaflet C–‡H‡÷NŒÐO–÷S—	0331.1351	Yes	-20°C ± 5°C
	Y0001615	Beta-sitosterol	1	25 mg	1	See leaflet Cœ„H—ÐO	2579	Yes	-20°C ± 5°C
	Y0001812	Sitagliptin phosphate monohydrate	1	160 mg	1	See leaflet CŒÿHŒ‡FÿN—O—, HœO	2778.2927	Yes	+5°C ± 3°C
	Y0001811	Sitagliptin containing impurity A	1	15 mg	1		2778	Yes	+5°C ± 3°C
	Y0001727	Sodium alendronate trihydrate	2	150 mg	1	see leaflet C÷HŒœNNaOŸPœ,3HœO ; Batch 1 is valid until 31 December 2016	1564	Yes	+5°C ± 3°C
	Y0001678	Sodium alendronate for system suitability	1	5 mg	1		1564	Yes	+5°C ± 3°C
	S0695000	Sodium amidotrizoate	1	125 mg	1		1150	Yes	+5°C ± 3°C
	Y0001669	Sodium aminosalicylate dihydrate	1	10 mg	1		1993	Yes	+5°C ± 3°C
	Y0000300	Sodium aminosalicylate dihydrate - reference spectrum	1	n/a	1
	Y0000039	Sodium ascorbate	1	50 mg	1		1791	Yes	+5°C ± 3°C
	S0700000	Sodium calcium edetate	1	100 mg	1		0231	Yes	+5°C ± 3°C
	S0710000	Sodium cetostearyl sulfate	1	100 mg	1		0847	Yes	+5°C ± 3°C
	S0750000	Sodium cromoglicate	2	10 mg	1		0562	Yes	+5°C ± 3°C
	Y0001300	Sodium cromoglicate for system suitability	1	20 mg	1		0562	Yes	+5°C ± 3°C
	S0760000	Sodium cyclamate	2	100 mg	1		0774	Yes	+5°C ± 3°C
	Y0001410	Sodium fusidate	1	10 mg	1		0848	Yes	+5°C ± 3°C
	S0780000	Sodium hyaluronate BRP	2	300 mg	1		0912	Yes	+5°C ± 3°C
	S0781000	Sodium hyaluronate - reference spectrum	1	n/a	1		1472
	Y0001468	Sodium iodohippurate	1	15 mg	1		2352	Yes	+5°C ± 3°C
	Y0000620	Sodium laurilsulfate	1	40 mg	1		0802	Yes	+5°C ± 3°C
	Y0001772	Sodium lauroylsarcosinate	1	550 mg	1		2542	Yes	+5°C ± 3°C
	Y0000808	Sodium phenylbutyrate	1	5 mg	1		2183	Yes	+5°C ± 3°C
	Y0000809	Sodium phenylbutyrate impurity C	1	10 mg	1	4-cyclohexylbutanoic acid	2183	Yes	+5°C ± 3°C
	S0785000	Sodium picosulfate	2	50 mg	1		1031	Yes	+5°C ± 3°C
	Y0000210	Sodium polystyrene sulfonate - reference spectrum	1	n/a	1		1909
	Y0000268	Sodium propionate - reference spectrum	1	n/a	1		2041
	S0800000	Sodium salicylate	1	100 mg	1		0413	Yes	+5°C ± 3°C
	S0808000	Sodium stearyl fumarate	1	50 mg	1		1567	Yes	+5°C ± 3°C
	S0808060	Sodium stearyl maleate	2	10 mg	1		1567	Yes	+5°C ± 3°C
	S0900000	Sodium taurocholate BRP	2	10000 mg	1		0350	Yes	+5°C ± 3°C
	S0930000	Sodium valproate	5	50 mg	1		0678	Yes	+5°C ± 3°C
	Y0001743	Solifenacin for system suitability	1	2.52 mg	1		2779	Yes	+5°C ± 3°C
	Y0001763	Solifenacin succinate	1	5 mg	1		2779	Yes	+5°C ± 3°C
	S0945000	Somatostatin	6	2.09 mg	1	See leaflet	0949	Yes	-20°C ± 5°C
	S0947000	Somatropin	3	55 mg	1	See leaflet	0950, 0951,0952, 2370	Yes	-20°C ± 5°C
	Y0000711	Somatropin/desamidosomatropin resolution mixture	1	33 mg	1	See leaflet	0950,0951,0 952	Yes	-20°C ± 5°C
	S0950000	Sorbic acid	2	10 mg	1		0592	Yes	+5°C ± 3°C
	Y0000385	1,4-Sorbitan	2	50 mg	1	See leaflet CÿHŒœO—	2048	Yes	+5°C ± 3°C
	S1000000	Sorbitol	4	1250 mg	1	See leaflet	0435,0436,0 437, 1235,1236,1 337, 1381,1531,2 048	Yes	+5°C ± 3°C
	Y0000114	Sotalol hydrochloride	1	25 mg	1		2004	Yes	+5°C ± 3°C
	Y0000115	Sotalol impurity B	2	20 mg	1	N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulfonamide	2004	Yes	+5°C ± 3°C
	Y0001011	Spanish sage oil for peak identification	2	250 mg	1		1849	Yes	+5°C ± 3°C
	Y0000549	Spectinomycin for system suitability	1	20 mg	1		1152, 1658	Yes	-20°C ± 5°C
	Y0000597	Spectinomycin hydrochloride	2	100 mg	1	See leaflet	1152, 1658	Yes	-20°C ± 5°C
	Y0000655	Spectinomycin sulfate tetrahydrate	1	10 mg	1		1658	Yes	-20°C ± 5°C
	Y0001126	Spike lavender oil	1	400 µl	1		2419	Yes	+5°C ± 3°C
	S1100000	Spiramycin	6	200 mg	1	See leaflet ; Batch 5 is valid until 21 October 2016	0179,0293,1 982,20702	Yes	-20°C ± 5°C
	Y0000381	Spirapril hydrochloride monohydrate	1	60 mg	1	See leaflet CœœH–ŒClNœO—Sœ	1766	Yes	+5°C ± 3°C
	Y0000332	Spirapril for system suitability	1	15 mg	1		1766	Yes	+5°C ± 3°C
	S1200000	Spironolactone	4	160 mg	1	See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688 only.	0688	Yes	+5°C ± 3°C
	Y0001295	Spironolactone for system suitability	2	2.057 mg	1		0688	Yes	+5°C ± 3°C
	Y0000185	Squalane	1	250 µl	1	See leaflet C–ÐHÿœ	1630	Yes	+5°C ± 3°C
	Y0001050	St. John's wort dry extract	2	500 mg	1	See leaflet	1874	Yes	-20°C ± 5°C
	S1250000	Stanozolol	2	50 mg	1		1568	Yes	+5°C ± 3°C
	S1250010	Stanozolol impurity A	1	10 mg	1	17β-hydroxy-17-methyl-5α-androstan-3-one (mestanolone)	1568	Yes	+5°C ± 3°C
	Y0001420	Stanozolol impurity B	1	10 mg	1	17β-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one (oxymetholone)	1568	Yes	+5°C ± 3°C
	S1300000	Starch BRP	4	50000 mg	1		0350	Yes	+5°C ± 3°C
	Y0000408	Stavudine	1	100 mg	1	see leaflet	2130	Yes	+5°C ± 3°C
	Y0001683	Stavudine impurity I	1	5 mg	1	1-(5-O-benzoyl-2,3-dideoxy-β-d-glycero-pent-2-enofuranosyl)-5- methylpyrimidine-2,4(1H,3H)-dione	2130	Yes	+5°C ± 3°C
	Y0000421	Stavudine for system suitability	1	10 mg	1		2130	Yes	+5°C ± 3°C
New	S1340000	Stearic acid	4	100 mg	1	Plastic additive 19 ; Batch 3 is valid until 30 November 2017	0229,0882,1 474, 1663, 2058, 30103, 30105,	Yes	+5°C ± 3°C
	S1350000	Stearyl alcohol	2	250 mg	1	See leaflet CŒ‡H–‡O	0702,0753,0 801, 0802,0847,0 969, 1123,1340,1 411	Yes	+5°C ± 3°C
	Y0000868	Streptokinase for system suitability	1	30 µl	1		0356	Yes	-20°C ± 5°C
	S1400000	Streptomycin sulfate	4	100 mg	1	See leaflet	0032,0033,0 053, 0485,20702	Yes	-20°C ± 5°C
	Y0001195	Strychnine	1	40 mg	1	see leaflet	2513.2514	Yes	+5°C ± 3°C
	Y0001324	Sucralfate	1	10 mg	1		1796	Yes	+5°C ± 3°C
	Y0001344	Sucralose	1	550 mg	1	See leaflet CŒœHŒ„Cl–O‡	2368	Yes	+5°C ± 3°C
	Y0001342	Sucralose impurity B	3	0.5 mg	1	1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 6-chloro-6-deoxy-α-D-glucopyranoside (1',6,6'-trichloro- 1',6,6'-trideoxysucrose) ; Batch 2 is valid until 30 April 2017	2368	Yes	+5°C ± 3°C
	S1600000	Sucrose	1	100 mg	1		0204,1570,2 318, 2319	Yes	+5°C ± 3°C
	S1608100	* - reference spectrum	1	n/a	1		1569
	S1609000	* citrate - reference spectrum	1	n/a	1		1269
	Y0000528	Sulbactam	2	150 mg	1	See leaflet	2209, 2211, 2212	Yes	-20°C ± 5°C
	Y0000529	Sulbactam sodium	1	10 mg	1	See leaflet	2209	Yes	+5°C ± 3°C
	Y0000550	Sulbactam for peak identification	1	20 mg	1		2209	Yes	+5°C ± 3°C
	S1700000	Sulfacetamide sodium	1	50 mg	1		0107.0295	Yes	+5°C ± 3°C
	S1800000	Sulfadiazine	1	100 mg	1		0294	Yes	+5°C ± 3°C
	Y0001480	Sulfadiazine for identification of impurity F	1	15 mg	1		0294	Yes	+5°C ± 3°C
	Y0001469	Sulfadiazine impurity A	1	20 mg	1	pyrimidin-2-amine	0294	Yes	+5°C ± 3°C
	Y0001677	Sulfadimethoxine	1	60 mg	1	see leaflet	2741, 2745	Yes	+5°C ± 3°C
	Y0001679	Sulfadimethoxine for peak identification	1	10 mg	1		2741, 2745	Yes	+5°C ± 3°C
	S1900000	Sulfadimidine	1	100 mg	1		0295	Yes	+5°C ± 3°C
	Y0001495	Sulfadimidine for peak identification	1	50 mg	1		0295	Yes	+5°C ± 3°C
	S1950000	Sulfadoxine	2	50 mg	1		0740	Yes	+5°C ± 3°C
	S1975000	Sulfafurazole	1	100 mg	1		0741	Yes	+5°C ± 3°C
	S1975600	Sulfaguanidine	2	60 mg	1		0295.1476	Yes	+5°C ± 3°C
	S2000000	Sulfamerazine	1	100 mg	1		0358.1571	Yes	+5°C ± 3°C
	S2050000	Sulfamethizole	1	100 mg	1		0637	Yes	+5°C ± 3°C
	S2100000	Sulfamethoxazole	1	50 mg	1		0108	Yes	+5°C ± 3°C
	Y0000412	Sulfamethoxazole impurity A	1	5 mg	1	N-[4-[(5-methylisoxazol-3-yl)sulfamoyl]phenyl]acetamide	0108	Yes	+5°C ± 3°C
	Y0000413	Sulfamethoxazole impurity F	3	5 mg	1	4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide	0108	Yes	+5°C ± 3°C
	S2150000	Sulfamethoxypyridazine	1	50 mg	1		0638	Yes	+5°C ± 3°C
	S2151000	Sulfanilamide	2	100 mg	1		1571	Yes	+5°C ± 3°C
	S2159100	Sulfapyridine	1	20 mg	1		0863	Yes	+5°C ± 3°C
	S2155000	Sulfasalazine	4	250 mg	2	See leaflet CŒ‡HŒ÷N÷O—S	0863.1457	Yes	+5°C ± 3°C
	S2155010	Sulfasalazine derivative for resolution	1	20 mg	1	2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic acid	0863	Yes	+5°C ± 3°C
	S2158000	Sulfathiazole	2	100 mg	1	Batch 1 is valid until 31 July 2016	0742	Yes	+5°C ± 3°C
	S2159000	Sulfinpyrazone	1	30 mg	1		0790	Yes	+5°C ± 3°C
	S2159010	Sulfinpyrazone impurity A	3	20 mg	1	1,2-diphenyl-4-[2-(phenylsulfonyl)ethyl]pyrazolidine-3,5-dione	0790	Yes	+5°C ± 3°C
	S2159015	Sulfinpyrazone impurity B	3	20 mg	1	1,2-diphenyl-4-[2-(phenylsulfanyl)ethyl]pyrazolidine-3,5-dione	0790	Yes	+5°C ± 3°C
	Y0001238	Sulfinpyrazone for system suitability	1	0.5 mg	1		0790	Yes	+5°C ± 3°C
	S2180000	Sulindac	3	50 mg	1	See leaflet CœÐHŒŸFO–S; Contains 0.3% m/m of E-isomer	0864	Yes	+5°C ± 3°C
	S2190000	Sulpiride	4	100 mg	1		1045.1348	Yes	+5°C ± 3°C
	S2191000	Sulpiride impurity A	4	20 mg	1	[(2RS)-1-ethylpyrrolidin-2-yl]methanamine	1045.1490	Yes	+5°C ± 3°C
	S2192000	Sulpiride impurity B	3	10 mg	1	methyl 2-methoxy-5-sulfamoylbenzoate	1045	Yes	+5°C ± 3°C
	Y0000530	Sultamicillin	1	10 mg	1		2211	Yes	+5°C ± 3°C
	Y0000532	Sultamicillin for peak identification	1	10 mg	1		2211	Yes	+5°C ± 3°C
	Y0000531	Sultamicillin tosilate	3	200 mg	1	See leaflet	2211.2212	Yes	+5°C ± 3°C
	Y0000022	Sumatriptan succinate	1	50 mg	1	See leaflet CŒ‡HœŸN–OÿS	1573	Yes	-20°C ± 5°C
	Y0000026	Sumatriptan impurity mixture	8	3 mg	1		1573	Yes	-20°C ± 5°C
	Y0000027	Sumatriptan for system suitability	6	10 mg	1	Batch 5 is valid until 30 June 2017	1573	Yes	-20°C ± 5°C
	S2200000	Suxamethonium chloride	1	1000 mg	1		0248	Yes	+5°C ± 3°C
	Y0001778	Rabeprazole for system suitability	1	15 mg	1		2331.2868	Yes	+5°C ± 3°C
	S2400000	Suxibuzone	1	50 mg	1		1574	Yes	+5°C ± 3°C
	S2400004	Suxibuzone impurity B	1	10 mg	1	(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate	1574	Yes	+5°C ± 3°C
	S2400006	Suxibuzone impurity C	1	10 mg	1	4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione	1574	Yes	+5°C ± 3°C
	S5000001	Swine erysipelas bacteria, serotyp 1 (for vaccines - vet. use) BRP	1	1 mg	1	See leaflet	See leaflet, 0064	Yes	+5°C ± 3°C
	S5000002	Swine erysipelas bacteria, serotyp 2 (for vaccines - vet. use) BRP	1	1 mg	1	See leaflet	See leaflet, 0064	Yes	+5°C ± 3°C
	Y0001854	Tacalcitol monohydrate	1	15 mg	1	see leaflet CœŸH÷÷O–,HœO	2272	Yes	-20°C ± 5°C
	Y0001610	Tacalcitol for system suitability	1	0.025 mg	1		2272	Yes	-20°C ± 5°C
	Y0001824	Tacalcitol impurity A	1	0.001 mg	1	(5E,7E)-(24R)-9,10-secocholesta-5,7,10(19)-triene-1α,3β,24-triol (trans- tacalcitol)	2272	Yes	-20°C ± 5°C
New	Y0001933	Tacrolimus for system suitability	1	10 mg	1		2244	Yes	+5°C ± 3°C
	Y0001910	Tacalcitol monohydrate - reference spectrum	1	1	1		2272
	Y0001417	Tadalafil	2	200 mg	1	see leaflet	2606	Yes	+5°C ± 3°C
	T0010000	Talampicillin hydrochloride	1	50 mg	1		0808.0852	Yes	+5°C ± 3°C
	T0014000	Tamoxifen citrate	2	80 mg	1		1046	Yes	+5°C ± 3°C
	T0015000	Tamoxifen citrate for performance test	3	10 mg	1		1046	Yes	+5°C ± 3°C
	Y0000650	Tamsulosin hydrochloride	1	10 mg	1		2131	Yes	+5°C ± 3°C
	Y0000651	Tamsulosin impurity D	2	10 mg	1	2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl] benzenesulfonamide	2131	Yes	+5°C ± 3°C
	Y0000652	Tamsulosin impurity H	2	10 mg	1	(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine	2131	Yes	+5°C ± 3°C
	Y0000653	Tamsulosin racemate	2	15 mg	1		2131	Yes	+5°C ± 3°C
	Y0001560	Tanshinone IIa	1	15 mg	1	See leaflet CŒ„HŒ‡O–	2663	Yes	+5°C ± 3°C
	Y0001840	Taxifolin	1	15 mg	1	See leaflet CŒ—HŒœOŸ	2726	Yes	-20°C ± 5°C
	Y0001102	Teicoplanin	2	50 mg	1	see leaflet	2358	Yes	-20°C ± 5°C
	Y0001047	Teicoplanin for identification	1	40 mg	1		2358	Yes	-20°C ± 5°C
	Y0000648	misartan	1	30 mg	1		2154	Yes	+5°C ± 3°C
	Y0000649	misartan for peak identification	3	10 mg	1	Batch 2 is valid until 31 August 2016	2154	Yes	+5°C ± 3°C
	Y0001003	misartan for system suitability	4	0.26 mg	1		2154	Yes	+5°C ± 3°C
	T0040000	Temazepam - * psy	1	50 mg	1		0954	Yes	+5°C ± 3°C
	Y0000344	Temazepam impurity C	1	5 mg	1	(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4- benzodiazepin-3-yl acetate	0954	Yes	+5°C ± 3°C
	Y0000345	Temazepam impurity D	1	5 mg	1	(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4- benzodiazepin-2-one	0954	Yes	+5°C ± 3°C
	Y0000346	Temazepam impurity F	2	10 mg	1	(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3- dione	0954	Yes	+5°C ± 3°C
	Y0000347	Temazepam impurity G	1	5 mg	1	(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4- benzodiazepine-2,3-dione	0954	Yes	+5°C ± 3°C
	Y0001827	Temozolomide	1	70 mg	1	See leaflet CÿHÿNÿOœ	2780	Yes	+5°C ± 3°C
	T0040800	Tenoxicam	2	100 mg	1		1156	Yes	+5°C ± 3°C
	Y0001114	Tenoxicam impurity mixture	1	0.0042 mg	1		1156	Yes	+5°C ± 3°C
	Y0000621	Terazosin hydrochloride dihydrate	1	40 mg	1		2021	Yes	+5°C ± 3°C
	Y0000622	Terazosin impurity A	1	10 mg	1	2-chloro-6,7-dimethoxyquinazolin-4-amine	2021	Yes	+5°C ± 3°C
	Y0000665	Terazosin impurity E	1	10 mg	1	2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)	2021	Yes	+5°C ± 3°C
	Y0000623	Terazosin impurity L	1	10 mg	1	1-(furan-2-ylcarbonyl)piperazine	2021	Yes	+5°C ± 3°C
	Y0000624	Terazosin impurity N	1	10 mg	1	See leaflet C„HŒÿNœOœ; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine	2021	Yes	+5°C ± 3°C
	Y0000666	Terazosin for system suitability	1	0.5 mg	1		2021	Yes	+5°C ± 3°C
	Y0000535	Terbinafine hydrochloride	1	10 mg	1		1734	Yes	+5°C ± 3°C
	Y0001143	Terbinafine for system suitability	2	10 mg	1		1734	Yes	+5°C ± 3°C
	T0050000	Terbutaline sulfate	2	100 mg	1		0690, 2451	Yes	+5°C ± 3°C
	T0050015	Terbutaline impurity C	4	15 mg	1	1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]ethanone ; Batch 3 is valid until 30 November 2016	0690	Yes	+5°C ± 3°C
	T0060000	Terconazole	2	250 mg	1		1270	Yes	+5°C ± 3°C
	T0071000	Terfenadine	1	100 mg	1		0955	Yes	+5°C ± 3°C
	T0080000	Terfenadine impurity A	2	20 mg	1	1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl] butan-1-one	0955	Yes	+5°C ± 3°C
	Y0001895	Teriparatide for system suitability	1	1.3 mg	1		2829	Yes	-20°C ± 5°C
New	Y0001898	Terlipressin for NMR identification	1	2.9 mg	1		2646	Yes	-20°C ± 5°C
New	Y0001899	Terlipressin impurity mixture	1	0.03 mg	1		2646	Yes	-20°C ± 5°C
	T0100000	Testosterone	3	30 mg	1		1373, 1048	Yes	+5°C ± 3°C
	Y0000342	Testosterone for impurity D identification	2	20 mg	1		1373	Yes	+5°C ± 3°C
	Y0000343	Testosterone for system suitability	3	20 mg	1		1373	Yes	+5°C ± 3°C
	T0210000	Testosterone caproate	1	50 mg	1		1048	Yes	+5°C ± 3°C
	T0240000	Testosterone decanoate	2	50 mg	1	See leaflet Cœ„H÷ÿO–	1048, 1736	Yes	-20°C ± 5°C
	Y0000696	Testosterone decanoate for system suitability	1	0.4 mg	1		1736	Yes	-20°C ± 5°C
	T0250000	Testosterone enantate	2	40 mg	1	Batch 1 is valid until 31 October 2016	1048	Yes	-20°C ± 5°C
	Y0001313	Testosterone enantate impurity H	1	10 mg	1	androst-5-ene-3β,17β-diyl diheptanoate	1048	Yes	-20°C ± 5°C
	Y0001312	Testosterone enantate for peak identification	1	10 mg	1		1048	Yes	-20°C ± 5°C
	Y0001317	Testosterone enantate for system suitability	1	2 mg	1		1048	Yes	-20°C ± 5°C
	T0260000	Testosterone isocaproate	2	50 mg	1	See leaflet Cœ—H–‡O–	1048.1737	Yes	+5°C ± 3°C
	Y0000716	Testosterone isocaproate for system suitability	1	5 mg	1		1737	Yes	+5°C ± 3°C
	T0300000	Testosterone propionate	2	60 mg	1	See leaflet CœœH–œO–	0297	Yes	+5°C ± 3°C
New	Y0001409	Testosterone propionate for system suitability	2	10 mg	1	Batch 1 is valid until 30 September 2017	0297	Yes	+5°C ± 3°C
	T0400000	Tetanus vaccine (adsorbed)	3	30 mg	1	See leaflet	See leaflet, 20708	Yes	-20°C ± 5°C
	T0500000	Tetracaine hydrochloride	1	100 mg	1		0057	Yes	+5°C ± 3°C
	Y0001002	Tetracaine for system suitability	1	2 mg	1		0057	Yes	+5°C ± 3°C
	T0550000	Tetracosactide	3	20.4 mg	2	See leaflet CŒ–ÿHœŒÐN÷ÐO–ŒS	0644	Yes	-20°C ± 5°C
	T0600000	Tetracycline hydrochloride	3	100 mg	1	See leaflet CœœHœ—ClNœO‡	0173, 0210,0211,1 654	Yes	+5°C ± 3°C
	Y0001165	Tetrandrine	1	20 mg	1	See leaflet C–‡H÷œNœOÿ	2478	Yes	+5°C ± 3°C
New	Y0001087	Tetra-O-acetyl-mannose triflate	2	80 mg	1	See leaflet CŒ—HŒ„F–OŒœS ; Batch 1 is valid until 30 November 2017	2294	Yes	-20°C ± 5°C
	Y0000015	Tetrazepam - reference spectrum	1	n/a	1		1738
	Y0000008	Tetrazepam impurity C	1	20 mg	1	7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one	1738	Yes	+5°C ± 3°C
	Y0000460	Tetryzoline hydrochloride	1	10 mg	1		2101	Yes	+5°C ± 3°C
	Y0000723	Thebaine - * narc	1	15 mg	1	see leaflet	0777,1839,1 840,1841	Yes	+5°C ± 3°C
	T0700000	Theobromine	2	25 mg	1		0298	Yes	+5°C ± 3°C
	T0800000	Theophylline	1	100 mg	1		0300.0301	Yes	+5°C ± 3°C
	Y0000294	Theophylline - reference spectrum	1	n/a	1		0299.0302
	Y0000336	Thiamazole	1	125 mg	1		0884.1706	Yes	+5°C ± 3°C
	Y0000372	Thiamazole impurity A	1	15 mg	1	2,2-dimethoxy-N-methylethanamine	1706	Yes	+5°C ± 3°C
	Y0000373	Thiamazole impurity C	4	20 mg	1	1-methyl-2-(methylsulfanyl)-1H-imidazole ; Batch 2 is valid until 30 November 2016 Batch 3 is valid until 31 March 2017	1706	Yes	+5°C ± 3°C
	Y0000467	Thiamine hydrochloride	2	10 mg	1		0303	Yes	+5°C ± 3°C
	Y0001749	Thiamine for system suitability	1	0.5 mg	1		0303.0531	Yes	+5°C ± 3°C
	Y0001758	Thiamine nitrate	1	15 mg	1		0531	Yes	+5°C ± 3°C
	T1100000	Thiamphenicol	1	125 mg	1		0109	Yes	+5°C ± 3°C
	Y0001789	Thiocolchicoside hydrate	1	60 mg	1	See leaflet CœŸH––NOŒÐS	2814.2896	Yes	+5°C ± 3°C
	Y0001790	Thiocolchicoside crystallised from ethanol	1	10 mg	1		2896	Yes	+5°C ± 3°C
	Y0001791	Thiocolchicoside for system suitability	1	10 mg	1		2814.2896	Yes	+5°C ± 3°C
	Y0000546	Thioctic acid	2	110 mg	1	See leaflet	1648	Yes	+5°C ± 3°C
	Y0000545	Thioctic acid containing impurity B	2	25 mg	1		1648	Yes	+5°C ± 3°C
	Y0000592	Thioctic acid for system suitability	2	15 mg	1	Batch 1 is valid until 30 June 2016	1648	Yes	+5°C ± 3°C
	Y0000109	Thiomersal	1	30 mg	1		1625	Yes	+5°C ± 3°C
	T1200000	Thiopental	1	500 mg	1		0212	Yes	+5°C ± 3°C
New	Y0001478	Thiopental for system suitability	2	10 mg	1	Batch 1 is valid until 31 December 2017	0212	Yes	+5°C ± 3°C
	Y0000704	Thioridazine	1	10 mg	1		2005	Yes	+5°C ± 3°C
	T1300000	Thioridazine hydrochloride	1	100 mg	1		0586	Yes	+5°C ± 3°C
	Y0000541	Thioridazine for system suitability	1	0.21 mg	1		0586, 2005	Yes	+5°C ± 3°C
	T1305100	Thioxanthene	3	20 mg	1		1347	Yes	+5°C ± 3°C
	T1305000	Thioxanthone	2	10 mg	1		1347	Yes	+5°C ± 3°C
	T1340000	Threonine	1	50 mg	1		1049	Yes	+5°C ± 3°C
	T1350000	Thymol	2	50 mg	1		0791	Yes	+5°C ± 3°C
	T1410000	Tiabendazole	1	50 mg	1		0866	Yes	+5°C ± 3°C
	Y0000379	Tiamulin - reference spectrum	1	n/a	1		1660
	Y0000333	Tiamulin hydrogen fumarate	2	500 mg	1	See leaflet C–œH—ŒNO‡S	1659.1660	Yes	+5°C ± 3°C
	Y0000414	Tiamulin for peak identification	2	10 mg	1		1659	Yes	+5°C ± 3°C
	Y0000151	Tianeptine sodium - reference spectrum	1	n/a	1		2022
	Y0000153	Tianeptine impurity A	1	30 mg	1	ethyl 7-bromoheptanoate	2022	Yes	+5°C ± 3°C
	Y0000152	Tianeptine for system suitability	1	30 mg	1		2022	Yes	+5°C ± 3°C
	T1405000	Tiapride hydrochloride	1	60 mg	1		1575	Yes	+5°C ± 3°C
	T1405050	Tiapride N-oxide	1	20 mg	1		1575	Yes	+5°C ± 3°C
	T1410900	Tiaprofenic acid	1	50 mg	1		1157	Yes	+5°C ± 3°C
	T1410910	Tiaprofenic acid impurity C	1	20 mg	1	(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid	1157	Yes	+5°C ± 3°C
	Y0000748	Tibolone - reference spectrum	1	n/a	1		1739
	Y0000668	Tibolone for system suitability	1	10 mg	1		1739	Yes	+5°C ± 3°C
	Y0000465	Ticarcillin monosodium	3	250 mg	1	see leaflet ; Batch 2 is valid until 8 February 2017	0956	Yes	-20°C ± 5°C
	T1420010	Ticarcillin impurity A	2	50 mg	1	See leaflet; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]- amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin)	0956	Yes	+5°C ± 3°C
	T1423000	Ticlopidine hydrochloride	3	50 mg	1		1050	Yes	+5°C ± 3°C
	T1423025	Ticlopidine impurity F	3	15 mg	1	6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine ; Batch 2 is valid until 31 August 2016	1050	Yes	+5°C ± 3°C
	Y0000325	Tilidine hydrochloride hemihydrate - reference spectrum	1	n/a	1		1767
	Y0000644	(R)-timolol	2	20 mg	1		0572	Yes	+5°C ± 3°C
	T1450000	Timolol maleate	3	100 mg	1		0572	Yes	+5°C ± 3°C
	Y0001690	Timolol impurity F	1	10 mg	1	4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine	0572	Yes	+5°C ± 3°C
	Y0001270	Timolol for system suitability	2	5.045 mg	1		0572	Yes	+5°C ± 3°C
	T1470000	Tinidazole	1	100 mg	1		1051		+5°C ± 3°C
	Y0000899	Tinidazole impurity A	1	15 mg	1	2-methyl-5-nitro-1H-imidazole	1051	Yes	+5°C ± 3°C
	T1471000	Tinidazole impurity B	4	20 mg	1	1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole	1051	Yes	+5°C ± 3°C
	T1490000	Tinzaparin sodium	1	250 mg	1		1271	Yes	+5°C ± 3°C
	Y0000292	Tioconazole - reference spectrum	1	n/a	1		2074
	Y0000282	Tioconazole for system suitability	1	50 mg	1		2074	Yes	+5°C ± 3°C
	Y0001188	Tiotropium bromide monohydrate	1	10 mg	1		2420	Yes	+5°C ± 3°C
	Y0001216	Tiotropium impurity F	3	15 mg	1	dithiophen-2-ylmethanone ; Batch 2 is valid until 30 September 2017	2420	Yes	+5°C ± 3°C
	Y0001189	Tiotropium for system suitability	2	10 mg	1		2420	Yes	+5°C ± 3°C
New	Y0001929	Tiotropium for system suitability 1	1	10 mg	1		2420	Yes	+5°C ± 3°C
	Y0001179	Tiotropium impurity mixture	2	0.08 mg	1		2420	Yes	+5°C ± 3°C
	Y0001700	Tizanidine hydrochloride	1	100 mg	1	See leaflet C„H„ClœN—S	2578	Yes	+5°C ± 3°C
	Y0001698	Tizanidine impurity B	1	10 mg	1	N-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiourea	2578	Yes	+5°C ± 3°C
	T1500000	Tobramycin	4	49 mg	1	See leaflet CŒ‡H–ŸN—O„; Suitable for LC assay only	0645	Yes	+5°C ± 3°C
	Y0001210	Tobramycin for identification	1	250 mg	1	Suitable for identification tests only	0645	Yes	+5°C ± 3°C
New	T1550000	alpha-Tocopherol	8	1.5 mL	1	See leaflet Cœ„H—ÐOœ ; Vitamin E ; Batch 7 is valid until 8 October 2016	0692.1256	Yes	+5°C ± 3°C
	T1600000	alpha-Tocopheryl acetate	9	500 mg	1	See leaflet C–ŒH—œO–	0439,0691,1 257	Yes	+5°C ± 3°C
	Y0000383	All-rac-alpha-tocopherol for peak identification	3	50 mg	1		0692	Yes	+5°C ± 3°C
	Y0000384	All-rac-alpha-tocopheryl acetate for peak identification	2	30 mg	1		0439	Yes	+5°C ± 3°C
	T1610000	RRR-alpha-Tocopheryl hydrogen succinate	1	150 mg	1	See leaflet C––H—÷O—	1258.1259	Yes	+5°C ± 3°C
	T1700000	Tolbutamide	1	100 mg	1		0304	Yes	+5°C ± 3°C
	Y0000154	Tolfenamic acid	1	100 mg	1		2039	Yes	+5°C ± 3°C
	T1707000	Tolnaftate	1	60 mg	1		1158	Yes	+5°C ± 3°C
	Y0001123	Tolnaftate for system suitability	1	10 mg	1		1158	Yes	+5°C ± 3°C
	Y0001696	Tolterodine tartrate	1	5 mg	1		2781	Yes	+5°C ± 3°C
	Y0001699	Tolterodine impurity E	1	5 mg	1	4-methyl-2-[(1RS)-3-[(1-methylethyl)amino]-1-phenylpropyl]phenol	2781	Yes	+5°C ± 3°C
	Y0001697	Tolterodine for system suitability	1	5 mg	1		2781	Yes	+5°C ± 3°C
	Y0000461	Torasemide anhydrous	1	10 mg	1		2132	Yes	+5°C ± 3°C
	Y0001366	Torasemide impurity E	2	0.0006 mg	1	ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate ; Batch 1 is valid until 31 August 2017	2132	Yes	+5°C ± 3°C
	Y0000462	Torasemide for system suitability	2	5 mg	1		2132	Yes	+5°C ± 3°C
	Y0000155	Tramadol hydrochloride	3	75 mg	1		1681	Yes	+5°C ± 3°C
	Y0000156	Tramadol impurity A	4	25 mg	1	(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol	1681	Yes	+5°C ± 3°C
	Y0000157	Tramadol impurity E	4	15 mg	1	(2RS)-2-[(dimethylamino)methyl]cyclohexanone ; Batch 3 is valid until 31 January 2017	1681	Yes	+5°C ± 3°C
	Y0000072	Tramazoline hydrochloride monohydrate	1	20 mg	1		1597	Yes	+5°C ± 3°C
	Y0000065	Tramazoline impurity A	2	15 mg	1	N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine	1597	Yes	+5°C ± 3°C
	Y0000066	Tramazoline impurity B	2	15 mg	1	See leaflet; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5- dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8- tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one ; Batch 1 is valid	1597	Yes	+5°C ± 3°C
	Y0000501	Trandolapril	1	10 mg	1		2245	Yes	+5°C ± 3°C
	Y0000495	Trandolapril impurity C	1	10 mg	1	(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino] propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)	2245	Yes	+5°C ± 3°C
	Y0000496	Trandolapril impurity D	1	10 mg	1	ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazi,2- a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine)	2245	Yes	+5°C ± 3°C
	T1810000	Tranexamic acid	5	50 mg	1		0875	Yes	+5°C ± 3°C
	T1820000	Trapidil	1	50 mg	1		1576	Yes	+5°C ± 3°C
	T1820002	Trapidil impurity A	1	20 mg	1	5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol	1576	Yes	+5°C ± 3°C
	T1820004	Trapidil impurity B	1	20 mg	1	1,2,4-triazol-3-amine	1576	Yes	+5°C ± 3°C
	Y0001172	Trehalose dihydrate	1	250 mg	1	See leaflet CŒœHœœOŒŒ,2HœO	2297	Yes	+5°C ± 3°C
	T1850000	Tretinoin	2	50 mg	1		0693,1019,1 385	Yes	+5°C ± 3°C
	G0400010	Triacetin - reference spectrum	1	n/a	1		1106
	T1899990	Triamcinolone	2	150 mg	1		1376	Yes	+5°C ± 3°C
	Y0000050	Triamcinolone impurity C	1	10 mg	1	9-fluoro-11β,16α,17,21-tetrahydroxypregn-4-ene-3,20-dione (pretriamcinolone)	1376	Yes	+5°C ± 3°C
	T1900000	Triamcinolone acetonide	6	150 mg	1	See leaflet Cœ÷H–ŒFOÿ	0533,0867,1 075	Yes	+5°C ± 3°C
	Y0001459	Triamcinolone acetonide for system suitability	1	10 mg	1		0533	Yes	+5°C ± 3°C
	T1950000	Triamcinolone hexacetonide	3	100 mg	1	See leaflet C–ÐH÷ŒFOŸ ; Batch 2 is valid until 31 December 2016	0533.0867	Yes	+5°C ± 3°C
	Y0000837	Triamterene	1	10 mg	1		0058	Yes	+5°C ± 3°C
	Y0000870	Triamterene impurity B	1	0.5 mg	1	2,7-diamino-6-phenylpteridin-4-ol	0058	Yes	+5°C ± 3°C
	T1975000	Triazolam - * psy	1	10 mg	1		1065	Yes	+5°C ± 3°C
	Y0000165	Tribenoside	3	150 mg	1	See leaflet	1740	Yes	-20°C ± 5°C
	Y0000166	Tribenoside impurity A	4	70 mg	1	See leaflet C–ÐH–÷Oÿ; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-α-d- glucofuranose	1740	Yes	-20°C ± 5°C
	Y0001628	Tribenoside impurity D	1	35 mg	1	Benzyl ether	1740		+5°C ± 3°C
	Y0001055	Tributyl acetylcitrate	2	1 mL	1		1770	Yes	+5°C ± 3°C
	Y0000799	Tributyl acetylcitrate for peak identification	1	25 mg	1		1770	Yes	+5°C ± 3°C
	T1977990	Tricaprin	2	150 mg	1	Batch 1 is valid until 31 May 2017	1410	Yes	-20°C ± 5°C
	T1977995	Tricaproin	1	40 mg	1		1410	Yes	-20°C ± 5°C
	T1978000	Tricaprylin	1	225 mg	1		1410	Yes	-20°C ± 5°C
	Y0000111	Trichloroacetic acid - reference spectrum	1	n/a	1		1967
	T1985000	Trichlorotrifluoroethane	1	2.5 ml	1		0393	Yes	+5°C ± 3°C
	Y0001737	Triclabendazole	1	10 mg	1		2609	Yes	+5°C ± 3°C
	Y0001723	Triclabendazole for system suitability	1	0.012 mg	1		2609	Yes	+5°C ± 3°C
	T1986000	Triethyl citrate - reference spectrum	1	n/a	1		1479
	T2000000	Trifluoperazine hydrochloride	1	100 mg	1		0059	Yes	+5°C ± 3°C
	T2005000	Triflusal	1	50 mg	1		1377	Yes	+5°C ± 3°C
	T2005010	Triflusal impurity B	1	15 mg	1	2-hydroxy-4-(trifluoromethyl)benzoic acid (4-(trifluoromethyl)salicylic acid)	1377	Yes	+5°C ± 3°C
	Y0000720	Triglycerol diisostearate	1	200 mg	1		2032	Yes	+5°C ± 3°C
	Y0000108	Trihexyphenidyl hydrochloride	1	100 mg	1		1626	Yes	+5°C ± 3°C
	Y0000068	Trihexyphenidyl impurity A	1	20 mg	1	1-phenyl-3-(piperidin-1-yl)propan-1-one	1626	Yes	+5°C ± 3°C
	T2009000	Trilaurin	3	1250 mg	1		1410	Yes	-20°C ± 5°C
	Y0001319	Trimebutine maleate	1	10 mg	1		2182	Yes	+5°C ± 3°C
	Y0001260	Trimebutine for system suitability	2	1.02 mg	1		2182	Yes	+5°C ± 3°C
	Y0000092	Trimetazidine dihydrochloride - reference spectrum	1	n/a	1		1741
	Y0000093	Trimetazidine for system suitability	3	50 mg	1		1741	Yes	+5°C ± 3°C
	T2100000	Trimethadione	1	250 mg	1	See leaflet CÿH„NO–	0440	Yes	+5°C ± 3°C
	T2200000	Trimethoprim	1	50 mg	1		0060	Yes	+5°C ± 3°C
	T2200010	Trimethoprim impurity B	5	15 mg	1	(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone	0060	Yes	+5°C ± 3°C
	Y0000684	Trimethoprim for system suitability	4	0.00075 mg	1	Batch 3 is valid until 30 November 2016	0060	Yes	+5°C ± 3°C
	Y0001497	3-trimethylsilyl-1-propanesulfonic acid sodium salt	2	120 mg	1	See leaflet CÿHŒ—O–SSi,Na	2645, 2165	Yes	+5°C ± 3°C
	T2450000	Trimethyltetradecylammonium bromide	2	200 mg	1		0378	Yes	+5°C ± 3°C
	T2500000	Trimipramine maleate	1	100 mg	1		0534	Yes	+5°C ± 3°C
	Y0000759	Trimipramine for peak identification	1	0.51 mg	1		0534	Yes	+5°C ± 3°C
	T2500100	Trimyristin	2	500 mg	1		1410	Yes	-20°C ± 5°C
	Y0000279	Tri-n-butyl phosphate	1	300 µl	1		1682	Yes	+5°C ± 3°C
New	Y0001113	Triolein	2	30 mg	1	See leaflet C—ŸHŒÐ÷Oÿ	2454	Yes	-20°C ± 5°C
	T2501200	Tristearin	1	100 mg	1		1410	Yes	-20°C ± 5°C
	T2545000	Trolamine	3	2250 mg	1		1577	Yes	+5°C ± 3°C
	Y0001184	Trolamine impurity A	2	250 mg	1	2-aminoethanol (ethanolamine) ; Batch 1 is valid until 30 June 2016	1577	Yes	+5°C ± 3°C
	Y0001183	Trolamine impurity B	3	1.5 mL	1	2,2′-iminodiethanol (diethanolamine) ; Batch 1 is valid until 31 August 2016	1577	Yes	+5°C ± 3°C
	T2550000	Trometamol	4	100 mg	1	Batch 3 is valid until 31 January 2017	1053	Yes	+5°C ± 3°C
	T2580000	Tropicamide	2	50 mg	1		1159.1197	Yes	+5°C ± 3°C
	Y0001247	Tropicamide impurity C	1	10 mg	1	(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)	1159	Yes	+5°C ± 3°C
	Y0001248	Tropicamide impurity D (Phenylacetic acid - * Drug Precursor)	1	10 mg	1	Phenylacetic acid	1159	Yes	+5°C ± 3°C
	Y0001316	Tropicamide for peak identification	1	10 mg	1		1159	Yes	+5°C ± 3°C
	T2580300	Tropine	1	50 mg	1		1308, 2102	Yes	+5°C ± 3°C
	Y0000616	Tropisetron hydrochloride	1	40 mg	1		2102	Yes	+5°C ± 3°C
	Y0000618	Tropisetron impurity B	1	10 mg	1	1H-indole-3-carboxylic acid	2102	Yes	+5°C ± 3°C
	Y0000429	Trospium chloride	1	10 mg	1		1798	Yes	+5°C ± 3°C
	Y0000432	Trospium impurity A	1	20 mg	1	hydroxydiphenylacetic acid (benzilic acid)	1798	Yes	+5°C ± 3°C
	Y0000431	Trospium impurity B	2	20 mg	1	(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate	1798	Yes	+5°C ± 3°C
	Y0000430	Trospium impurity C	3	5 mg	1	(1R,3R,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]	1798	Yes	+5°C ± 3°C
	Y0000497	Troxerutin	1	30 mg	1		2133	Yes	+5°C ± 3°C
	T2600000	Trypsin BRP	2	100 mg	1	See leaflet	0476,0579,0 580, 0694	Yes	+5°C ± 3°C
	T2610000	Tryptophan	2	100 mg	1	See leaflet	1272, 2290	Yes	+5°C ± 3°C
	T2880000	Tylosin	2	150 mg	1	see leaflet	1273,1274,1 661, 20702	Yes	+5°C ± 3°C
	T2880100	Tylosin D	2	5 mg	1		1273,1274,1 661	Yes	+5°C ± 3°C
	T2880200	Tylosin tartrate - reference spectrum	1	n/a	1		1274
	Y0000498	Tylosin phosphate for peak identification	1	10 mg	1		1273,1274,1 661	Yes	+5°C ± 3°C
	T2900000	Tyrosine	2	50 mg	1		1161, 1384	Yes	+5°C ± 3°C
	T3000000	Tyrothricin	2	20 mg	1		0907.1662	Yes	+5°C ± 3°C
	U0020000	Ubidecarenone	3	70 mg	1	See leaflet C—„H„ÐO÷ ; Batch 2 is valid until 30 June 2016	1578	Yes	+5°C ± 3°C
	U0020008	Ubidecarenone impurity D	2	5 mg	1	5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35- nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4- dione (ubiquinone-9)	1578	Yes	+5°C ± 3°C
	Y0001861	Uncaria stem with hooks dry extract for system suitabilit	1	10 mg	1		2729	Yes	-20°C ± 5°C
	U0020001	Ubidecarenone for system suitability	3	1 mg	1		1578	Yes	+5°C ± 3°C
	U0100000	Uracil arabinoside	2	60 mg	1		0760	Yes	+5°C ± 3°C
	U0600000	Urea	2	100 mg	1		0743	Yes	+5°C ± 3°C
	U0800000	Ursodeoxycholic acid	3	100 mg	1	Batch 2 is valid until 30 June 2017	1189.1275	Yes	+5°C ± 3°C
	Y0001163	Ursodeoxycholic acid for system suitability	3	1.26 mg	1	Batch 2 is valid until 31 October 2016	1275	Yes	+5°C ± 3°C
	Y0001523	Ursolic acid	1	25 mg	1	See leaflet C–ÐH÷‡O–	2439	Yes	+5°C ± 3°C
	Y0000834	Valaciclovir hydrochloride (anhydrous)	1	100 mg	1	See leaflet CŒ–HœŒNÿO÷Cl	1768.2751	Yes	+5°C ± 3°C
	Y0001096	Valaciclovir impurity D	1	10 mg	1	2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-l-valinate	1768	Yes	+5°C ± 3°C
	Y0001097	Valaciclovir impurity E	1	10 mg	1	2-[(2-amino-6-oxo-1,6 dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy) carbonyl]-L-valinate	1768	Yes	+5°C ± 3°C
	Y0001098	Valaciclovir impurity F para-toluenesulfonate	1	12 mg	1	2-hydroxyethyl L-valinate	1768	Yes	+5°C ± 3°C
	Y0001099	Valaciclovir impurity G	1	10 mg	1	N,N-dimethylpyridin-4-amine	1768.2751	Yes	+5°C ± 3°C
	Y0001662	Valaciclovir impurity P	1	5 mg	1	2,2′-[methylenebis[imino(6-oxo-1,6-dihydro-9H-purine-9,2-diyl) methyleneoxy]]diethyl di(l-valinate)	2751	Yes	-20°C ± 5°C
	Y0001655	Valaciclovir impurity S	1	15 mg	1		2751	Yes	+5°C ± 3°C
	Y0001225	Valaciclovir for system suitability	1	10 mg	1		1768.2751	Yes	+5°C ± 3°C
	Y0000583	Valerian dry extract	3	400 mg	1	See leaflet	0453,1898,1 899,2400,25	Yes	-20°C ± 5°C
	V0030000	Valine	1	50 mg	1		0796	Yes	+5°C ± 3°C
	Y0000584	Valnemulin hydrochloride	1	10 mg	1		2137	Yes	+5°C ± 3°C
	Y0000586	Valnemulin impurity E	1	10 mg	1	(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1- oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin)	2137	Yes	+5°C ± 3°C
	Y0000585	Valnemulin for peak identification	1	10.25 mg	1		2137	Yes	+5°C ± 3°C
	Y0000533	Valnemulin hydrogen tartrate	1	120 mg	1	See leaflet C–—H—‡NœOŒŒS	2137	Yes	+5°C ± 3°C
	V0033000	Valproic acid	3	100 mg	1		1378	Yes	+5°C ± 3°C
	Y0001422	Valproic acid for system suitability	3	10 mg	1	Batch 2 is valid until 30 November 2016	0678.1378	Yes	+5°C ± 3°C
	Y0001132	Valsartan	1	15 mg	1		2423	Yes	+5°C ± 3°C
	Y0001131	Valsartan for peak identification	2	10 mg	1		2423	Yes	+5°C ± 3°C
	Y0001145	Valsartan for system suitability	2	0.202 mg	1		2423	Yes	+5°C ± 3°C
	V0045000	Vancomycin hydrochloride	3	100 mg	1	See leaflet	1058.20702	Yes	-20°C ± 5°C
	V0050000	Vanillin	2	100 mg	1	Batch 1 is valid until 30 November 2016	0747	Yes	+5°C ± 3°C
	Y0001648	Vardenafil for system suitability	1	10 mg	1		2782	Yes	+5°C ± 3°C
	Y0001647	Vardenafil hydrochloride	1	120 mg	1	See leaflet	2782	Yes	+5°C ± 3°C
	Y0001198	Varicella vaccine ( live)	1	420 mg	1	See leaflet	0648, 2442	Yes	-20°C ± 5°C
	Y0000561	Vecuronium bromide	1	10 mg	1		1769	Yes	+5°C ± 3°C
	Y0001862	Vecuronium for system suitability system suitability CRS	1	15 mg	1		1769	Yes	+5°C ± 3°C
	Y0001093	Vedaprofen	1	5 mg	1		2248	Yes	+5°C ± 3°C
	Y0001118	Vedaprofen impurity mixture	1	0.006 mg	1		2248	Yes	+5°C ± 3°C
	Y0000587	Venlaine hydrochloride	2	50 mg	1		2119	Yes	+5°C ± 3°C
	Y0000588	Venlaine for system suitability	3	1.002 mg	1		2119	Yes	+5°C ± 3°C
	V0100000	Verapamil hydrochloride	1	100 mg	1		0573	Yes	+5°C ± 3°C
	V0100018	Verapamil impurity I	3	5 mg	1	(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl] (methyl)amino]ethyl]-3-methylbutanenitrile	0573	Yes	+5°C ± 3°C
	V0100026	Verapamil impurity M	2	10 mg	1	5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1- methylethyl)pentanenitrile]	0573	Yes	+5°C ± 3°C
	Y0000661	Verbenalin	1	11 mg	1	See leaflet CŒŸHœ÷OŒÐ	1854	Yes	+5°C ± 3°C
	V0180000	VERO cells	1	1 ml	2	Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of live measles, mumps and rubella vaccines	0213,0538,1 057	Yes	Liquid nitrogen
	Y0001400	Vigabatrin	1	10 mg	1		2305	Yes	+5°C ± 3°C
	Y0001401	Vigabatrin impurity A	1	25 mg	1	See leaflet CÿH„NO; (5RS)-5-ethenylpyrrolidin-2-one	2305	Yes	-20°C ± 5°C
	Y0001402	Vigabatrin impurity B	1	20 mg	1	(2E)-2-(2-aminoethyl)but-2-enoic acid	2305	Yes	+5°C ± 3°C
	Y0001404	Vigabatrin impurity D	1	50 mg	1	4-aminobutanoic acid	2305	Yes	+5°C ± 3°C
	Y0001403	Vigabatrin impurity E	1	10 mg	1	2-[(2RS)-2-aminobut-3-enyl]propanedioic acid	2305	Yes	+5°C ± 3°C
	V0300000	Vinblastine sulfate	4	5.01 mg	1	See leaflet C÷ÿHÿÐN÷OŒ–S	0748.0749	Yes	-80°C ± 10°C
	V0305000	Vinblastine sulfate - reference spectrum	1	n/a	1		0748
	V0400000	Vincristine sulfate	5	4.96 mg	1	see leaflet	0748.0749	Yes	-80°C ± 10°C
	V0405000	Vincristine sulfate - reference spectrum	1	n/a	1		0749
	V0500000	Vindesine sulfate	3	5 mg	1	See leaflet C÷–H—ŸN—OŒŒS	1276	Yes	-80°C ± 10°C
	V0500010	Vindesine sulfate - reference spectrum	1	n/a	1		1276
	Y0000463	Vinorelbine tartrate	3	50 mg	1		2107	Yes	-80°C ± 10°C
	Y0000464	Vinorelbine impurity B	4	7 mg	1	methyl (3aR,4R,5S,5aR,10bR,13aR)-3a-ethyl-9-[(6R,8S)-4-ethyl-8- (methoxycarbonyl)1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino [4,3-b]indol-8-yl]-4,5-dihydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a- octahydro-1Hindolizino[8,1-cd]carbazole-5-carboxylate	2107	Yes	-80°C ± 10°C
	Y0000589	Vinpocetine	1	10 mg	1		2139	Yes	+5°C ± 3°C
	Y0000590	Vinpocetine impurity A	2	15 mg	1	ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b- octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate (ethyl vincaminate) ; Batch 1 is valid until 31 January 2017	2139	Yes	+5°C ± 3°C
	Y0000591	Vinpocetine impurity B	2	10 mg	1	methyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1- de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine) ; Batch 1 is valid until 31 January 2017	2139	Yes	+5°C ± 3°C
	Y0000790	Vinpocetine impurity C	2	15 mg	1	ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H- indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine)	2139	Yes	+5°C ± 3°C
	Y0000760	Vinpocetine impurity D	2	10 mg	1	ethyl (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H- indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine) ; Batch 1 is valid until 28 February 2017	2139	Yes	+5°C ± 3°C
	Y0000793	Vinyl acetate	1	200 mg	1		2152.2523	Yes	+5°C ± 3°C
	Y0001395	Voriconazole	2	120 mg	1	See leaflet CŒÿHŒ÷F–N—O	2576	Yes	+5°C ± 3°C
	Y0001396	Voriconazole impurity B	2	10 mg	1	(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol ; Batch 1 is valid until 31 December 2016	2576	Yes	+5°C ± 3°C
	Y0001398	Voriconazole impurity D	2	10 mg	1	(2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4- triazol-1-yl)butan-2-ol (voriconazole enantiomer)	2576	Yes	+5°C ± 3°C
	Y0001397	Voriconazole impurity E	1	50 mg	1	[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid ((+-)-camphorsulfonic acid)	2576	Yes	+5°C ± 3°C
	W0100000	Warfarin sodium	2	10 mg	1		0698	Yes	+5°C ± 3°C
	Y0000778	Warfarin sodium clathrate	1	10 mg	1		0699	Yes	+5°C ± 3°C
	Y0001599	Wedelolactone	1	15 mg	1	See leaflet	2564	Yes	-20°C ± 5°C
	X0075000	Xylazine hydrochloride	1	125 mg	1		1481	Yes	+5°C ± 3°C
	Y0000158	Xylazine impurity C	3	50 mg	1	2,6-dimethylphenyl isothiocyanate ; Batch 2 is valid until 28 February 2017	1481	Yes	+5°C ± 3°C
	Y0001224	Xylazine impurity mixture	1	0.02 mg	1		1481	Yes	+5°C ± 3°C
	X0080000	Xylitol	2	500 mg	1	See leaflet	1381	Yes	+5°C ± 3°C
	X0100000	Xylometazoline hydrochloride	3	100 mg	1		0972.1162	Yes	+5°C ± 3°C
	X0101000	Xylometazoline impurity A	3	15 mg	1	N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide ; Batch 2 is valid until 30 June 2017	1162	Yes	+5°C ± 3°C
	X0200000	Xylose	1	100 mg	1		1278	Yes	+5°C ± 3°C
	Y0000656	Yohimbine hydrochloride	1	20 mg	1	See leaflet CœŒHœŸClNœO–	2172	Yes	+5°C ± 3°C
	Y0001715	Zanamivir hydrate	1	5 mg	1		2611	Yes	+5°C ± 3°C
	Y0001703	Zanamivir impurity F	1	10 mg	1	see leaflet C÷HŸClN÷; 1H-pyrazole-1-carboximidamide	2611	Yes	+5°C ± 3°C
	Y0001702	Zanamivir for assay	1	50 mg	1	see leaflet CŒœHœÐN÷OŸ	2611	Yes	+5°C ± 3°C
	Y0001708	Zanamivir for system suitability	1	10 mg	1		2611	Yes	+5°C ± 3°C
	Z1900000	Zidovudine	3	60 mg	1	see leaflet	1059	Yes	+5°C ± 3°C
	Z1904000	Zidovudine impurity B	3	5 mg	1	1-(3-chloro-2,3-dideoxy-β-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4 (1H,3H)-dione	1059	Yes	+5°C ± 3°C
	Y0001654	Zidovudine impurity D	1	15 mg	1	Triphenylmethanol	1059	Yes	+5°C ± 3°C
	Y0001641	Zidovudine for system suitability	1	10 mg	1		1059	Yes	+5°C ± 3°C
	Y0001807	Pregabalin impurity B	1	5 mg	1	(3R)-3-(aminomethyl)-5-methylhexanoic acid (pregabalin enantiomer)	2777	Yes	+5°C ± 3°C
	Z2000000	Zinc acexamate	1	50 mg	1		1279	Yes	+5°C ± 3°C
	Z2000010	Zinc acexamate impurity A	1	50 mg	1	6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid	1279	Yes	+5°C ± 3°C
	Y0001286	Ziprasidone hydrochloride monohydrate	1	100 mg	1	see leaflet CœŒHœœClœN÷OS	2421.2649	Yes	+5°C ± 3°C
	Y0001626	Ziprasidone mesilate trihydrate	1	30 mg	1		2649	Yes	+5°C ± 3°C
	Y0001272	Ziprasidone for system suitability 1	1	10 mg	1		2421, 2649	Yes	+5°C ± 3°C
	Y0001241	Ziprasidone for system suitability 2	1	0.465 mg	1		2421, 2649	Yes	+5°C ± 3°C
	Z2500000	Zolpidem tartrate - * psy	3	200 mg	1		1280	Yes	+5°C ± 3°C
	Z2500010	Zolpidem impurity A	4	10 mg	1	N,N-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl] acetamide	1280	Yes	+5°C ± 3°C
	Z3000000	Zopiclone -* psy	2	40 mg	1		1060	Yes	+5°C ± 3°C
	Y0001822	Zopiclone Impurity B	1	10 mg	1	(7RS)-6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b] pyrazin-5-one	1060	Yes	+5°C ± 3°C
	Z3001000	Zopiclone oxide	3	20 mg	1		1060	Yes	+5°C ± 3°C
	Y0000062	Zuclopenthixol decanoate - reference spectrum	1	n/a	1		1707
	Y0000083	Zuclopenthixol impurity B	1	10 mg	1	2-chloro-9H-thioxanthen-9-one	1707	Yes	+5°C ± 3°C
	Y0000534	Zuclopenthixol for system suitability	1	0.26 mg	1		1707	Yes	+5°C ± 3°C
New	Y0001925	Betamethasone dipropionate for system suitability A	1	10 mg	1		0809	Yes	+5°C ± 3°C
	Y0001843	Triamcinolone Hexacetonide for system suitability	1	10 mg	1		0867	Yes	+5°C ± 3°C

產(chǎn)品咨詢

留言框

產(chǎn)品：
您的單位：
您的姓名：
聯(lián)系電話：
常用郵箱：
省份：
詳細(xì)地址：
補充說明：
驗證碼：

請輸入計算結(jié)果（填寫阿拉伯?dāng)?shù)字），如：三加四=7

上一篇：USP美國藥典標(biāo)準(zhǔn)品
下一篇：重金屬標(biāo)準(zhǔn)品

欧美特黄特色大片在线观看,亚洲Av无码精品色午夜蜜芽,六月婷婷最新中文字幕网站,国产电影精品久久久久

EP歐洲藥典標(biāo)準(zhǔn)品

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補充說明：

驗證碼：